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I - Summary 
 
 
Cytotoxic lymphocytes are comprised of natural killer (NK) cells, specific to innate immunity, and 
cytotoxic T lymphocytes (CTLs) which man the adaptive immune response. These two cell types 
come equipped with an arsenal of cytotoxic granule-enzymes named granzymes (Gzms). Although NK 
cells and CTLs mediate the elimination of diseased cells in a number of different fashions, e.g. by FAS 
ligand or TNFα induced receptor-mediated cytotoxicity, the principal cytotoxic mechanism, known as 
the granule exocytosis pathway, delivers granzymes into the target cell cytosol, in a receptor 
independent manner, via the membrane perturbing perforin (PFN) of cytotoxic granules.  
  
The human granzyme family is comprised of five members. Of these five, only two, namely granzyme 
A (GzmA) and granzyme B (GzmB), have received ample attention and are confirmed as being 
strongly apoptogenic. Of the remaining three, very little is known and, consequently, the trio has been 
labelled “orphan granzymes”. Recently however, advances in the field have confirmed that granzyme 
K (GzmK) and granzyme M (GzmM) are cytotoxic. Our granzyme of interest is granzyme H (GzmH). 
No functional studies have, until now, been performed on the protease and a physiological substrate 
remains to be found, leaving the question open as to whether the protease is indeed cytotoxic. 
Additionally, the importance of GzmH is underscored by the fact that structural equivalents are only 
present in placental mammals. In rodents, multiple copies derived from a common GzmH ancestral 
precursor do exist, but none of these granzymes can be regarded as a functional equivalent of human 
GzmH. To accomplish the goals of this thesis, we set out to develop a procedure to produce 
recombinant GzmH. Our method utilized inclusion body material from Escherichia coli (E. coli) as the 
starting material for in vitro refolding, a technique which successfully allowed us to purify 
catalytically active recombinant GzmH, along with its inactive variant, in large quantities and in 
highly pure form.    
 
Several studies have recently shown GzmH to be constitutively and highly expressed in human NK 
cells and to possess chymotrypsin-like (chymase) enzymatic activity. In this work, we show for the 
first time that GzmH efficiently kills cells after entry into the targeted cytosol. Using PFN, but more 
specifically its bacterial counterpart streptolysin O (SLO), as translocators of granzymes across the 
target cell plasma membrane, GzmH-induced cell death was characterized by apoptotic morphology 
such as increased granularity, condensed nuclei, membrane irregularities and phosphatidyl serine 
externalization. Additional hallmarks, such as mitochondrial depolarization, ROS generation and DNA 
degradation also defined cell death mediated by this chymotrypsin-like protease. Contrary to GzmB, 
however, cell death by GzmH did not involve the activation of the executioner caspases, the cleavage 
of Bid or ICAD, or the release of cytochrome c. During this study, we also verified the expression of 
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GzmH in various leukocyte populations while attempting to prove that the granule protease is indeed 
released upon cytotoxic attack into the immunological synapse. As previously reported, we confirm 
that GzmH is constitutively expressed in NK cells and demonstrate, in a strictly controlled manner, 
that following target cell attack, GzmH can be detected in the medium supernatant by immunoblotting.  
 
In summary, our data demonstrate that GzmH is a functional cell-death-inducing protease of killer cell 
granules and its high expression in NK cells and release during target cell killing suggest a pivotal role 
for the granzyme in innate immunity. In addition, in recent collaborative work, headed by Felipe 
Andrade, we also demonstrated that GzmB and GzmH have anti-adenoviral activity. Excitingly, the 
study reveals that both granzymes work in synergy to outsmart viral defense mechanisms. Indeed, in 
the event of GzmB inhibition GzmH, is not only able to cleave a common vital viral protein, but, 
interestingly, can also free GzmB from inhibition. It seems, too, that on top of their abilities to mediate 
cell death, granzymes have also acquired alternative strategies to overcome viral infection.  
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II - Introduction 
 
 
II.1 - Granzymes 
 
 
Definition 
In 1986, while attempting to understand the mechanisms by which cytotoxic lymphocytes achieve 
target cell lysis, a group from the University of Lausanne in Switzerland, lead by Jürg Tschopp, first 
employed the term Granzyme (Gzm) to describe the expanding family of Granule-associated Enzymes 
found uniquely within these cells (Masson et al., 1986). 
 
Granzymes are chymotrypsin (CHT)-like serine proteases expressed in the secretary granules of CTLs 
and NK cells. Upon the encounter of diseased cells, granyzmes are released by exocytosis, along with 
other granular proteins, into the immunological synapse where they are subsequently taken up into 
rogue cells via the actions of the pore forming protein perforin (PFN). Once in the target cell cytosol, 
granyzmes proteolytically cleave a variety of death substrates that, in turn, lead to eventual cell 
suicide. 
 
 
 
II.1.1 - Human and mouse granyzmes: genetic organization 
 
 
Nomenclature 
Granzymes are a highly conserved set of serine proteases that are present in all placental mammals. 
Mice and humans are the most studied species accounting for fourteen members between them, mice 
possessing a present tally of ten members, while humans have five. Interspecies comparisons between 
the present mouse and human granzyme cDNA reveal that certain members have near identical 
nucleotide sequences and, as homologues, should thus share the same alphabetic nomenclature. The 
human and mouse granzyme homologues are granyzmes A, B, K and M. The remaining mouse 
members include granyzmes C, D, E, F, G and N whereas solely granzyme H (GzmH) remains to 
complete the human family. Coincidently, the above group of mouse granyzmes is linked to GzmH in 
that they are also referred to as “orphan” granyzmes.  
 
Chromosome locations: family clusters and enzyme activities   
The human and mouse granzyme genes are situated on three separate chromosomes where they are 
contained within separate clusters named after GzmA, GzmB and GzmM respectively. The GzmA 
cluster, found on chromosome 5 in humans and on chromosome 13 in mice, harbours GzmA and 
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GzmK. Both proteases are tryptases indicating their preference to cleave after basic residues such as 
arginine and lysine. In both species, the second cluster is located on chromosome 14 and is named 
after the most studied of all granzymes, GzmB. In this tightly linked gene cluster, the GzmB gene is 
linked with the cathepsin G (CG) and mast cell chymase genes, the only difference between men and 
mice being the presence of the mouse granyzme genes C, D, E, F, G and N in-between GzmB and CG, 
whereas in humans only GZMH occupies this space. GzmB cleaves caspase 8-like specific sequences 
after acidic residues. In contrast, GzmH, like mast cell chymase and CG, has chymotrypsin-like 
activity with a preference for hydrophobic, aromatic amino acid residues (Phe or Tyr) at the P1 site 
(Edwards et al., 1999). The proteolytic activities of the mouse orphan granzymes remain unknown. 
The GzmM gene cluster is the third, and last, granzyme locus, the human granzyme residing on 
chromosome 19 and the mouse counterpart on chromosome 10. Granzyme M is a metase and prefers 
to cleave after residues with long, uncharged side chains such as methionine and leucine (Kelly et al., 
2004; Smyth et al., 1993). In humans, GzmM is linked to the neutrophile elastase (NE) gene cluster 
that contains genes such as proteinase 3 (PR3). NE and PR3 are also granular serine proteases that 
once released from neutrophiles are reported to participate in microbial removal and neutrophile 
migration through the extracellular matrix at sites of inflammation (Jenne, 1994; Pham et al., 1996; 
Sugawara, 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure II.1 - Human and mouse granzyme gene clusters. Closed boxes represent both exons and introns, and 
are drawn to scale. Arrows indicate the direction of transcription within the loci. Abbreviations are described as 
follows: Ψ, pseudogene; AZU1, azurocidin; CMA1, mast cell chymase 1; DF, D component of 
complement/adipsin; ELA2, mouse elastase 2; ELA2, human neutrophile elastase; h, human; m, mouse; MMCP-
8, mouse mast cell protease 8; PR3, proteinase 3. Taken from “The orphan granzymes of humans and mice” 
Current  Opinions in Immunology (Grossman et al., 2003). 
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GzmB, GzmH and mouse homologues 
It is the GzmB cluster, on chromosome 14, which is home to our gene of interest, namely GZMH. 
GZMH is neighbour to GZMB, lying just downstream. Moreover, the two proteases share the highest 
structural homology (71% amino acid identity) in the human granzyme family and cDNA comparisons 
between the members of the mouse GzmB gene cluster, reveal that the mouse GzmB is also most 
closely related to its immediate down stream partner, namely GzmC. Despite the high sequence 
homologies between the human and mouse GzmB and their respective downstream neighbours, both 
enzyme pairs display very distinct enzymatic activities. As described previously, in both humans and 
mice, GzmB is an aspase cutting after aspartate residues whereas GzmH is a chymotrypsin-like 
proteinase. Although the enzymatic activity of GzmC still remains to be determined, a functional study 
has recently demonstrated that the granzyme is distinct from mouse GzmB in that it is capable of 
inducing cell death in a caspase-independent manor (Johnson et al., 2003). It has been proposed that 
GzmC is the mouse homologue of GZMH. Recently, molecular modelling has predicted GzmC to 
cleave after asparagine, or serine, at the P1 position, while GzmD through to G are said to prefer 
leucine, or more interestingly phenylalanine, as is the case for GzmH (Grossman et al., 2003; Trapani, 
2001). At present, however, none of these related mouse genes can, as yet, be regarded as functional 
GzmH homologue. 
 
 
 
II.1.2 - Granzyme synthesis of storage 
 
 
Proteolytic processing in three-steps 
Granyzmes are synthesized in the endoplasmic reticulum (ER) as pre-pro-enzymes and finally reach 
the status of “active-granular-enzyme” after a three-step conversion process. The signal-peptide, or 
pre-sequence, is 18 to 24 residues long and is required for the compartmentalization of the nascent 
granzyme into the ER, following translation. The propeptide, in turn, then ensures that the protease 
remains inactive during its transport through the ER and Golgi network, thus preventing inappropriate 
or premature degradation of substrates. 
 
Like other serine proteases of hematopoietic-cell secretory granules, such as the previously mentioned 
CG, NE and PR3, granzymes are synthesized as zymogens that must be converted to their mature form 
by intracellular proteolysis. The propeptide consists of very short dipeptides (usually Gly-Glu or Glu-
Glu) and is processed by the broadly reactive lysosomal enzyme dipeptidyl peptidase I (DPPI), an 
exopeptidase otherwise known as cathepsin C (Kummer et al., 1993; McGuire et al., 1993) (refer to 
Figure IV.5 page 65 and for a detailed description of cathepsin c to material and methods page 40). 
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With the exception of GzmM, which carries a hexapeptide, the remaining granzymes all possess 
dipeptide pro-sequences. Once the propeptide is removed, the granzyme, its N-terminus now starting 
with the highly conserved sequence Ile-Ile-Gly-Gly (refer to appendix), will finally acquire an active 
and mature status by undergoing conformational change. Indeed, the catalytic domains of granzymes 
harbour flexible stretches that only achieve functional conformation by cleavage of the propeptide. 
 
The importance of the amino-terminal propeptide cleavage event has been illustrated experimentally 
by expressing recombinant GzmB either with or without the amino-terminal dipeptide (Caputo et al., 
1993). Furthermore, it has been shown that CTL effector function is impaired in response to inhibition 
of dipeptidyl peptidase I activity (Thiele et al., 1997). On the contrary though, a study on the cellular 
consequences of cathepsin C deficiency found in the human Papillon-Lefevre syndrome surprisingly 
reports that the absence of DPPI is not essential for the activation of GzmA and GzmB, although it is 
required for the optimal activation and stability of these proteases. The deficiency is also associated 
with the severe reduction in the activity of the neutrophile-derived serine proteases CG, NE and PR3 
(Pham et al., 2004).     
 
Finally, a third, not so well characterized cleavage event has been reported to take place in the 
processing of the azurophilic granule enzyme neutrophile elastase (NE). In addition to pre-pro 
sequences, NE also contains a protolytically processed 19-residue C-terminal extension which is 
reported not to be required for proteolytic activity and granule localization (Benson et al., 2003; 
Matsumoto et al., 1995). However, it has recently been shown that some diseases stem from the 
inability to remove the NE C-terminal extension, thus preventing its interaction with AP3, a trafficking 
protein, resulting in the misdirection of the protease to membranes, and not granules, the default 
destination for cargo proteins in the absence of AP3 (Horwitz et al., 2004). The later event has not 
been reported to take place in granyzme processing. 
 
From zymogen to active serine protease, an example: Chymotrypsin  
The chymotrypsin-like proteases are the most abundant proteases in nature and are unique in that their 
catalytic domain exhibits allosteric properties, the "activation domain" oscillating between a more 
loosely folded "inactive" and a compact "active" conformation (Branden and Tooze 1991). Let us take 
the example of chymotrypsin. Removal of the propeptide sequence is, in this case, managed by trypsin 
or enterokinase cleavage of the Arg15-Ile16 peptide bond (chymotrypsin numbering), thus resulting in 
a new N-terminus starting with residue Ile16. Ile16 then proceeds to form a salt bridge with the 
carboxylate side chain of Asp194, thereby, initiating the formation of the mature, active protease 
through conformational change. These conformational changes occur in the segment lying between 
Ser189 and Asp194. As mentioned above, metaphorically, the segment resembles a loop pointing 
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inwards in the zymogen, but following conversion, then changes to point outwards, towards the 
solvent, thus forming a reconstructed activation domain which houses a substrate recognition site, 
oxyanion hole and S1 specificity pocket. Processing and conformational change result in a mature, 
active chymotrypsin, its N-terminus now protected from any further attack from exopeptidases such as 
enterokinase and cathepsin C.  
 
Secretory granules store subdued active granzymes 
Following their synthesis and initial processing in the lumen of the ER and Golgi apparatus, 
granzymes are sent to cytotoxic granules in which they are packaged together with other granule 
components (Matsumoto et al., 1995). The location of the final processing event, leading to full 
protease maturation is not yet known. Inhibition of zymogen activation though suggests that secretory 
proteases only become fully mature in post-Golgi organelles (Benson et al., 2003; Matsumoto et al., 
1995; Rao et al., 1996). Indeed, preventing the premature activation of proteases, such as the 
granzymes, until they reach secretory granules, can only be advantageous to the host cell. To ensure 
that secretory zymogens arrive at their intended destination they are subject to glycosylation. The 
added sugars, which include mannose-6-phosphate residues, are important for targeting proteases, 
such as GzmA and GzmB, to cytolytic granules although other targeting mechanisms are likely to 
exist (Griffiths and Isaaz, 1993). Indeed, both GzmK and mouse GzmC, which lack consensus 
sequences for N-glycosylation, are transported via different mechanisms. Once installed, the mature 
granzymes (overall positively charged) are kept inactive by sitting tightly packed, in favourable ionic 
conditions, to chondroitin sulfate proteoglycans (negatively charged) in an acidic environment of pH 
5.5 (Masson et al., 1990). Whether or not the granzyme-proteoglycan attachment is retained upon 
cytotoxic stimulation and granule-content release into the immunological synapse remains unclear. 
However, Spaeny-Dekking et al. in 2000 demonstrated that in patients with various viral diseases and 
rheumatoid arthritis, GzmA was found at elevated levels and that a certain percentage of GzmA was 
still found complexed to proteoglycans. It is postulated that this interaction might protect the protease 
against plasma inhibitors. Furthermore, the results support the notion that granzymes may exert 
extracellular functions distant from the site of CTL or NK cell interaction with their target cells 
(Spaeny-Dekking et al., 2000). 
 
 
 
II.1.3 - Structural characteristics of granzymes 
 
 
Granzymes not only need the precise three-dimensional arrangement of catalytic residues to function, 
they also rely on nonspecific, main chain substrate interactions and other key structural features such 
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the previously mentioned oxyanion hole to stabilize transition states of the enzyme-substrate complex. 
Additionally, residues making up a feature called the specificity pocket determine the protease’s 
specificity or nature of the peptide bond to be cleaved. As we have seen, processing of the maturing 
granzyme triggers the formation of the precise conformation required to provide these features that 
together determine the enzyme’s specificity (Trapani, 2001).  
 
The activity of granzymes, as with all members of the CHT-like family, depends on the highly 
conserved amino acid triad, His57 Asp102 and Ser195 (chymotrypsin numbering), otherwise known 
as the catalytic triad. Other conserved residues include those that are involved in the formation of the 
oxyanion hole (193 and 195), those involved in nonspecific main chain substrate binding, residues 
189, 216 and 226, which are important in determining the specificity pocket, and cysteine residues 
required for disulphide bridge formation. 
 
Granzymes also display features that are not seen in other CHT-like family members. For instance, the 
mature enzymes found in granules share a strictly conserved N-terminal sequence from positions +1 to 
+4 (Ile-Ile-Gly-Gly) and positions +9 to +16 (Pro-His-Ser-Arg-Pro-Tyr-Met-Ala) as well as the 
previously mentioned propeptide sequence consisting of either Gly-Glu or Glu-Glu. Cysteine (Cys) 
residues involved in disulphide bond formation are also highly conserved in the granzyme family. 
Apart from GzmA, most chromosome 14 granzymes characteristically contain three disulphide bridges 
and lack a bridge between Cys-191 and Cys-220 otherwise present in CHT family members such as 
CHT, trypsin and elastase. Again, in contrast to other granzymes, GzmA possesses a free cysteine (93) 
at its carboxyl terminal allowing the protease to exist as a stable, disulphide-linked 60 kDa homodimer 
(Fink et al., 1993; Hink-Schauer et al., 2003).  
 
 
 
II.1.4 - Enzyme specificity of granzymes 
 
 
Ser195 of serine proteases  
Proteases are a group of enzymes that catalyze the hydrolysis of covalent peptide bonds. Indeed, in the 
case of serine proteases, such as granzymes, once a substrate attaches to the enzyme at the main chain 
binding site and specificity pocket, with the scissile bond (substrate bond to be cleaved) exposed to the 
previously mentioned catalytic triad, a nucleophilic attack on the targeted peptide bond is initiated by 
the triad residue Ser195, explaining the family’s nomenclature. In many cases, the nucleophilic 
property of the group is improved by the presence of a histidine, held in a "proton acceptor state" by 
an aspartate. Thus, the aligned side chains of His57, Asp102 and Ser195 build the catalytic triad in 
serine proteases, the serine initiating a nucleophilic attack on the scissile amide bond, a required first 
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step in the hydrolysis of substrate peptide bonds. The chapter entitled “enzyme specificity” shows the 
specificity pocket of GzmH, our enzyme of interest. As we shall discuss later, GzmH prefers bulky, 
hydrophobic amino acids such a phenylalanine (refer to Figure III.2A) and tyrosine. The catalytic triad 
allows the initiation of the proteolytic activity that will also be discussed in the next chapters.   
 
The Schechter and Berger nomenclature 
The active site of serine proteases is shaped as a cleft where the amino acids of polypeptide substrates 
bind to enzyme subsites. In 1967, Schechter and Berger introduced a nomenclature to describe the 
interaction between enzyme and substrate. The enzyme subsites were termed S, after subsite and the 
substrate residues P, after peptide. The amino acids located on either side of the scissile bond, where 
the cleavage occurs, are named P1 and P1’ and those residues leading towards the N-terminus and C-
terminus are named P2, P3, P4 etc. and P2’, P3’, P4’ respectively, their respective enzyme subsites 
numbered accordingly (Schechter and Berger, 1967).  
 
 
 
 
 
 
A B 
Figure II.2 – The GzmH active site and the Schechter and Berger nomenclature. (A) The active site of 
GzmH prefers bulky, hydrophobic amino acids such a phenylalanine and tyrosine. The catalytic triad allows the 
initiation of proteolytic activity, serine 195 initiating a nucleophilic attack on the scissile amide bond (green 
circle). (B) The general nomenclature for the substrate cleavage site positions was formulated by Schechter and 
Berger in 1967. They designate the cleavage site between P1-P1', the numbering in direction of the N-terminal of 
the cleaved peptide bond continuing as P2, P3, P4, etc. On the carboxyl side the numbering is notated likewise, 
P1', P2', P3' etc.  
 
 
Enzyme specificity 
The serine proteases exhibit different substrate specificities which are related to amino acid 
substitutions in various enzyme subsites (see nomenclature of Schechter and Berger) interacting with 
the substrate residues. Some enzymes have an extended interaction site with the substrate, whereas 
others have a specificity restricted to the P1 substrate residue. The granzyme family members have 
very similar three-dimensional structures but differ in specificity. Indeed, the 3D structure 
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determinations by X-ray crystallography of GzmA, GzmB and GzmK have allowed the analysis of 
their respective active sites. GzmA and GzmB cleave adjacent to positively charged and acidic side 
chains respectively (Estebanez-Perpina et al., 2000; Hink-Schauer et al., 2003) whereas GzmH has 
been shown to preferably cleave after bulky aromatic residues (Edwards et al., 1999). The three 
residues at positions 189, 216 and 226 are responsible for these preferences and together form the 
biophysical properties of the S1 specificity pocket.  
 
Residues 216 and 226 line the walls of the pocket. In most granzymes, such as GzmA and GzmH, 
these amino acids are both Gly and because of their small size, allow side chains of the substrate to 
penetrate easily into the specificity pocket (see Figure II.3). GzmB however, preferably accommodates 
a negatively charged residue such as Asp or Glu at the P1 position forming a salt bridge with the 
guanidinium group of Arg226 at the top of the S1 pocket (Estebanez-Perpina et al., 2000). This 
probably explains why bulky residues such as Phe cannot be accommodated.    
 
Figure II.3 - Schematic diagrams of granzyme specificity pockets. The representations illustrate the 
preferences of granzymes A, B and H for side chains adjacent to the scissile bond in polypeptide substrates. 
GzmA prefers a positively charged side chain that can interact with Asp189. GzmB, on the other hand, shows 
preference for a negatively charged, acidic amino acid, namely Asp, a specificity that is attributed to the Arg in 
position 226. GzmH, like GzmA displays an open specificity pocket and prefers aromatic side chains such as 
Phe. The blue circles represent nitrogen and red circles oxygen. Charge is indicated in yellow.  
 
 
Residue 189 (S1 position) is at the bottom of the specificity pocket and can interact with the P1 
residue of the substrate. Indeed, the 189 residue of trypsin, like that of GzmA, is an Asp that interacts 
positively with the substrate side-chains of Lys or Arg accounting for its cleavage preference. 
However, in the case of chymotrypsin or GzmH, Ser or Thr can occupy the S1 position, both residues 
being small and aliphatic except for the presence of a polar hydroxyl group on each. Bulky aromatic 
P1 side-chains, such as Phe or Tyr, are here preferred as they can fill up the mainly hydrophobic 
pocket. Interestingly, the preference of GzmB for acidic P1 amino acids such as Asp or Glu is 
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attributed to Arg226 and not Thr189. Indeed, as previously mentioned, Arg226 is involved with the 
negatively charged carboxylate group of Asp. Cleavage on the carboxyl side of Asp residues is unique 
to GzmB in the granzyme family but it is also the requirement of another family of proteases, the 
caspases, which are intimately connected with cell death (Perfettini and Kroemer, 2003; Wolf et al., 
1999). 
 
In some instances, cross-reactivity may be expected at P1. This is the case for GzmA and GzmK, 
which both show a preference for basic residues such as Lys and Arg, or for the chymotrypsin-like 
enzymes, such as chymase and GzmH, which tolerate aromatic residues such as Phe and Try. Here, the 
distinct specificities at P2 to P4, and also at P1’-P4’, should further contribute to selectivity.    
 
 
 
II.2 - Cytotoxic effector cells and granzyme cytotoxicity 
 
 
CTL and NK cells are the two main types of cytotoxic effector cells of the immune system. In recent 
years, it has become increasingly clear that both cell types share common effector mechanisms, both 
granule- and receptor-mediated, that induce target cell death. Granule-mediated cell death or “granule 
exocytosis” destroys unwanted cells by releasing the content of host cytotoxic granules, namely 
perforin and granzymes, into the immunological synapse before it is then taken up into the target cell. 
Alternatively, target cells perish through stimulation of cell-surface receptors, such as the members of 
the tumor-necrosis factor receptor (TNF-R) family, including FAS (CD95). Of these different 
mechanisms, findings in genetically manipulated mice, human genetics diseases and in vitro studies, 
show that the granule exocytosis pathway has the dominant role in eliminating viral infections, 
intercellular pathogens and tumor cells (Balkow et al., 2001; Kagi et al., 1994). Indeed, in vitro 
experiments have revealed that effector cells prefer to kill via the granule mediated pathway and that 
only when the latter is interrupted do levels of FAS stimulation increase. A plausible explanation for 
this phenomenon might be the fact that CTL and NK cell granules come pre-loaded with cytotoxic 
proteases, the granzymes, and hence killing through this pathway occurs more rapidly (Barry and 
Bleackley, 2002).  
 
The granule exocytosis model 
Although granzymes may possess a number of different functions it is now widely accepted that the 
family’s major business lies in the heart of cytotoxic effector cell function and, more specifically, in 
the granule-mediated response to diseased cells (Griffiths and Isaaz, 1993). The first ideas on how 
these effector cells achieved cell death were rather simple and it was initially believed that mere 
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membrane damage would suffice. It has now become evident, however, that this is not the case and 
that more complex cell death pathways are at work (Shresta et al., 1999).  
 
Granule (i) 
Perforin
Cytotoxic CD8+ T cell 
TNF receptor 
Target cell 
TRENDS in Neurosciences 
 
Figure II.4 - CTLs trigger different pathways to achieve target cell destruction. CD8+ CTLs recognize their 
targets cells by binding of its T-cell receptor (TCR) to the appropriate combination of major histocompatibility 
complex (MHC I) and peptide (here represented as a square). Destruction of the target, which can also be 
performed by natural killer (NK) cells (which do not require the TCR-MHC I recognition) is mediated by (i) the 
secretion of cytotoxic granule content, i.e. perforin and granzymes, resulting in cell death induction once perforin 
(PFN) allows the passage of granzymes across the plasma membrane. (ii) the activation of FAS/CD95 receptors 
by FAS ligand/CD95 ligand (FASL) triggering apoptosis, and (iii) the release of cytokines, such as tumor 
necrosis factor (TNF). Taken from Trends in Neuroscience (Neumann et al., 2002).   
 
 
Our understanding of how CTL and NK cells deliver their granule content was greatly increased after 
microscopical analysis, based on effector-target cell interactions, revealed that engagement was 
transient and sequential. Additionally, it was shown that upon target cell interception, effector 
organelles, such as the microtubule-organizing centre, the Golgi and the lytic granules began to 
reorganize, rapidly orientating themselves towards the site of conjunction (Kuhn and Poenie, 2002; 
Stinchcombe et al., 2001; Stinchcombe and Griffiths, 2006). Furthermore, it was also demonstrated 
that acid phosphatase, that is normally restricted to lytic granules, was found at the site of site of 
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effector-target cell engagement (Zagury, 1982). The above observations combined with preliminary 
data on the content of lytic granules lead to the formulation of the cytotoxic granule exocytosis model 
(Henkart, 1985; Zagury, 1982) which, although now more complex, remains valid today (Lieberman, 
2003). The original description of granule exocytosis suggests that the process involves the 
rearrangement of the effector cell cytoplasm after which perforin (PFN), a calcium sensitive pore-
forming protein, is released and delivered to the target cell. Indeed, PFN was first described as the key 
effector protein of lytic granules (Henkart, 1985) but the exocytosis model has now become much 
more complex, the granules harboring other key molecules released upon killer cell attack. 
 
Granzyme delivery: where does perforin open the door to death?  
Perforin (PFN) was the first component of effector cell lytic granules to be discovered, along with 
cytolysin, (Podack and Konigsberg, 1984) and is exclusively found in CTL and NK cells where it 
plays a pivotal role in the induction of granule mediated cell death. The importance of PFN has been 
demonstrated with both cytotoxic cells and mice deficient in the protein. Indeed, cytotoxic 
lymphocytes from PFN deficient mice are unable to efficiently trigger target cell apoptosis and PFN 
knockout mice are profoundly immunodeficient, showing an enhanced susceptibility to viral infections 
and tumour growth (Kagi et al., 1994; Rossi et al., 1998; van den Broek et al., 1996). Earlier studies 
define PFN as a cytotoxic membrane damaging agent that triggers cell death by damaging the target 
cell plasma membrane (Dennert and Podack, 1983; Dourmashkin et al., 1980; Podack and Konigsberg, 
1984). More recent work however, clearly demonstrates that the protein alone is unable of triggering 
all the features associated with CTL/NK induced cell death (Shresta et al., 1999). As expected, other 
granule components are involved in the exocytosis pathway, their presence necessary in order to 
achieve the full array of morphological and biochemical cell death characteristics (Stinchcombe et al., 
2001). Granule mediated cell death is therefore a concerted effort which, along with PFN, requires the 
presence of other granule proteins. The above observations lead to the original hypothesis that PFN 
allows the entry of cytotoxic granule components into the target cytosol by building multimeric pores 
on the plasma membrane (Stinchcombe et al., 2001). See Figure II.4. 
 
The initial plasma membrane pore model, mentioned above, was put into doubt when a recent study 
showed that granzymes do not require the presence of PFN to be endocytosed into endosomes despite 
target cells remaining healthy (Edwards et al., 1999). If PFN is not required for granzyme uptake into 
endosome-like vesicles, then where does the pore-forming protein act to liberate granzyme into the 
target cell cytosol? To help answer these questions, PFN was added to target cells which had already 
internalized granzymes. Soon thereafter, features of CTL induced cell death were detectable. It now 
seemed likely that granzymes require the actions of PFN once they are safely endocytosed within 
target cell endosomes (Trapani et al., 1998; Zhang et al., 2001). However, the idea that PFN, acting 
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from outside the target cell, could trigger the release of granzymes contained within endosomes 
seemed somewhat unrealistic. Revised studies revealed that once internalized, if real care is taken in 
removing all surface-bound GzmB, PFN was actually unable to effectively deliver the previously 
endocytosed granzymes (Babe et al., 1998) and it was therefore hypothesized that both granzymes and 
PFN must be eternalized together in order to induce efficient apoptosis. On the other hand, the original 
model may, indeed, be the actual method of entry. Interestingly, a second study by Lieberman’s group 
in 2005 showed that when cells are incubated with sublytic PFN, granzymes are endocytosed, 
probably by macropinocytosis, much more rapidly and efficiently than in its absence (Keefe et al., 
2005; Sutton et al., 1997).  
 
The second model devised by Froelich and colleagues, mentioned previously, highlights how basic 
granzymes are, and that removing them form target cell plasma membranes requires a great deal more 
than simply attempting to wash them off with simple cell culture medium. Surface bound receptors 
such as the cation-independent mannose-6-phosphate receptor (CI-MPR) and heparin have also been 
shown to bind GzmB on the cell surface. These receptors are not only considered a method of entry 
for granzymes but also, when present, are thought to contribute to the enhanced killing of target cells 
in the presence of PFN (Edwards et al., 1999; Jans et al., 1996; Woodard et al., 1998). Recently, 
however, the need for membrane receptors was questioned by several studies. In one study, CTLs 
from patients with I-cell disease, which can not synthesis mannose-6-phosphate-containing GzmB, can 
nevertheless kill target cells as efficiently as their wild type counterparts (Griffiths and Isaaz, 1993). In 
another study, the authors demonstrated that target cells that lack heparin receptors are just as 
efficiently killed by recombinant, unglycosylated GzmB, and conclude that receptors for GzmB are 
not crucial for killer-cell-mediated apoptosis (Kurschus et al., 2004). Several other studies also argue 
that receptor mediated uptake is not required for granzyme delivery into the target cell cytosol (Sayers 
et al., 2001; Smyth et al., 1993).   
 
Most recently, Liebermann and colleagues have published data suggesting a “hybrid” PFN entry 
model that supports to some extent the previous hypothesis. The work favours a model in which PFN 
triggers rapid endocytosis of itself and granzymes into large endosome-like vesicles, the pore forming 
protein then releasing the cytotoxic proteases into the target cell cytosol. The group shows that PFN 
can form small pores on the plasma membrane but that these pores are, apparently, only large enough 
to allow the entry of small dyes and calcium, but not granzymes. It appears that, at the right PFN 
concentration, enough calcium influx is achieved to allow efficient cell death induction while, at the 
same time, triggering membrane repair responses to avoid eventual necrosis. Exactly how PFN 
achieves the internalization of granzymes into endosomal vesicles still needs to be resolved, but it is 
believed that both granzymes and PFN may be endocytosed and that, once inside, the pore-forming 
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protein damages the vesicular membrane to form large enough pores through which the granzymes can 
then be released (Pipkin and Lieberman, 2007). Alternatively, PFN may perturb the endosome by 
forming small pores that disrupt the acidification of the vesicle, thus destabilizing it and causing it to 
burst (Pipkin and Lieberman, 2007). Taken together, both Froelich’s and Lieberman’s models seem to 
agree with one another, but a lot still needs to be done in order to fully understand the actions of PFN. 
Despite that fact, many think it likely that granzymes do actually enter the target cell cytosol through 
pores in the plasma membrane, the original model still remaining very much possible.   
 
 (b) Endomolysis model  (c) Hybrid model  (a) Original pore model  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure II.5 - The three perforin-mediated granzyme entry models. (a) The initial pore model states that 
granzymes access the target cell cytosol via PFN that multimerizes on the plasma membrane to form pores. (b) 
The endomolysis model, proposed by Froelich and colleagues, says that granzymes are endocytosed 
independently of PFN and that PFN then acts to release the protease as an endomolysin. (c) The hybrid model is 
the result of much work by Judy Lieberman’s group. They propose that PFN causes the influx of calcium and 
that this triggers a membrane repair response that leads to quick repair of the membrane pores. Thereafter, the 
previous actions of PFN lead to the endocytosis of both granyzmes and PFN together. PFN would then either 
allow the release of granzymes from the endosomes by the formation of large pores or its action on the 
endosomal membrane could cause the vesicle to burst also allowing the granzymes to escape into the target cell 
cytosol. Scheme taken from a review entitled “ Delivering the kiss of death: progress on understanding how PFN 
works”, Current Opinions in Immunology (Pipkin and Lieberman, 2007).  
 
 
Granzymes: natural-born killers 
As discussed in the above chapter on PFN, cytotoxic cells induced target cell death only in the 
presence of both PFN and other granule components. Indeed, sublytic PFN alone is not a threat to the 
target cell, but, together with granzymes, is responsible for DNA fragmentation (Duke et al., 1983). 
Work from Bleackley and colleagues in 1986, focusing on identifying genes involved in CTL induced 
cell death, singled out two genes, namely B10 and C11, which belonged to a family of serine 
 - 15 -
 Introduction 
____________________________________________________________________________
  
 
proteases. In particular, C11 or cytotoxic cell protease I (CCPI) was found to encode for the now 
named GzmB, its expression patterns closely correlating with the induction of CTL cytotoxicity (Lobe 
et al., 1986).  
 
Granzyme B (GzmB) 
GzmB is unique among its kind owing to its ability to activate a family of apoptogenic cysteine 
proteases named caspases, which, coincidently, also share the same proteolytic specificity at the P1 
position. In the early 90s, it was shown that purified GzmB, from rat natural killer cells, could, along 
with PFN, induce rapid DNA fragmentation within 1 hour of exposure to target cells (Shi et al., 1992). 
Exciting research from the Henkart lab then went on to show that, by transfecting a rat basophilic cell 
line (RBL-1) with GzmB and PFN constructs, RBL-1 acquired cytotoxic activity (Nakajima et al., 
1995). Additionally, Ley et al. also made an important step towards understanding the role of 
granzymes in granule mediated cell death when they generated mice deficient in the GzmB gene. 
These GzmB-null mice developed normally and had normal hematopoiesis and lymphopoiesis. In 
vitro, however, CTLs derived from the mice displayed a reduced capacity to induce 51Cr-release from 
target cells. Furthermore, the cells showed a profound defect in their ability to induce rapid DNA 
fragmentation and apoptosis in target cells. It was concluded that GzmB had a critical, and none 
redundant, role in the rapid induction of target cell DNA fragmentation and apoptosis (Heusel et al., 
1994). Taken together, the above findings, spanning a decade of research, clearly show that GzmB, in 
the presence of PFN, is a key player in CTL killing. Indeed, it is now an established fact that GzmB is 
the most potent granzyme in the family owing to its ability to act at multiple points in the initiation of 
diseased cell death.   
 
Granzyme A (GzmA) 
Mice deficient in this GzmA have an increased susceptibility towards certain viral infections, despite 
being able to efficiently eradicate tumors. Additionally, CTLs from these mice have normal cytotoxic 
responses in vitro (Ebnet et al., 1995; Heusel et al., 1994; Mullbacher et al., 1996; Pereira et al., 2000; 
Shresta et al., 1999; Zajac et al., 2003). In cell death studies using recombinant GzmA, in the presence 
of sublytic concentrations of PFN, target cells not only undergo rapid cytolysis but also acquire single-
strand DNA nicks in a caspase-independent manner (Pinkoski et al., 1998). In addition, it has been 
observed that GzmB-induced DNA fragmentation is significantly enhanced in the presence of GzmA, 
indicating that GzmA induces a form of cell death that is distinct from that triggered by GzmB 
(Browne et al., 1999; Pinkoski et al., 1998; Zajac et al., 2003). GzmA has been demonstrated to cause 
direct and indirect mitochondrial dysfunction. Indeed, GzmA-treated cells show a loss of 
transmembrane potential but do not cause the release of proapoptotic intermembrane space proteins 
such as cytochrome c. More recently, it was shown that GzmA transferred into target cells via PFN, 
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leads to the fast generation of reactive oxygen species (ROS) which, in turn, then induces the nuclear 
transfer of the previously described ER-associated SET complex. Once in the nucleus, GzmA relieves 
the active nuclease NM23-H1 by destroying its bound inhibitor SET (Martinvalet et al., 2005). GzmA 
is also known to target the DNA-binding protein HMG-2 and the base excision repair enzyme Ape-1 
(Lieberman and Fan, 2003). Interestingly, when target cells are preincubated with antioxidants such as 
Tiron and NAC (N-Acetyl cysteine), GzmA is no longer able to execute its cell-death pathway. Are 
then reactive oxygen species an absolute necessity for cell death?  
 
Orphan granzymes 
With regard to the remaining three members of the human granzyme family, no concrete, fully 
explored role in CTL-mediated cell death has yet been established for this trio of proteases known as 
the orphan granzymes. However, GzmK, a tryptase like its closely linked chromosome neighbour 
GzmA, has recently been reported to induce a caspase-independent form of cell death defined by 
phosphatidylserine (PS) externalization, mitochondrial depolarization, nuclear morphological changes 
and single-stranded DNA nicks. Additionally, GzmK, like GzmA, is also able to cleave the 
nucleosome assembly protein SET in its recombinant and native forms. Once cleaved, SET is released 
from the bound nuclease NM23H1 and, in turn, becomes active and goes on to nick chromosomal 
DNA (Zhao et al., 2007b). Earlier in 2007, however, a second study from the same group further 
demonstrated that GzmK directly processes the Bcl-2 family member Bid, resulting in the release of 
cytochrome c and endonuclease G from the mitochondria. (Zhao et al., 2007a). In this same study, 
ROS was also shown to be released resulting form injury of the mitochondrial respiratory chain. 
Moreover, the authors reported that the pretreatment of target cells with antioxidants completely 
blocked GzmK-induced cell death, as was the case with GzmA (above) in a study by Lieberman’s 
group (Martinvalet et al., 2005). These studies suggest that ROS does, indeed, play an essential role in 
accomplishing target-cell eradication. See the comment in ‘Immunity’ entitled “Do cytotoxic 
lymphocytes kill via reactive oxygen species?”, (Williams and Henkart, 2005).   
 
GzmM is a metase and prefers to cleave after residues with long, uncharged side chains such as Met 
and Leu. The protease has also recently been labeled as cytotoxic because of its ability to induce 
caspase-independent cell death (Kelly et al., 2004). In this report, no target cell substrates were 
identified, the authors defining GzmM cytotoxicity by significant 51Cr release (equimolar amounts of 
GzmB and GzmM triggering similar levels of cell death) and chromosomal condensation. 
Interestingly, and contrary to GzmA, GzmB and GzmK, the authors report a complete lack of 
mitochondrial perturbation. Very recently though, a study by Fan and colleagues revealed that, in their 
hands, the metase initiated caspase dependent apoptosis (Lu et al., 2006). The work goes on to 
demonstrate how GzmM triggers cell death by DNA fragmentation, but not DNA nicking, and how 
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the protease can degrade the inhibitor of caspase activated DNase (ICAD) thus releasing the active 
caspase-activated nuclease (CAD). Finally, the study reveals that GzmM cleaves the DNA damage 
sensor enzyme poly(ADP-ribose) polymerase (PARP), consequently preventing the target cells form 
DNA repair (Kelly et al., 2004; Lu et al., 2006). Unlike GzmB, but like GzmA, GzmM has been 
shown to be constitutively stored at high levels in NK cell granules. Additionally, along with the fact 
that GzmM appears to trigger cell death in concert with the kinetics of NK cell mediated cytolysis 
(Suck et al., 2005), it has been suggested that GzmM may indeed play a crucial role in NK target cell 
attack (Kelly et al., 2004). Recently, however, a report on GzmM deficient mice reveals that the mice 
display normal NK-mediated cytotoxicity against tumor cells, the knock-out mice only troubled by the 
slow clearance of mouse cytomegalovirus (MCMV) infection. In conclusion, the authors suggest that 
GzmM is not critical for NK-mediated cell death (Pao et al., 2005).   
 
 
* 
Table II.1 - Properties of granzymes in humans and rodents 
 
 
 
 
 
 
 
 
 
 
 
Table II.1 – Properties of granzymes in humans and rodents. * GzmH has chymotrypsin-like proteolytic 
activity and it has been reported that the protease prefers not only Phe but also Tyr and Met at the P1 position.  
The red rectangle is indicative of predicted cleavage specificities. This table is taken from a review entitled 
“Cytotoxic lymphocytes: all roads lead to cell death”, ‘Nature Reviews Immunology’ (Barry and Bleackley, 
2002). 
 
 
Granzyme H, the least studied of the orphan trio and only member of the family to be found 
exclusively in humans, has yet to be added to the list of cytotoxic proteases. This chymotrypsin-like 
protease, and “granzyme of interest” in this thesis, will be discussed in more detail in the following 
chapters.  
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II.3 – Granzyme B and its multiple apoptogenic substrates 
 
 
GzmA and GzmB are the most abundant granzymes in mice and humans and have, therefore, received 
the most attention, particularly GzmB because of its ability to activate caspase-dependent pathways 
that lead to the most common type of cell death, otherwise known as apoptosis. Moreover, GzmB can 
also achieve its cytotoxic goals by triggering caspase-independent pathways, as seen with the cell 
death pathway triggered by GzmA.  
 
In order to analyze GzmB and its functions, the protease was first purified and activated in its native 
form and then, soon after, expressed and purified as an active recombinant enzyme (Caputo et al., 
1993; Shi et al., 1992). In the mid nineties, Bleackley and colleagues made the first step in identifying 
the crucial substrate for GzmB. They showed that active, recombinant GzmB cleaves and activates 
CPP32 or procaspase 3, which, in turn, leads to the cleavage of poly(ADP-ribose) polymerase (PARP) 
(Darmon et al., 1995). Since then, many more apoptogenic substrates have been found to be cleaved 
by GzmB.  As we shall see, it is the variety of pathways through which GzmB can inflict apoptosis on 
target cells, and the speed at which this granzyme destroys its prey, that crowns it as the ultimate 
weapon in granule mediated cytotoxicity. Additionally, purified GzmB, or a recombinant variant of 
the protease, can also be used as the perfect comparative tool in studies, such as this one, which seek 
to unravel the possible cytotoxicity of other members of the granzyme family. 
 
The caspase-dependent cell death pathway  
GzmB is not the only protease that prefers to cleave after aspartic acid residues. Interleukin-1ß-
converting enzyme (ICE), which also has this specificity, belongs to a family of cysteine proteases 
called the caspases. ICE, or caspase 1, was found to have high homology with the C. elegans Ced 3 
protein which is essential in the developmental cell-death program of the worm. This finding led to 
speculation hinting that the caspase family might also play an important role in mammalian cell death. 
Indeed, the caspases are now well established in the community of cell-death inducing proteases, 
especially in the art of DNA fragmentation.  
 
Caspases are synthesized as inactive precursors and acquire active conformation only after cleavage at 
aspartate residues, suggesting that the family would be excellent substrates for GzmB. This was later 
confirmed by work from Bleackley and colleagues who demonstrated the cleavage and activation of 
caspase 3 by GzmB and, furthermore, went on to underline the cytotoxic importance of this caspase in 
a number of studies. They revealed that the cleavage of caspase 3 results from the action of GzmB, 
and not from that of GzmA, in target cell lysates. Furthermore, caspase 3 is activated in vivo in cells 
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under attack from CTLs. Additionally, use of GzmB knock-out mice revealed that the cleavage of 
caspase 3 is specific to the actions of the aspase.  
 
Although other members of the caspase family have been shown to be activated by GzmB, caspase 3 
is believed to play the most important role in GzmB-mediated cell death (Froelich et al., 1996b; 
Shresta et al., 1999). Caspase-3 has recently been shown to cleave a number of proapoptotic proteins 
such as PARP, mentioned above, ICAD, which leads to DNA fragmentation, and, more recently, 
gelsolin, a protein involved in the maintenance of the cytoskeleton and also in the loss of 
aminophospholipid translocase activity, a protein involved in phosphatidylserine (PS) externalization 
(Kothakota et al., 1997). Together, the cleavage of these substrates results in the hallmarks that 
currently define the state of apoptosis, namely chromatin condensation, nuclear fragmentation, and PS 
externalization, among others. The loss of mitochondrial transmembrane potential (ΔΨ) is another 
apoptotic hallmark of GzmB-triggered cell death but was thought, initially, to be independent of 
caspases. Therefore, this phenomenon will be discussed in the following chapter (Beresford et al., 
1999; Zhang et al., 2001). Recent studies, however, have revealed that caspase 3 and 8 can cleave and 
activate a proapoptotic protein, named Bid, a member of the Bcl-2 family of proteins, which leads to 
the formation of pores in the outer mitochondrial membrane, thus allowing the release of other 
proapoptotic proteins which, in turn, go on to amplify the apoptotic cascade. Until these observations 
were made, Bid was thought to be the direct physiological substrate for GzmB. The exact involvement 
of caspases, under physiological conditions, will require further research (Metkar et al., 2003).  
 
The caspase-independent cell death pathway 
Cell death induced by CTLs can also proceed in the absence of caspases, as demonstrated using 
peptide caspase inhibitors, or in target cells expressing viral caspase inhibitors such as baculovirus p35 
and the poxvirus inhibitor, crmA (Henkart et al., 1997; Sarin et al., 1997). Nuclear changes and other 
signatures of cell death still occur, even in target cells over-expressing the anti-apoptotic protein Bcl-2 
(Chiu et al., 1995; Sutton et al., 1997). Accordingly, many studies report the capacity of GzmB to 
induce cell death independently of caspase activation, all the substrates mainly being downstream 
caspase substrates, GzmB here substituting for the blocked initiator or effector caspases (Beresford et 
al., 1999; Sarin et al., 1997; Trapani et al., 1998). As mentioned above, Bid (BH3-interacting domain 
death agonist) is one of the most important targets for GzmB. Indeed, once Bid is cleaved and 
activated, the truncated protein (tBid) damages the integrity of the mitochondrial membrane in concert 
with two other Bcl-2 family members, BAX and BAK, thereby causing the release of a number of 
proapoptotic proteins from the organelle’s inter-membrane space. Cytochrome c (crucial for activating 
procaspase 9), endonuclease G (which activates DNA damage) and HtrA2/OMI (a recently identified 
serine protease that inhibits the inhibitor of apoptosis protein (IAP)) are all released upon GzmB 
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induced caspase-independent cell death. Interestingly, only the apoptosis-inducing factor (AIF), a 
fourth mitochondrial inter-membrane space protein (MIMP), is reported to remain contained (Alimonti 
et al., 2001).  
 
Mitochondrial depolarization has also been shown to occur independently of cytosolic mediators, 
GzmB reportedly being directly able to act on the mitochondrial membrane (Alimonti et al., 2001; 
MacDonald et al., 1999). Disruption in the mitochondrial membrane potential is followed by an 
increase in ROS but the underlying mechanisms remain unknown.  
Figure II.6 - GzmB activates both caspase dependent and independent pathways to achieve death of the 
target cell.  Two early substrates of GzmB are procaspase 3 and Bid. Truncated Bid (tBid) disrupts the outer 
mitochondrial membrane to cause the release of cytochrome c and other proapoptotic factors such as 
endonuclease G (which leads to DNA damage) and HtrA2/OMI (a protein which blocks inhibitors of apoptotsis). 
Importantly, cytochrome c release is an essential event that leads to the formation of the apoptosome through 
binding to APAF1 and recruitment of procaspase 9.  Once assembled, the apoptosome causes the autocatalytic 
activation of procaspase 9; the active caspase then going on to activate caspase 3. GzmB is also reported to 
directly disrupt the mitochondrial membrane although the mechanism by which the aspase achieves this remains 
unknown. GzmB, along with active caspase 3, cleaves the inhibitor of caspase activated DNase (ICAD) to free 
CAD. The liberated DNase then causes DNA fragmentation, as seen in the form of DNA laddering. APAF1: 
apoptotic protease-activating factor 1; BAD: BCL-2 antagonist of cell death; BAX: BCL-2-associated X protein; 
CTL: cytotoxic T lymphocyte; ROS: reactive oxygen species. Taken from a review entitled “The ABCs of 
granule-mediated cytotoxicity: new weapons in the arsenal”, ‘Nature reviews Immunology’(Lieberman, 2003).  
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In the case of Bid activation and outer membrane perturbation, the escape of cytochrome c (the 
smallest MIMP) triggers an essential pathway necessary for the amplification of caspase activity. 
Moreover, if caspases are truly involved in activating Bid, as is suggested in the previous chapter, 
cytochrome c may also be involved in the amplification of mitochondrial membrane disruption and 
MIMP release. After its release, cytochrome c binds to APAF1, which, in turn, recruits procaspase 9 to 
form the apoptosome. Apoptosome assembly ensures the autocatalytic activation of caspase 9 which 
then goes on to activate procaspase 3. It is also known that partially activated caspase 3 can dimerise 
and activate itself (Lieberman, 2003).  
 
Finally, GzmB can also directly cleave ICAD in the absence of caspase activation thus ensuring that, 
along with endonuclease G, these two nucleases fulfill target cell DNA damage (Li et al., 2001; 
Sharif-Askari et al., 2001; Thomas et al., 2000). Additionally, GzmB has also been shown to cleave a 
number of downstream caspase substrates such as PARP, the catalytic subunit of DNA-dependent 
protein kinase (DNA-PKcs), which is involved in repairing double-stranded DNA breaks, and the 
nuclear-envelope intermediate-filament protein lamin B (Andrade et al., 1998; Froelich et al., 1996a; 
Zhang et al., 2001).        
 
 
 
II.4 - Granzyme H 
 
 
Human granzyme H (GzmH) is our serine protease of interest. As a brief reminder, GzmH is a 
chymase that lies among the members of the GzmB cluster on chromosome 14. GzmH is not the only 
chymase of the locus and is neighbour to other serine protease genes, namely those of GZMB, 
CATHEPSIN G and MAST-CELL CHYMASE, the later two also being chymotrypsin-like enzymes. 
GzmH has the highest amino acid identity with GzmB, over 90%, and in particular with sequences 
near the N-terminus of the aspase, despite both proteases boasting distinct proteolytic activities. 
Indeed, it has been suggested that GZMH arose by duplication of part of the 5’ end of GZMB, housing 
exons 3 and 4, followed by fusion of this segment with the 3’ end of another primordial serine 
protease gene with chymase activity (Haddad et al., 1991). As a reminder, the mouse GzmB locus 
holds no direct structural equivalent of GzmH but is home to six other granzyme genes, four of which 
are also predicted to code for functional chymotrypsin-like proteases.  
 
The current state of knowledge on GzmH is, for the most part, based on three papers that span a 14-
year period: 1990 to 2004. Haddad, Jenne and colleagues, in 1990, revealed the structure and 
evolutionary origin of human GzmH as described above. Nearly a decade later, two studies from the 
Trapani lab, in 1999 and 2004, reported upon the expression of GzmH in blood lymphocytes, the 
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enzyme’s proteolytic activity and its uptake into target cell vesicles in the absence of perforin 
(Edwards et al., 1999; Sedelies et al., 2004).  
 
Using a novel monoclonal antibody raised against the 33 kDa glycosylated recombinant enzyme, 
Trapani and colleagues showed in greater detail, that GzmH is stored constitutively at high levels in 
unstimulated natural killer (CD3-CD56+) cells. GzmB, on the other hand, was much less abundant in 
unstimulated NK cells but not in stimulated CD4+ and CD8+ T cells where the aspase was very highly 
expressed. GzmH, in comparison, was hardly detectable in the latter CTLs. Neither was GzmH 
detectable in NKT cells, monocytes and neutrophiles. The work also showed that there was a good 
correlation between mRNA and protein expression in cells, such as NK cells, that express both GzmB 
and GzmH, suggesting that both granzyme genes are similarly regulated. The work concludes that, 
although the genes are tightly linked, the protein expression of these two granzymes differs greatly, 
GzmH, unlike GzmB, being more frequently abundant in NK cells. It is also interesting to note that, 
along with GzmH, GzmA and GzmM have also been shown to be expressed at high constitutive levels 
in NK cells (Bratke et al., 2005; Sayers et al., 2001; Sedelies et al., 2004).   
 
Trapani’s team was the first to report the esterolytic (but not amidolytic) activity of glycosylated 
recombinant GzmH, secreted from baculovirus-infected Sf21 insect cells, by showing cleavage of the 
thiobenzyl ester Suc-Phe-Leu-Phe-SBzl and suggesting GzmH as a chymotrypsin-like (chymase) 
serine protease. Additionally, this study also showed that, like fluoresceinated GzmB, fluoresceinated 
GzmH was also internalized by target cells in a PFN-independent but temperature dependent mannerr 
thus suggesting an intracellular function for the chymase-like protease (Edwards et al., 1999).     
 
Most recently, however, a study by Craik and colleagues has compared the extended substrate 
specificities of all granzymes by using combinatorial libraries of protease substrates. In this work, the 
optimal P4-P3-P2-P1 substrate specificities, with amide bond hydrolysis occurring following P1, were 
determined to be IGNR for GzmA, IEPD for GzmB, YRFK for GzmK, KVPL for GzmM and, more 
importantly for our interests, PTSY for GzmH. The results clearly show that the P4-P1 substrate 
specificities of the five granzymes are quite distinct from one another. The profiles obtained for Gzms 
A, B and M largely confirm previous findings based on other positional scanning combinatorial 
libraries. The P1 preferences for Gzms H and K, however, differ somewhat, Mahrus et al. suggesting 
that GzmK strongly prefers lysine over arginine and, more interestingly for our purposes, that GzmH 
in fact exhibits a noticeable preference for tyrosine over phenyalanine and tryptophan. Moreover, the 
work defines for the first time the P4-P2 substrate specificities for these two granzymes.     
 
Until now, no functional data on GzmH has been reported. The above studies, while raising a number 
of questions regarding the cytotoxicity of the chymotrypsin-like protease, have probably encountered 
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various problems in investigating the question, one such problem seemingly being the inability to 
produce large enough amounts of recombinant active granzyme. Another obstacle could also be the 
task to produce enough stably active PFN, the natural granzyme translocator. Once these problems are 
solved, the fact that GzmH is expressed at high constitutive levels in NK cells, where the caspase 
activating GzmB is present in much reduced amounts, is suggestive of a role for GzmH in innate 
immunity, a role that probably complements that of GzmB, found at its highest levels in activated 
CTLs of the adaptive immune system.   
 
 
 
II.5 - Granzymes and antiviral strategies 
 
 
Apart from the alternative pathways that allow granyzmes such as Gzms A and B to efficiently 
eradicate transformed tumor cells, the family also plays an important role in eliminating host cells 
infected by intracellular pathogens such as viruses. The mechanisms by which these serine proteases 
exert their antiviral activity remain elusive. A collaborative study conducted by Felipe Andrade has 
shed new light on some of these mechanisms. The host-virus relationship is a complex business in 
which the virus attempts to escape capture and elimination. It achieves this by minimizing its 
visibility. About a third of the viral genome is devoted to this purpose and immediately after infection 
numerous viral proteins begin to interfere with host cells defense mechanisms, some inhibiting 
apoptosis at the mitochondrial level, others removing apoptosis-inducing receptors such as FAS and 
TNK-related apoptosis inducing ligand (TRAIL). The transport of MHC class I molecules to the cell 
surface can also be targeted. Andrade and collogues recently showed that the 100K assembly protein, 
which has essential functions in the adenovirus life cycle (such as virus assembly and activation of late 
viral protein synthesis), also directly inhibits GzmB (Andrade et al., 1998; Andrade et al., 2001). In a 
recent collaboration with Dr. Andrade, we report the new finding that, in cells infected with 
adenovirus in which GzmB and down stream apoptosis pathways are inhibited, GzmH directly cleaves 
viral substrates essential for replication of the adenovirus. Moreover, GzmH was also found to cleave 
the 100K assembly protein, also a major inhibitor of GzmB, an event that leads to the freeing of GzmB 
from inhibition. These results introduce another granzyme into the battle of “host versus foe” and 
show that granzymes can act synergistically to outsmart viral defenses. Although, the antiviral 
properties of GzmH are not the topic of this thesis, our recent publication will be briefly mentioned in 
more detail during the discussion. Understanding how effector cells tame and eliminate target cells 
which have been hijacked by viral defense mechanisms is of extremely important if we are to make 
advances in antiviral treatment.        
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II.6 - In vitro granzyme delivery by an alternative pore forming protein 
 
 
Bacterial streptolysin O (SLO) 
Our experimental approach to deliver proteins does not rely on purified human PFN but upon a 
bacterial counterpart. The delivery of our recombinant granzymes into target cells is based upon a 
reconstituted system where entry of our granule enzymes is achieved by a recombinant bacterial 
substitute for PFN, namely streptolysin O (SLO). SLO and PFN monomers assemble on membranes 
into pore complexes through which granzymes can illegally enter. Whether PFN monomerises on 
plasma membranes or with internalized endosomes of target cells to allow granzyme entry is not yet 
clear. SLO, on the other hand, is reported to act on the plasma membrane (Walev et al., 2001).     
 
Mutant streptolysin O 
Additionally, along with the commercial SLO, which requires the reduction, and hence the presence of 
reducing agents such as cysteine in the permeabilization buffer, we also use a mutant SLO variant, 
namely SLOC530A. SLOC530A is oxygen stable and therefore does not need to be reduced in order to 
perform its pore-forming duties. Additionally, and more importantly in experiments measuring ROS 
production, the mutant SLO was used to circumvent the need for prior activation under reducing 
conditions.     
 
Bacterial streptolysin O versus human perforin 
The decision to use SLO was not only made because of the protein’s affordability and availability but 
also because of its purity and stability in cell death assays. PFN, on the other hand, although being the 
natural delivery agent of CTL and NK cells, is just the opposite, the commercially available protein is 
very expensive, its availability, purity and activity uncertain and it is reported to be unstable in vitro. 
Despite the use of a bacterial substitute, our reconstituted system efficiently allows GzmB to induce 
apoptosis in an identical manner to that observed in studies using purified human PFN. We, therefore, 
suggest that our reconstituted system is a reliable method with which to question the role of GzmH in 
the induction of cell death.  
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II.7 - Aim 
 
 
Granzymes (Gzms) are a family of serine proteases which comprise the content of lysosome-like 
lymphocyte granules. These granule enzymes, of which five are known to date in humans, are of particular 
interest because of their different proteolytic specificities and potential abilities to trigger cell death in 
tumour and virally infected cells.  Indeed, GzmA and GzmK, both “tryptases”, cleave after basic residues 
and GzmB, an “aspase” preferring to cleave after acidic residues, have evolved distinct apoptotic pathways. 
GzmH is referred to as an orphan granzyme because its biological functions and relationship to cell death 
are still unknown. Recent reports show that the protease is predominantly expressed in natural killer cells 
and is predicted to have chymotrypsin-like (chymase) activity. Like GzmA, GzmB and GzmM, GzmH has 
been shown to be taken up by target cells in endosome-like vesicles. How it should then effect the cellular 
environment upon its release into the cytosol is the underlying interest of this thesis. 
 
So that we might question the possibility that GzmH could be involved in the induction of cell death, our 
first goal was to establish a procedure allowing the production and purification of large homogenous 
quantities of uncontaminated granzyme. In order to achieve this, we sought to refold GzmH inclusion body 
material according to a protocol developed by Wilharm and colleagues in 1999. Wilharm et al successfully 
describe the generation of catalytically active granzyme K in milligram quantities per litre of Escherichia 
coli culture. Additionally, the refolding of catalytically inactive GzmH, GzmHS195A, was also attempted in 
order to appropriately control our apoptosis experiments. Importantly, this inclusion body (IB) refolding 
method was also adapted to produce catalytically active and inactive GzmB, the granzyme we use as a 
positive control of apoptosis induction in our experiments.   
 
Before, exploring the potential of GzmH as a cell-death inducing enzyme, we first attempted to confirm the 
findings of several studies that define GzmH as having chymotrypsin-like (chymase) activity with a 
preference for hydrophobic, aromatic amino acid residues (Phe or Tyr) at the P1 site. Its esterolytic activity 
is also reported to be inhibited by 0.1 mM of the general protease inhibitor 3,4-dichloroisocoumarin. 
Additionally, the GzmH protein has been shown to be predominantly expressed in NK cell lines, but as 
mentioned its functional role in vitro has yet to be determined. Once the latter is achieved, the study of the 
protease’s possible cytotoxic functions will be possible through the application of the many available 
apoptotic assays, controlled by the caspase activating GzmB, the proteolytically inactive GzmH, and the 
two chymotrypsin-like proteases that are neighbours to GzmH on Chromosome 14, namely cathepsin G and 
mast cell chymase. Additionally, if produced in large enough quantities, an attempt could be made to 
crystallise active GzmH alone, or, much more elegantly, in complex with a natural inhibitor which is yet to 
be named.    
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III – Material & Methods 
 
 
III.1 - Cloning in plasmid vectors 
 
 
Plasmid DNA purification from E. coli  
A number of methods have been developed that efficiently remove contaminating chromosomal DNA 
leaving plasmid DNA free in solution. The Qiagen mini and maxiprep systems provide fast and simple 
protocols designed for the respective preparation of up to 20/500 µg of plasmid DNA from 5/500 ml 
overnight cultures of E. coli in Luria-Bertani (LB) medium (Bacto trypone 10 g, yeast extract 5 g, 
NaCl 5 g and deionized (d) H2O, 1 L) containing the appropriate selective antibiotic. The desired 
plasmids were isolated using the appropriate Qiagen kits, mentioned above, according to the provided 
protocols. The resulting plasmid DNA was then used for sequence verification or for further cloning 
procedures after transformation into the E. coli host strain DH5α (Birnboim, 1983; Birnboim and 
Doly, 1979). 
 
 
DNA amplification (PCR)  
The polymerase chain reaction or PCR process, here performed in the PCR-Thermocycler “Trio-
Thermobloc” from Biometra, is used to amplify short target segments (100-500 bp) from a longer 
DNA molecule. A typical amplification reaction includes the sample of target DNA, two 
oligonucleotide primers, deoxynucleotide triphosphates (dNTPs), reaction buffer, magnesium and a 
thermostable DNA polymerase, here the PfuTurbo-DNA polymerase (Stratagene Kit with supplied 
10x Pfu-buffer). All PCR reactions were started with a preincubation step know as “Hot Start” which 
denatures the template DNA at 95-100°C so that the primers can anneal after cooling. The second step, 
otherwise referred to as “touchdown” allows the oligonucleotide primers to anneal to the denatured 
template by lowering the temperature to 37-65°C depending on the Tm (annealing temperature) of the 
primers. The reaction proceeds with the extension, or elongation of the primers at 72°C, the optimal 
temperature for PfuTurbo-DNA polymerase. The duration of the extension steps can be increased if 
long amplicons are being amplified, but for the majority of PCRs, times of up to 2 minutes are usually 
sufficient. Often, the elongation time of the final cycle is longer (up to 10 minutes) in an attempt to 
ensure that all the product molecules are fully extended. Steps 1-3 constitute one cycle of the PCR, 
where the number of cycles of the whole reaction is between usually 25-30 cycles. With increasing 
cycle numbers it is common to observe an increase in the amount of unwanted artifacts and no 
increase in the desired product.  
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Typical amplification reaction:   50 ng    Template DNA 
             5 µl    10x Pfu-buffer (Stratagen kit) 
            5 µl    2 mM dNTP-Mix 
10 µM   Forward primer  
10 µM   Reverse primer 
 2.5 U    PfuTurbo-DNA polymerase (Stratagen kit) 
              Add d H2O to 50 µl 
 
 
 
DNA restriction digestion 
Restriction digestion of plasmid DNA was performed following a standardized protocol for the use of 
one or more endonucleases (Ausubel., et al. 1999). The definition of 1 Unit (U) of restriction enzyme 
activity is the amount needed to completely digest one microgram of substrate DNA (often Lambda 
DNA) in one hour at the optimal temperature (usually 37°C). Additionally, each reaction is carried out 
with a buffer that ensures 100% activity of the endonuclease in question. As a rule of thumb, the total 
volume of restriction enzyme in the digest should not exceed 10% of the total digest volume which 
also ensures that the glycerol concentration in the reaction mixture remains below 5%. Once all the 
components, DNA, dH2O and buffer, have been added to the reaction mix, the endonulease is then 
applied, so it enters optimal reaction conditions. Under non-standard conditions, restriction 
endonucleases are capable of cleaving sequences which are similar but not identical to their defined 
recognition sequence. This is termed “star” activity. Star activity is completely controllable in the vast 
majority of cases and is generally not a concern when the enzymes are used under the recommended 
conditions. Cleaving plasmid DNA with two restriction endonucleases simultaneously (double 
digestion) is achieved by selecting a buffer that provides reaction conditions that are amenable to both 
restriction endonucleases. Choosing the optimal buffer for both enzymes should be done carefully 
under the guidelines supplied by the manufacturer. Alternatively, if no single buffer is available to 
satisfy the buffer requirements of both enzymes, the reactions should be done sequentially; the salt 
conditions adjusted in between digestions using a small volume of a concentrated salt solution to 
approximate the reaction conditions of the second restriction endonuclease. Reactions were brought to 
a halt either by thermal inactivation or by the addition of loading-buffer in preparation for gel 
electrophoresis.    
 
 
Agarose gel electrophoresis 
Agarose gel electrophoresis allows the visualization of a restriction enzyme digestion. The technique 
enables the user to determine precisely the yield and purity of a DNA preparation or PCR reaction, but 
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also to size fractionate DNA molecules, which can then be eluted from the gel. Prior to gel casting, 
dried agarose is dissolved in buffer by heating and is then poured into a self assembled mold into 
which a comb is fitted while the mixture is still wet. The percentage of agarose in the gel varies. In this 
work 0.8% agarose was used, 1% agarose gels being necessary for the accurate size fractionation of 
DNA molecules smaller than 1 kb. Ethidium bromide (EtBr) (end concentration: 1 µg/ml) was 
included in the gel matrix to enable fluorescent visualization of the DNA fragments under UV light. 
The gels were then submerged in electrophoresis buffer (TAE) in a horizontal electrophoresis 
apparatus. After the samples were mixed with gel loading dye and loaded into the sample wells, the 
electrophoresis was initiated by applying 60 mV for 30 minutes to 1 hour at RT.  Size markers are co-
electrophoresed with DNA samples for fragment size determination. Two size markers, 1 kb and 50 
bp, were used from Peqlab. After electrophoresis, the gel was placed on a UV light box and the 
fluorescent ethidium bromide-stained DNA pictured using the thermal imaging system FTI-500 from 
Pharmacia Biotech.  
 
TAE buffer (10 fold):      242 g    Tris  
    57.1 ml    Acetic acid   
     100 ml    0.5 M EDTA, pH 8.0 
                    H2O to 1 L 
 
 
DNA purification form agarose gels  
After electrophoresis, DNA fragments were visualized on a UV light box before being removed from 
the gels by the use of scalpels. Once captured, the DNA was eluted from the jellified agarose 
following the instructions of the “QIAquick Gel Extraction Kits” from Qiagen.        
 
 
DNA concentration and purity determination 
DNA concentration and purity was determined by using the Eppendorf spectrophotometer 
“BioPhotometer” (Hamburg, Germany). The concentration was determined by measuring the 
absorbance at 260 nm and purity was measured by calculating the ratio of absorbance at OD 
260/OD280 nm. 
 
 
DNA fragment ligation 
Purified and restriction-enzyme treated DNA fragments (PCR product) were cloned as described 
(Ausubel., et al. 1999) into the desired plasmid vectors, also having been digested with the same 
endonucleases producing compatible overhangs. After the vector and insert DNA have been prepared 
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and their respective concentration determined, various vector to insert DNA ratios were tested in order 
to determine the optimum ligation ratio. In most cases a 1 to 3 molar ratio of vector and insert proved 
successful. All ligations were performed with ATP-dependent T4 DNA ligase and the provided buffer 
(Boehringer) overnight at 16°C or for 3 hours at RT. Following the reaction, the ligated DNA was 
transformed into an appropriate host strain, here the E. coli stain DH5α.     
 
 
Construction of expression plasmids - pET24c(+)MKH6GzmH 
Granzyme H (GzmH) cDNA was amplified from the homo sapiens cDNA clone IMAGE:15434 
(vector pT7T3D) using the sense strand primer DJ2715 (5´-GAG GAT ATC ATC GGT GGC CAT 
GA-3´) and the antisense strand primer DJ2716 (5´-GCC TAA CGT TAG AGG CGT TTC ATG GTA 
CGT TTG ATC C-3´). The resulting PCR product was digested with Eco RV and Hind III and 
subsequently cloned into the Pml I and Hind III (173) cut pET24c(+) E. coli expression vector 
(Novagen). Vector pET24c(+) was previously modified by introducing the codon sequence MKH6 into 
the vector’s multiple cloning site cleaved at restriction sites Nde I and Bam HI. The MKH6 tag was 
constructed as a duplex with primers DJ2333 (5’-TAT GAA ACA TCA CCA TCA TCA CCA CGT 
G-3’ - introducing codons Met and Lys and the mentioned Pml I site) and DJ2334 (5’-GAT CCA CGT 
GGT GAT GAT GGT GAT GTT TCA-3’). The cloning of modified GzmH cDNA directly upstream 
from the MKH6 tag produced a sequence coding for a mature-like GzmH starting with codons Ile-Ile-
Gly-Gly.  
 
pET24c(+)MKH6GzmHS195A
The catalytically inactive GzmHS195A construct was obtained using pET24c(+)GzmH as a template for 
the amplification of sense primer DJ 2871 (5’-ACA CAC CGG TTT CAA AGG TGA CGC CGG-3’) 
introducing a 5’ Age I restriction site, and antisense primer T7-ter from. Sense primer DJ 2871 
contains a point mutation which replaces the reactive Ser195 with Ala and rendering the protease 
unable to act proteolytically. The resulting PCR product was digested with Age I and Hind III and sub-
cloned into the identically cut pET24c(+)MKH6GzmH vector. The sequences of positive clones from 
both constructs were verified by sequencing analyses and transformed into the E. coli strain B834 
(mentioned later page 32) ready for expression (DE3) (Novagen).  
 
 
Expression constructs 
Construct   Primer  Restriction Sites       Target DNA                    Temp.(AT)  
pET24c(+)MKH6GzmH  DJ2715/16 Pml I / Hind III        Clone154343(human)  53°C 
pET24c(+)MKH6GzmHS195A DJ2871/27 Age I / Hind III        pET24c(+)MKH6GzmH       58°C 
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DNA sequencing 
The sequencing of plasmids and PCR products was performed by Toplab (Martinsried) using 
fluorescently labeled nucleotides as described by Sanger and colleagues (Sanger et al., 1977).  
 
 
 
III.2 - DNA transformation 
 
 
Preparation of CaCl2 competent cells  
A single DH5α colony was inoculated from an LB plate in 2.5 ml of LB medium and incubated 
overnight at 37°C with shaking (~225 rpm). On the following day, the entire o/n culture was used to 
inoculate 250 ml of LB medium (1:100 dilution). The cells were then grown until the OD600 nm 
reached 0.4-0.6 (5-6 hours). In pre-cooled falcon tubes, cells were pelleted by centrifugation (Sorvall 
GSA) at 3000 rpm (4°C, 7 minutes) before being resuspended in one-fifth of the volume (based on the 
original culture volume) of ice cold 0.1 M CaCl2 solution. For the remaining steps, the cells were kept 
on ice and all flasks, pipettes (Eppindorf, Milan, Italy), and tubes were pre-chilled. Cells were then 
incubated on ice for 5 minutes at 4°C. After centrifugation at 3000 rpm (5 minutes, 4°C), the cells 
were gently resuspended in one-twenty fifth of the original culture volume of ice cold 0.1 M CaCl2 
solution. For long term storage of competent cells at -80°C, 20% glycerin was added to the CaCl2 
solution.  
 
CaCl2 solution:    0.1 M    CaCl2
       20%    Glycerin (Glycerol)  
   10 mM    PIPES [piperazine-N,N’-bis(2-hydroxypropanesulfinic acid)] 
 pH 7.0 
    
 
Transformation of CaCl2 competent cells 
An aliquot of 100 µl competent cells was thawed on ice to which 10 ng of plasmid-DNA or ligation 
preparation was added and mixed by gentle swirling of a pipette tip (over 10 ng of DNA may decrease 
the efficiency with some competent cell preparations). The mixture was incubated on ice for 30 
minutes. Thereafter, the tube was transferred to 42°C for 2 minutes before being immediately placed 
back on ice to cool for 2 minutes. After cooling, 1 ml LB medium (without antibiotic) was added and 
incubated for 1 h at 37°C with shaking at ~150 rpm. Centrifugation was performed at 6000 rpm for 5 
minutes. The bacteria were then resuspended in the remaining supernatant and plated out on 
kanamycin selection agar destined for overnight incubation at 37°C (Cosloy and Oishi, 1973; Dagert 
and Ehrlich, 1979). 
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III.3 - Recombinant protein expression in E. coli 
 
 
The pET expression system 
The cloning and expression of recombinant GzmH and the inactive variant GzmHS195A in E. coli was 
accomplished using the pET system from Novagen. This method is based upon the T7 promoter-
driven system originally developed by Studier and colleagues (Moffatt and Studier, 1987; Rosenberg 
et al., 1987; Studier, 1991). The gene of interest is cloned into a pET plasmid of choice under control 
of the bacteriophage T7 promotor. Expression is only induced upon providing a source of T7 RNA 
polymerase in the host cell. The T7 RNA polymerase is so selective and active that, when fully 
induced, almost all of the cell’s resources are converted to target gene expression. The desired product 
is comprised more than 50% of the total cell protein only a few hours after induction. Although this 
system is extremely powerful, it is also possible to attenuate the expression level simply by lowering 
the concentration of inducer. Decreasing the expression level may enhance the soluble yield of some 
target proteins. Another important benefit of this system is its ability to maintain target genes 
transcriptionally silent in the uninduced state. Target genes are initially cloned using hosts that do not 
contain the T7 RNA polymerase gene, in our case the E. coli stain DH5α (genotype: F-
φ,80dlacZΔM15, Δ(lacZYA-argF) U169,recA1,endA1,hsdR17 (rK-,mk+),supE44,λ-,tfi-1,gyrA,relA1, 
Invitrogen), thus eliminating plasmid instability due to the production of proteins potentially toxic to 
the host cell. Once established in a non-expression host, target protein expression may be initiated by 
transferring the plasmid into an expression host containing a chromosomal copy of the T7 RNA 
polymerase gene under lacUV5 control. Expression is induced by the addition of IPTG (1 mM) to the 
bacterial culture (see Figure III.1).  
 
Both GzmH constructs were transformed into the E. coli expression host B834 (DE3) (genotype: F-
,ompT,hsdSB(rB B-mB-),gal,dcm,met(DE3), Novagen) which is a protease deficient, methionine auxotroph 
that, as explained above, bears the T7 RNA polymerase gene (λDE3 lysogen) under the control of the 
lacUV5 promoter. To prevent constitutive expression of the target gene, 2% glucose was added to the 
overnight pre-culture (400 ml LB-kanamycin) where it acts as a catabolic suppressor. Glucose is then 
removed by centrifugation (7000 rpm, 15 min, Sorvall Evolution – SLC 6000 rotor) after which the 
bacteria are resuspended in 80 ml LB containing kanamycin (kana) before being introduced into 10 
liters of the above selection medium. The culture then undergoes shaking at 37°C until an OD (600 
nm) of 0.6 is reached at which point an end-concentration of 1 mM ITPG is added thus allowing T7 
RNA polymerase expression, and shortly thereafter, target gene expression. During this procedure, 
probes are taken and visualized on silver stained SDS electrophoresis gels in order to define the 
optimal duration of protein induction. In our case an incubation time of 5-6 h provided sufficient target 
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protein production. The 10 L of bacteria were then subject to centrifugation (Sorvall Evolution, SLC 
6000 rotor) at 7000 rpm for 15 minutes. The supernatant was removed and the bacteria where washed 
in 1x PBS, centrifuged under the same conditions, the supernatant again discarded and the resulting 
pellet frozen at -20°C until further use.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III.1 - Double induction by IPTG: the bacterial host λDE3 lysogen encodes the T7 RNA 
polymerase. When IPTG is absent, during the growth period, the lac I gene is always expressed and the protein 
product binds to the operators in both the host genome and the pET plasmid. Both genes (T7 RNA polymerase 
and the cloned gene) are silent. The cloned gene of interest (target gene) is transcribed by the T7 RNA 
polymerase enzyme which is only transcribed in the presence of IPTG, namely in the protein production period. 
Taken from Novagen, innovations, vol. 1, number 1, 1994.   
 
 
Following the transformation of E. coli, with constructs encoding the desired recombinant protein, the 
host produces inactive, insoluble aggregates known as inclusion bodies (IB). IB formation is the rule 
rather than the exception and occurs because of over-expression of the target protein and due to the 
lack of eukaryotic protein folding mechanisms such as posttranslational modification, chaperone 
assistance and correct redox status. Indeed, the oxidative folding of disulphide-bonded proteins may 
be compromised severely in the reducing environment of the bacterial cytosol, making aggregation 
inevitable even under optimum chaperone assistance. IB are large spherical particles that occupy a 
large proportion of the host cell and due to their refractive character can be seen directly in the living 
cell by phase contrast microscopy. Due to their relatively high specific density, IB can be harvested 
after cell lysis by a series of washing and centrifugation steps. 
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Inclusion body isolation  
As mentioned above inclusion bodies (IB) are large spherical particles obtained by the over-expression 
of a desired recombinant protein in the cytosol of a transformed microbial host. More precisely, upon 
high-level expression of heterologous proteins, the natural folding pathway is frequently perturbed and 
instead of native, soluble protein, large inactive conglomerates (IB) accumulate within the host cell 
where they eventually come to span the entire diameter of the E. coli cell. In fact, IB formation, which 
is often considered a nuisance, actually has various benefits. On one hand, the resultant conglomerates 
provide a high enrichment of the desired protein at an early stage of purification while on the other 
hand, IB formation protects the recombinant protein against proteolysis by intracellular proteases. 
Additionally, the production of recombinant proteins initially as IB may be the method of choice for 
proteins that, if active, may be harmful or even lethal to the host cell.   
 
Harvesting IB is made easy due to their relatively high specific density and so following lysis of the 
host cell, they can be isolated by a series of centrifugation steps which are preceded by lengthy 
washing in buffers composed of high salt concentrations and detergents such as Triton X-100. 
Moderate rotor speeds (12000 rpm, 20 minutes, Sorvall Evolution, SLC 6000 rotor) allowed the IB to 
sediment more rapidly than the bulk of the cell debris and the washing steps further rid the preparation 
of host contaminants such as cell walls or membrane fragments.  
 
The first step, cell lysis, was performed using a combination of lyzosyme (final concentration: 1 
mg/ml, Sigma-Aldrich) and DNase (10 µg/ml, Sigma-Aldrich) treatment in a lysis mix (detailed 
below) containing MgCl2 but void of EDTA as the chelator scavenges bivalent ion cofactors for 
metalloproteases and inhibits DNase activity. The lysis mix (25 ml / liter culture) was incubated for 30 
minutes while being vigorously shaken after which 5 bursts of sonification (the Output Control and 
Duty Cycle of the Branson sonifier-450 set to 6) were applied. The mixture was incubated on ice to 
prevent over-heating. Wash-buffer I (see below) was added to the lysis mix (one-third of the lysate-
volume) and shaken again vigorously at RT for an hour. The lysate was then spun down at 12000 rpm 
for 20’ (SLC-1500 rotor, Sorvall). The IB pellet was then resuspended using a Potter-S homogenizer 
(Sartorius). This cycle of “wash, centrifugation and homogenization” was then repeated there times 
with Wash-buffer I (30 ml / 4 L culture) and then again three times with Wash buffer II (detailed 
below, 30 ml / 4 L culture). After the final centrifugation step, the pelleted IB were removed, weighed 
and stored at -20°C until use. A 10 L culture of GzmH transformed B834 hosts generally producing 4-
5 g of IB material.   
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Lysis mix:  50 mM    Tris HCl, pH 7.2 
2 mM    MgCl2 
 
Wash buffer I: 50 mM    Tris HCl, pH 7.2  
 60 mM    EDTA 
   1.5 M    NaCl 
       6%    Triton X-100  
 
Wash buffer II: 50 mM    Tris HCl, pH 7.2 
                                       60 mM    EDTA 
                                    
 
Solubilization of inclusion bodies 
IB disintegration requires the use of rather drastic denaturants. Indeed, even though IB conglomerates 
contain relatively high secondary structure content, they do not disentangle under physiological 
solvent conditions. In our protocol 6 M guanidinium chloride (GdmCl) was chosen as the preferred 
denaturant due to its ability to solubilise particularly sturdy IB that are often resilient to solubilisation 
by other chaotrophs such as urea. Another consideration concerning the composition of the 
solubilisation buffer (SB buffer) was whether or not the recombinant protein in question contains 
cysteine residues. Isolated IB usually contain a number of interchain disulphide bonds which reduce 
the solubility of IB in the absence of reducing agents such dithiothreitol or Cleland’s reagent (DTT), 
dithioerythritol (DTE) and glutathione. The addition of these thiol reagents, in combination with the 
above chaotrophs, results in the reduction of the interchain disulphide bonds by thiol-disulphide 
exchange. Recombinant GzmH contains 7 cysteine residues, as does GzmB, which were successfully 
solubilised following a protocol described for GzmK (Wilharm et al., 1999). Here oxidized and 
reduced glutathione (GSSG and GSH respectively) (Fluka) was the redox-system of choice. Finally, 
because the reactive species in the thiol-disulphide exchange is the thiolate anion, IB solubilisation in 
the presence of a reducing agent is usually performed under mildly alkaline conditions and should 
additionally be carried out in the presence of EDTA to prevent the oxidation of thiols by molecular 
oxygen and metal ions at neutral to alkaline pH values.  
 
Recombinant GzmH IB were first of all homogenised, as described above, in freshly prepared SB 
buffer at pH 8 (1 ml per 100 mg IB, composition detailed below). Once well resuspended, the 
solubilisation mixture was shaken over night in a rotating fashion at RT. Following centrifugation (10’ 
at 4000 rpm, GSA rotor, Sorvall Evolution) the supernatant was prepared for dialysis to rid the 
solubilisate of the redox-system and EDTA. In the case of considerable pellet formation, the remaining 
IB were homogenised and sonified, as previously explained, before centrifugation. Persistent pellet 
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formation was dealt with by again resuspending the IB in fresh SB buffer. Dialysis was performed 
three times and changed every 8 hours, in 6 M GdmCl, pH 5, after which the solubilisate was diluted 
1:40 and its concentration measured at 280 nm. Prior to refolding, the solubilisate was filtered (0.22 
µm) and stored at 4°C.    
 
SB buffer:                    6 M    Guanidinium Cl 
                                         100 mM    Tris HCl, pH 8.0 
                                           20 mM    EDTA 
                                           15 mM    GSH 
                                         150 mM    GSSG 
                                            
 
Renaturation of IB proteins 
Renaturation (or refolding) of solubilised IB proteins was achieved by rapid dilution of the solubilisate 
in an optimised refolding buffer (RF buffer). This was preferred to refolding by dialysis where, at the 
stage of folding intermediates, intermediate denaturant conditions lead to high levels of precipitation. 
The preference of a given protein for refolding by dilution or by dialysis cannot be deduced from its 
molecular properties. Instead, the optimum procedure has to be determined on a case-by-case basis. 
Whatever the method of choice, misfolding, as well as aggregation, competes with the correct folding 
pathway (see Figure III.2). The cause of aggregation may be the result of non-specific hydrophobic 
interactions of predominately unfolded polypeptide chains or even due to incorrect interactions of 
partially structured folding intermediates. Importantly, aggregation has been shown to be 
concentration dependent and predominates upon refolding above a “limiting” or “threshold” 
concentration of solubilisate. Finding the threshold for a given solubilisate is therefore essential for 
successful dilution refolding.  
 
Another parameter to consider in protein renaturation is the number of disulphide bonds the protein in 
question possesses. Not only must the correct noncovalent secondary, tertiary, and quaternary 
structures be regenerated but also the correct disulphide bonds. Disulphide bond formation is aided by 
exchange reactions with low molecular weight thiols, most commonly oxidised and reduced 
glutathione otherwise known as “oxido-shuffling” reagents although depending on the protein, other 
low weight thiols, such as cysteine, may better aid disulphide bond formation as is the case with our 
granzymes. Importantly, because thiol disulphide exchange proceeds via a nucleophilic attack on the 
thiolate anion, mildly alkaline conditions are used, the pH in our protocol being set at 7.3. Physical 
parameters such as pH, ionic strength and temperature are also reported to have a great effect on the 
folding process. Furthermore, buffer compounds or prosthetic groups may additionally be essential. 
Indeed, buffering compounds such as Tris buffer and L-arginine have been reported to greatly improve 
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the stability of certain proteins, again such as the members of the granzyme family, although their 
exact functions as “folding enhancers” remain unclear.        
 
Finally, after sufficient renaturation time, the refolded material is filtered and concentrated to a volume 
suitable for dialysis. The correctly refolded protein is repetitively dialysed, following the 1:25 dilution 
rule, into a suitable, stabilising buffering solution thus separating the protein from RF components 
such as L-arginine (L-Arg) which if not removed may have an effect on the protein’s purification via 
cation exchanger columns.        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III.2 - Folding and aggregation during protein renaturation. Correct folding reactions, leading to the 
native state [(1) and (2)]. Irreversible aggregation reactions, starting from different conformations during the 
refolding process [(3) and (4)]. 
 
 
GzmH was purified essentially as described (Wilharm et al., 1999), the limiting solubilisate 
concentration, as reported for GzmB and GzmK, remaining unchanged at 100 µg/ml. Dilution 
renaturation was carried out in a final volume of 5 L of RF buffer (see below). Renaturation was 
performed overnight at 4°C, the solubilised protein added at RT (with light stirring) followed by 
gradual cooling. Importantly, cysteine (0.5 mM) was given to the RF buffer just before the 
solubilisate. Alternatively, the solubilisate can be added in pulses every 8 hours (Cysteine always 
added beforehand) although a single pulse with overnight incubation at 4°C was found to produce 
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higher yields of correctly folded GzmH. The solubilisate was added to 5 L RF buffer at a 
concentration of 100 µg/ml.  
 
RF buffer:      50 mM    Tris HCl, pH 7.3 
    0.5 M    L-arginine 
    1 mM    EDTA 
150 mM    NaCl 
 0.5 mM    cysteine 
 
 
After overnight incubation at 4°C, the refolding solution was filtered (0.22 µm) and concentrated from 
5 L to 1 L using a 10 kDa cut off minisette filter from Palfilltron. Protein concentration was 
determined spectroscopically using ε280 nm = 24,960 M -1 cm -1, before and after concentration so as to 
determine the amount of protein loss. The concentrated inactive GzmH was then dialysed 5 times, in 5 
L of 25 mM MES buffer (pH 5.5) containing physiological salt (150 mM NaCl) and 20 mM CaCl2. 
Protein purity can also be checked at this point by SDS-PAGE followed by silver staining (see p 42). 
 
 
FPLC protein purification  
Following renaturation, concentration and dialysis into a stabilising buffed solution, soluble granzyme 
is further purified using a technique known as Fast Protein Liquid Chromatography or FPLC. FPLC 
is a form of column chromatography used to separate and concentrate proteins from complex 
mixtures. Columns used with an FPLC can separate proteins based on size (gel filtration), hydrophobic 
interaction, affinity (ligand affinity, such as a His-tagged protein) and charge distribution (ion 
exchange, cation or anion).  
 
GzmH was purified using an FPLC system (ÄKTAprime, Amersham, Pharmacia Biotech, Piscataway, 
NJ, USA) equipped with an ion exchange column. The separation is here based on the reversible 
interaction between a charged protein and an oppositely charged chromatographic medium. After 
loading of the desired protein, the elution is usually performed by increases in salt (NaCl) 
concentration (or changes in pH) in form of a continuous gradient. Target proteins are thus 
concentrated during binding and collected in a purified, concentrated form. The net surface charge of 
proteins varies according to the surrounding pH which when above the isoelectric point (pI) of the 
protein in question will cause it to bind to an anion exchanger, while if the pH is below the pI will 
force the protein to bind to a cation exchanger. GzmH has a theorectical pI of 9.94 and is buffered in 
150 mM NaCl, 25 mM MES at pH 5.5. Following these criteria, the strong cation ion exchanger 
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Source 15S media (Pharmacia) with a binding capacity of 25 mg protein /ml gel, was chosen and 
loaded onto a HR 5/5 column (Pharmacia). 
 
Once loaded with the desired packing material, the column must be charged and equilibrated. First the 
ion exchanger is charged with counter ions (buffer B) and then equilibrated using the buffering 
solution in which the protein is contained (buffer A). After sample application the column is further 
washed with equilibration buffer A until the salt gradient is started. GzmH was eluted using buffer B 
and collected in fractions of 2ml. Fractions were selected and pooled after analysis by both protein 
determination measurements and SDS-PAGE analysis. Fractions were kept at 4°C. 
 
Buffer A (Degassed):    25 mM    MES, pH 5.5 
    150 mM    NaCl 
    
Buffer B (Degassed):    25 mM    MES, pH 5.5 
           2 M    NaCl 
 
Our purification protocol for GzmA, GzmB, GzmH and GzmK uses two ion exchange column steps. 
First, the proform is purified and concentrated. Next, activation of the granzyme is achieved by the 
removal of its pro sequence, explained next. Finally, the second FPLC purification step is needed to 
not only separate any remaining proGzmH from its active counterpart but also to rid the protein of the 
applied converting agents. Although the size difference between the two forms is very small (8 amino 
acids) the loss of 6 histidines and a lysine causes enough reduction in positive change to allow the 
active form to elute slightly before the proform. Active protein fractions are pooled after SDS-PAGE 
analysis and dialysed into the appropriate buffering solution. Overnight dialysis against 25 mM MES 
pH 5.5 and physiological NaCl (150 mM) provided stable one-time-use conditions for storage at -
80°C. Under these conditions a final SDS-PAGE analysis revealed the pure and efficient conversion of 
both GzmH and GzmHS195A. 
 
 
Granzyme activation - processing by Cathepsin C 
The activation of granzymes is achieved by the removal of their prosequences, in our case the MKH6 
tag, creating a N-terminal sequence beginning, as in all granzymes, with the characteristic Ile-Ile-Gly-
Gly. As explained, this cleavage allows the granzymes to undergo conformational change resulting in 
the formation of a salt bridge between the amino group of Ile16 and the carboxylate group of Asp 194, 
and hence a mature, active protease.  
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The enzyme responsible for this activation step in vivo is cathepsin C, otherwise known as DPPI 
(dipeptidyl peptidase I). Cathepsin C is a papain family cysteine protease that, at the correct pH 
(between 6.7 and 7.2) sequentially removes dipeptides from the free N-termini of proteins and 
peptides. It has broad specificity except that it does not cleave after basic amino acids such as Arg or 
Lysine (Lys) in the N-terminal position or proline (Pro) on either side of the scissile bond. We have 
placed a Lys (a stop codon for cathepsin C) after methionine as a protective measure in case of Met 
removal by bacterial methionine aminopeptidases. Importantly, once the last of the MKH6 tag’s three 
dipeptides is removed, conformational change and salt bridge formation between Ile16-Asp194 
ensures that the new N-terminus is protected from further attack by exopeptidases such as cathepsin C.    
 
Following the purification step, described above, bovine cathepsin C (Sigma-Aldrich) was activated 
by incubating the desired amount of the enzyme (0.5 U/mg protein) in conversion buffer (detailed 
below) for 1 h at 37°C. Concentrated proGzmH (500 µg/ml) is then added to the activated cathepsin C 
along with sodium acetate (50 mM NaOAc, pH 5.5) at one tenth of the total volume. Finally, 1 mM 
DTE is added ensuring that cathepsin C remains active. As explained above, the pH must be kept in 
the optimal range and therefore should be checked before leaving the mix for 6-8 hours at 30°C.     
 
Conversion buffer:   50 mM    NaOAc, pH 5.5 
    100 mM    NaCl 
    1 mM    DTE 
 
   
As mentioned, in our purification protocol, source S15 columns were used to purify both the pro and 
active forms of GzmH. As a final note, although a H6 tag was adjoined as a prosequence, the use of a 
nickel NTA column for proGzmH purification was finally decided against. The source S15 ion 
exchange media proved to provide much cleaner results. Additionally, it was thought that nickel might 
interfere with the H6 tag by attaching to histidine residues and thus interfering with cathepsin C 
conversion. Elution by imidazol was also thought to interfere directly with cathepsin C, possibly by 
blocking its active site.  
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III.4 - Protein separation 
 
 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Gel electrophoresis is a useful method to separate and identify proteins. In sodium dodecyl sulphate 
(SDS) polyacrylamide gel electrophoresis (PAGE) or SDS-PAGE, proteins are separated on the basis 
of polypeptide length, therefore allowing their molecular weight to be estimated. Our protocol uses 
Laemmli buffer (a denaturing buffer) and a discontinuous gel system composed of both a stacking and 
separating gel. The stacking gel is slightly acidic (pH 6.8) and has a low acrylamide concentration to 
make a porous gel. Under these conditions proteins separate poorly but form thin, sharply defined, 
bands. The separating gel, is more basic (pH 8.8), and has a higher polyacrylamide content (in our case 
mostly 15%), which causes the gel to have narrower channels. As the protein of interest travels 
through the separating gel, the narrower pores have a sieving effect on the proteins, allowing smaller 
proteins to travel more easily and hence rapidly through the matrix (Laemmli, 1970).   
 
 
SDS polyacrylamide gels (15%): Eight-gel assembly 
 
 Stacking Gel (20 ml) Separating Gel (40 ml)
d H2O  13.6 ml 9.4 ml 
30% acrylamide 3.32 ml  20 ml 
1 M Tris HCl, pH 6.8 2.56 ml - 
1.5 M Tris HCl, pH 8.8 -  10 ml 
20% SDS             100 µl              200 µl 
10% APS             200 µl              400 µl 
TEMED  20 µl 16 µl 
Bromophenol blue   5 µl - 
 
 
Once polymerized, the polyacrylamide gels were next mounted in a Mini-protean II apparatus (Bio-
Rad) and covered with 1x running buffer based on glycine (10x running buffer: 250 mM Tris, 1.92 M 
glycine and 1% SDS in an aqueous solution). The low molecular weight protein marker, Roti-Mark 
prestained (Roth) was loaded (3 µl for silver staining and 5 µl for coomassie staining) in one of twelve 
wells during sample preparation. Concentrated Laemmli buffer ((4x denaturing buffer: 200 mM Tris 
HCl, pH 6.8, 40% Glycerol (denser than water, makes the sample fall to the bottom of the well), 30% 
β-mercaptoethanol (disulphide bridge reduction), 10% SDS (confers negative charge) and 0.2% 
bromophenol blue (visualisation)) was added to the samples which were then boiled (95°C, 5 minutes) 
and loaded. For the best results all samples should be in identical, low ionic strength buffers and 
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should be loaded in equal volumes. The protein amount per well should not exceed 30-40 µg. Finally, 
gels were run at a constant voltage (200 mV/s) using a Bio-Rad electrophoresis apparatus.   
 
 
 
III.5 - Protein detection 
 
 
Silver nitrate staining of proteins after SDS-PAGE 
After the separation of proteins comes their detection. One of the most popular detection methods is 
silver staining which can detect as little as 3-10 ng of loaded protein. In fact, while a 100 fold more 
sensitive than Coomassie blue staining, silver staining comes close to the sensitivity provided by 
Western Blot analysis.   
 
Following electrophoresis, polyacrylamide gel plates were disassembled and briefly washed in d H2O. 
Next, the gels are soaked, while shaking, in a fixing solution composed of 50% Methanol, 12% acetic 
acid and 0.5 ml 37% formaldehyde (topped up to 1 L with d H2O) for 1 hour after which 3 baths of 10 
minutes in 50% ethanol are required. Thereafter, the gels were introduced into a sodium thiosulphate 
solution (0.2 g Na2S2O3 x 5 H2O per litre) for 1 minute before being washed 3 times for 20 seconds in 
d H2O. A freshly made silver nitrate solution (2 g AgNO3 and 750 µl 37% formaldehyde per litre) was 
then exposed to the gels. After 30 minutes the staining solution is removed by several washing steps in 
d H2O. A developing solution (60 g/L Na2CO3, 4 mg/L Na2S2O3 x 5 H2O, 0.5 ml 37% 
formaldehyde/L) is then applied and eventually stopped by thorough washing with d H2O. Two 
methanol based washes follow, first a10 minute incubation in 50% methanol, 12% acetic acid and then 
a 20 minute bath in 50% methanol. Both solutions were brought to 1 L with d H2O. The gels were 
finally stored in d H2O. The washing procedure is always accomplished by shaking.  
   
 
SDS-polyacrylamide coomassie blue staining      
Coomassie blue staining is much less sensitive than silver staining as described above. Its purpose is 
geared towards simple protein verification but is not intended for monitoring protein purification 
schemes such as is the case with our granzyme production protocols.  
 
Following SDS-PAGE, the gel was incubated for 1 hour in Coomassie blue solution (25% 
isopropanol, 10% acetic acid and 0.05% Coomassie Brilliant Blue G per litre) after which it was 
heated to 60°C, with lid, for 1 minute in a microwave oven. After careful removal, the gel is left to 
shake in the solution for 5-10 minutes. The Coomassie solution is then removed (back into original 
bottle) and the gel is bathed in de-staining solution (10% ethanol, 10% acetic acid) until bands appear. 
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For the efficient removal of excess coomassie staining, absorbing paper can be used along with the 
exchange of destaining solution. If proteins bands take time to appear, further heating in a microwave 
can help accelerate development (Meyer and Lamberts, 1965).   
 
 
Western blot analysis - protein detection using chemiluminescense    
Simply put, Western Blot analysis is a technique used for the determination of relative amounts of 
proteins from different samples which have been previously separated by SDS-PAGE and thereafter 
blotted onto a “Hybond ECL” (nitrocellulose) membrane (Amersham-Pharmacia) again by 
electrophoresis, and reacted with a specific primary antibody. A secondary antibody-enzyme 
conjugate, which recognises the primary antibody is then added to find the locations where the 
primary antibody is bound by means of chemiluminescenstie. Alternatively, proteins can also be 
transferred onto a different kind of membrane, a “Immunobilon-PSQ” (PVDF) membrane which can 
then be used for N-terminal sequencing of the desired protein. Before sequencing however, the 
membrane is stained very briefly with Coomassie blue and then destained with 30% acetic acid until a 
strong enough signal is detected (Bronstein et al., 1992; Towbin et al., 1979). 
 
In this work both Wet-Transfer (Bio-Rad apparatus) and Semi-Dry (Biometra) Western blotting (WB) 
was performed. As a rule of thumb, Semi-Dry WB was used for low molecular weight proteins up to 
30-35 kDa. Wet-Transfer WB on the other hand was chosen for proteins exceeding 35 kDa in size. 
Fresh transfer buffer was made before both procedures and although the Wet Transfer WB also 
worked well for proteins of low molecular weight, Semi-Dry WB was often the method of choice as 
much less transfer buffer (25 mM Tris HCl, 200 mM glycine, 20% methanol, 0.1% SDS) is needed 
along with less Whatman 3 mm paper.     
  
Before the Wet Transfer run is carried out, the SDS polyacrylamide gel and both Whatman and 
membrane of choice are equilibrated in transfer buffer. Then, after assembly and correct set up of the 
Bio-Rad Protean apparatus (filled with transfer buffer and containing an ice pack) the transfer is 
initiated and run for 1 h at 100 V. Constant stirring is applied during the transfer.  
 
The Semi-Dry procedure differs in a number of aspects. Apart form being preferred for low molecular 
weight proteins, as noted above, the quantity of buffer is largly reduced. Secondly, the sandwich 
assembly is horizontal, the bottom surface being the cathode. Further differences include the use of 
fewer Whatman sheets (3 each side as opposed to 5 in Wet-Transfer WB) and importantly, depending 
on the surface area with the membrane, an increasing surface requires an increase in the voltage 
applied.    
 
 - 43 -
 Material & Methods 
____________________________________________________________________________
  
 
Once the run of choice is through, the transfer is verified by checking the presence of a similarly sized 
pre-stained marker bands (Roth). Thereafter, the membrane is washed three times in PBS-T (1x PBS, 
0.05% Tween) and blocked in a milk solution (PBS-T, 5% non-fat-powered-milk (NFPM)) for 1 h at 
RT (shaking). The membrane was then washed three times in PBS-T with shaking before being 
exposed overnight to the desired primary antibody, diluted appropriately in PBS-T containing 5% 
NFPM, at 4°C with rotation. To save antibody, the membrane was sealed within a tight, special plastic 
poach. Again, the membrane is washed three times, with shaking in PBS-T. The PBS-T was then 
drained off before the ECL substrate solution (Amersham Pharmacia), 1 ml of both solutions mixed 
for a membrane of 5x10 cm in size, was added for 1 min. Finally, the membrane was exposed to X-ray 
ECL film (Amersham Pharmacia) for 20 seconds to 30 minutes until the expected bands developed.   
           
 
 
Spectrophotometric determination of protein concentration 
 
 
The concentration of a sample protein in solution can be determined by spectrophotometric methods. 
Absorbance can be measured at 280 or 215-230 nm, a simple method that can be used for crude 
lysates or for purified or partially purified proteins. Indeed, proteins have two absorbance peaks in the 
UV region, one between 215-230 nm, where the peptide bonds absorb, and another at 280 nm where 
light is absorbed by aromatic amino acids, tyrosine (Tyr), tryptophane (Trp) and phenylalanine (Phe).  
 
Protein concentration was calculated as such:  c(mg/ml) = (A280 x MW) / (ε280 x b) 
 
where, c is the concentration, A280 is the measured absorbance at this wave length (biophotometer, 
Eppendorf), MW, the molecular weight of the protein in question, ε280, the absorption coefficient and 
b, the path length, which for most spectrometers is 1 cm. Alternatively, a coefficient factor can be 
calculated, MW / (ε280 x b), that can multiplied against A280. 
 
Although proteins have little absorbance at 260 nm, both proteins and nucleic acids absorb at 280 nm 
and therefore, if mixed, their spectra interfere with one another. Because nucleic acids have maximal 
absorbance at 260 nm, protein purity can be estimated by dividing A260/A280 where a ratio of 0.6 is 
characteristic of pure protein. Finally, our spectrophotometer (Biophotometer, Eppendorf) also 
displays a 320 nm reading for protein measurement which should show virtually no absorbance since 
neither nucleic acids nor proteins absorb at this wave length [Warburg et al., 1942; Layne et al., 1957].  
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Colorimetric determination of protein concentration 
 
 
The colorimetric methods make use of the property that certain ions change in adsorption maximum 
on binding to other molecules such as proteins. In this work, the colorimetric quantification of proteins 
was based on the Bradford assay, where instead of Coomassie Brilliant Blue G, a Bio-Rad protein dye 
equivalent was used which also has absorption maximum shifting from 465 to 595 nm upon binding to 
proteins. Standard cuvettes were used in this assay. In the cuvettes, different quantities of BSA (1-10 
µg) were carefully mixed with 200 µl of Bio-Rad protein dye. Absorption was then measured at 595 
nm and the BSA values drawn as a standard curve. The desired protein sample(s) are dealt which as 
above and their concentration determined against the linear BSA curve (Bradford, 1976).  
 
 
 
III.6 - Enzymatic tests 
 
 
Recombinant granzyme activity assays  
The enzymatic analysis of GzmH was performed in 96 well plates and monitored using a Dynatech 
MR4000 microplate reader. The esterolytic activity of GzmH was previously demonstrated by 
Edwards and colleagues using a thiobenzyl ester. As reported, the enzymatic hydrolysis of peptide 
thioester substrate Suc-Phe-Leu-Phe-SBzl was measured in a activity buffer (50 mM Tris HCl pH 8, 
150 mM NaCl, and 0.01% X-100) at RT. A 10x assay buffer was made for convenience. From the 
GzmH stock preparation (500 µg/ml in 25 mM MES, 150 mM NaCl, pH 6), the enzyme was diluted to 
300 nM in 1x assay buffer. Ten µl was then added to a well containing 90 µl of 1x activity buffer. A 
further 50 µl, containing 2.25 µl substrate Suc-Phe-Leu-Phe-SBzl (0.9 mM), 2.25 µl DTNB (0.9 mM) 
and 45.5 µl 1x assay buffer was then added bringing the final concentrations in 150 µl total volume 
to 20 nM GzmH (20 nM = 0.5 µg), 0.3 mM substrate and 0.3 mM DTNB. Once the substrate added, 
its hydrolysis was monitored by absorbance at OD 405 using a Dynatech MR4000 microplate reader. 
In some assays Cathepsin G or mast cell chymase (both from Merck Biosciences) were used as 
positive controls.  
 
New peptide substrates H-Pro-Thr-Ser-Tyr-AMC and H-Ala-Thr-Ser-Tyr-AMC, a kind gift from Dr. 
Doerner (Merck Biosciences) were tested. Both amide substrates were delineated from a peptide 
substrate library scan PS-SCL, positional scanning synthetic combinatorial libraries, described by 
Mahrus and Craik in 2005. The substrates were dissolved in 99.5% pure DMSO (Sigma Aldrich) to a  
concentration of 50 mM and diluted to 250 µM in activity buffer. Fluorescence intensities were 
recorded with a Fluostar Optima (BMG Labtech, Offenburg, Germany) at RT and evaluated using the 
Fluostar Optima software. 
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Enzymatic activity of GzmB (200 nM) was measured using the substrate Ac-IEPD-pNA (10 mM in 
99.5% DMSO) at a final concentration of 250 µM in 100 µl activity buffer. Absorption of the resulting 
cleavage was again monitored at OD 405 using the above reader.  
 
 
Recombinant GzmH inhibition assays  
Inhibition by DCI (3,4-Dichloroisocoumarin), a highly reactive, potent irreversible general serine 
protease inhibitor and the phosphonate inhibitors from J.C. Powers, were measured as described 
above. Inhibition was measured by incubating 4.5 µl GzmH (11.11 µM) with 0.5 µl inhibitor (10 mM) 
for 20 min at room temperature. The 5 µl was then transferred to 166.6 µl of buffer bringing down the 
molarity to 300 nM. After mixing, 3x 10 µl was immediately added to 90 µl buffer triplicates. The 
substrate, DTNB, and buffer were added to assay the residual enzyme activity as described above. As 
a note, the incubated of enzyme (E) and inhibitor (I) was performed at stock concentrations thus 
increasing E-I interaction instead of previous dilution in an assay buffer; DCI is not so very stable in 
aqueous solutions. Finally, for optimal E-I interaction a physiological salt concentration of 137 mM 
and of pH 7.4 is optimal. 
 
 
Reagents:  
• Suc-Phe-Leu-Phe-SBzl (Bachem) for GzmH. Stock solution: 20 mM in 99.5% pure DMSO 
(Sigma). Final concentration in test: 0.3 mM  
• H-Pro-Thr-Ser-Tyr-AMC and H-Ala-Thr-Ser-Tyr-AMC (Merck Biosciences) for GzmH. Stock 
solutions: 50 mM in 99.5% pure DMSO (Sigma). Final concentration in test: 0.25 mM  
• Ac-IEPD-pNA (Calbiochem) for GzmB. Stock solutions: 10 mM in 99.5% pure DMSO (Sigma). 
Final concentration in test: 0.25 mM  
• DCI (Sigma). Stock solution: 10mM in 99.5% pure DMSO (Sigma). Final concentrations in test: 1 
and 10 mM 
• DTNB (Sigma). Stock solution: 20mM in 99.5% pure DMSO (Sigma). Final concentration in test: 
0.3 mM. 
• Assay buffer: 50 mM Tris HCl pH 8, 150 mM NaCl, and 0.01% Triton X-100 
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III.7 - Apoptosis assays 
 
 
Culture of target cells 
K562 (immortalized erythroleukemia cells derived from a patient with chronic myelogenous leukemia, 
initalised CML), HL-60 (Human Caucasian promyelocytic leukaemia cell line) and U937 (Human 
leukemic monocyte lymphoma cell line) cells were cultured in RPMI 1640 supplemented with 10% 
fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin/ streptomycin (Gibco) in a 
humidified atmosphere at 37°C with air containing 5% CO2. The NK cell lines, YT, NK92 and NKL 
were also maintained in RPMI comtaining GlutaMax, 15% FBS, 100 U/ml penicillin/streptomycin and 
200 U/ml interleukin-2 (IL-2). 
 
Changes in membrane integrity 
 
 
FITC- annexin V & propidium iodide staining  
Killing assays and target cell staining with annexin V-FITC (AV) and propidium iodide (PI) were 
performed in triplicates in 96-microwell plates (NUNC #163320, Wiesbaden, Germany) using 1 x 105 
cells in 50 µl (2 x 106/ml) per well in serum free, 0.5% BSA RPMI GlutaMax medium. All assays 
were performed in 50 µl total volume (100,000 cells) unless indicated. GzmB and GzmH (both at 
stock concentrations of 500 µg/ml) were added to the cells at the indicated final concentrations (see 
figure legends) before the addition of translocator proteins, namely perforin (PFN) and Streptolysin O 
(SLO). SLO, but not perforin, was activated prior to use in medium containing 40 µM cysteine for 10 
minutes at RT, diluted and freshly added to the cells at a final concentration which depended on the 
cells type. Indeed, sublytic concentrations of every new batch of perforin (a generous gift from C. J. 
Froelich, Evanston, IL), SLO (Sigma-Aldrich) were determined separately for K562, U937 and HL60 
cells and were defined as the concentration required to induce cell death in 10% to 20% of all cells. 
PFN was used at final concentrations of 75-80 ng/ml with HL60 cells and 200-225 ng/ml with K562 
cells. SLO was used at 75 ng/ml and 125-175 ng/ml respectively.  
 
After the necessary incubation period, cells were washed twice in 1x PBS. Cells were then stained for 
15 minutes in a volume of 25 µl at RT with fluorescein isothiocyanate (FITC)-annexin V (15 µM, 
recombinantly produced and FITC labeled) at 1:100 and propidium iodide (BD biosciences, stock 
concentration 1 mg/ml) 1:20 in annexin binding buffer (BD biosciences). Following this, the cells 
were diluted in binding buffer and analysed by fluoresence activated cell sorter (FACS) with 
CellQuest software (BD Biosciences, Heidelberg, Germany). In some experiments the caspase 
inhibitors zVAD-FMK, zDEVD-FMK and zVDVAD-FMK (Bachem, Bubendorf, Switzerland) were 
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applied at a final concentration of 50 µM from 50 mM stock solutions resuspended in 99.5% pure 
DMSO (Sigma) (Kurschus et al., 2004; Kurschus et al., 2005).  
 
 
Figure III.3 - The annexin V-FITC, propidium iodide assay.  Propidium iodide (PI) intercalates into the major 
groove of double-stranded DNA and produces a highly fluorescent adduct that can be excited at 488 nm with a 
broad emission centered around 600 nm. Annexin V-FITC (AV), on the other hand detects the relocation of 
membrane phosphatidylserine from the intracellular surface to the extracellular surface. Following one hour of 
GzmB treatment K562 cells, for example, display apoptotic features, many of which can be detected by flow 
cytometry.  Following staining with AV and PI, a dot plot would display living cells as AV negative and PI 
negative, whereas apoptotic but not dead cells would be defined by an AV+ and PI- population while necrotic 
cells would be displayed as being AV+ and PI+. 
 
 
Trypan blue staining 
Trypan blue is so-called because it can kill trypanosomes, the parasites that cause sleeping sickness. 
The dye is also known as diamine blue and Niagara blue. Trypan blue is a vital dye. The reactivity of 
trypan blue is based on the fact that the chromophore is negatively charged and therefore does not 
interact with the cell unless the membrane is damaged allowing the researcher to distinguish between 
viable and non viable cells. Trypan blue staining of K562 and HL60 cells was performed by mixing 
equal volumes of cell suspension with a 0.4% trypan blue solution diluted to 0.1% (T8154, Sigma-
Aldrich). Cells were then counted using a hemocytometer. The percentage of trypan-blue-positive 
cells was then scored. 
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Caspase activation 
 
 
Purified recombinant pro-caspases as potential substrates 
Caspases are synthesized as inactive pro-enzymes and are activated by cleavage at specific aspartate 
cleavages sites to release an N-terminal pro domain, leaving two subunits (p20 and p10) to 
heterodimerise. Since all caspases are cleaved at specific aspartate residues, it raises the possibility 
that some caspases sequentially activate others thereby establishing a hierarchy of caspases. A 
distinctive feature of caspases is the absolute requirement of aspartate residue in the P1 position. The 
carboxylate side chain of the substrate P1 Asp is tethered by four residues in caspase 1 (Arg179 and 
Gln238 from p20; Arg341 and Ser347 from p10) that are well conserved in all family members. The 
P4 residue is important in substrate recognition and specificity (caspase-1 prefers a hydrophobic 
tyrosine whereas capsase 3 prefers an anionic aspartic acid residue). Generally, the catalysis involves a 
cysteine proteinase mechanism. The tetrapeptides used in this work to identify differential caspase 
activities correspond to the substrate P4-P1 residues.   
 
Catalytically inactive human procaspases 3 and 7 (5 µM), in which the active site Cys285 was 
replaced by an Ala residue (Riedl et al., 2001; Riedl et al., 2005), were used to avoid auto-activation (a 
gift of Stefan Riedl). The procaspases were incubated with either recombinant GzmH or GzmB for 1 h 
at 37°C in activity buffer (50 mM Tris HCl pH 8, 150 mM NaCl, and 0.01% TX-100) in a final 
volume of 10 µl. Refer to figure legends for GzmB and GzmH final concentrations. Samples were 
boiled in reducing Laemmli buffer, loaded and separated on an 18% polyacrylamide gel. 
Electrophoretically separated bands were visualized by silver staining. 
 
 
Caspase activity in living cells 
Caspase activity can be assayed using either a fluorophore (AMC, AFC) or a chromophore (pNA) 
attached to a substrate sequence although fluorogenic substrates offer a greater sensitivity of detection 
compared to colorimentric substrates. To increase the cell permeability of caspase substrates, aspartate 
residues were esterified (OMe).  
 
Caspase activity, in intact (non-lysed) target cells, was measured with fluorogenic substrates. The cells 
were mixed with the substrates acDEVD-AMC, acLEHD-AMC or zVDVAD-AFC (Merck 
Biosciences) at a final concentration of 100 µM in RPMI 1640 medium (without phenol red). This 
medium contained 0.5% BSA (Sigma-Aldrich), hepes (25 mM), 100 U/mL of both penicillin and 
streptomycin and 2 mM L-glutamine (Invitrogen, Karlsruhe, Germany). Each mix was then plated on 
a 96-well plate, with flat bottom, for 1 hour at 37°C in a 5% CO2 atmosphere. In several experiments 
caspase inhibitors were included in the cell culture medium before treating the cells with granzymes 
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and sublytic concentrations of PFN or SLO. Substrate hydrolysis was directly monitored using a 
Wallac Victor 2 multi-label counter, model 1420, (Perkin Elmer, Fremont, CA) at 37°C. AMC was 
monitored by excitation at 380 nm and emission at 460 nm, AFC by excitation at 420 nm and emission 
at 520 nm. 
 
 
DNA Laddering  
A caspase-3-activated DNase, most likely caspase activated DNase (CAD), produces internucleosomal 
DNA cleavage, otherwise known as DNA laddering. GzmB is also reported to directly cleave the 
inhibitor of CAD. Apoptotic DNA-laddering was done as described by Hermann et al., in 1994. After 
treatment with GzmB (10 µg/ml) or GzmH (20 µg/ml) K562 cells were pelleted and treated for 10 
minutes in lysis buffer (1% NP-40 in 20 mM EDTA, 50 mM Tris HCl, pH 7.5). Ten µl of lysis buffer 
was used per 106 cells (e.g. 5x106 in 50 µl). After 5 minutes of centrifugation at 3000 rpm, the 
supernatant was collected and the extraction is repeated with the same volume of lysis buffer. The 
supernatants (and the resuspended nuclei as control for the complete recovery of apoptotic DNA 
fragments) are brought to 1% SDS (20% stock) and treated for 2 h with RNase A (stock concentration 
10 mg/ml, final concentration 100 µg/ml) at 56°C. Digestion with proteinase K (stock concentration 
10 mg/ml, final concentration 100 µg/ml) followed for 2 hours at 37°C. After the addition of half the 
volume of 10 M ammonium acetate, the DNA was precipitated with 2.5 volumes of 100% ethanol.  
Pellets were collected and dried before being dissolved in 20 µl TE buffer (10 mM Tris HCl, pH 7.5 1 
mM EDTA) and separated by electrophoresis in 1% agarose gels (Herrmann et al., 1994).    
 
Assay Scheme: 
• K562 cells (5x106 in 50 µl total vol.) were treated with GzmB (10 µg/ml) and GzmH (20µg/ml). 
• After treatment for 4 & 12 hours, cells were pelleted and lysed in lysis buffer (10 µl per 106 cells). 
• After 10 minutes, cells were again pelleted (3000 rpm, Eppendorf) and the supernatants collected. 
• Supernatants were treated with SDS (1%) and RNase A (100 µg/ml) for 2 h at 56°C. 
• Proteinease K (100 µg/ml) was added for additional 2 h at 37°C.  
• A half vol. of 10 M NH4-acetate is added and the DNA precipitated with 2.5 vol. of 100% ethanol.  
• Finally, the pellets were dried, dissolved in 20 µl TAE buffer and separated by electrophoresis.  
 
 
ICAD cleavage  
Caspase activated DNase is constitutively inhibited by the inhibitor of CAD (ICAD), which can be 
cleaved by active caspase 3 or directly by GzmB. The inhibitor-enzyme complex then dissolves and 
CAD executes DNase activity leading to DNA fragmentation (Enari 1998). Cleavage of endogenous 
ICAD was analyzed after K562 cells were incubated with GzmB or GzmH and SLO (see figure 
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legend). At defined time points, 100 µl of cells at 1x105 were harvested and washed in PBS before 
being directly boiled in reducing Laemmli buffer. After SDS-PAGE on a 15% gel, protein bands were 
blotted on nitrocellulose (Amersham Biosciences) and probed with the anti-human ICAD polyclonal 
rabbit antibody (eBioscience, San Diego, CA). The anti-actin mouse monoclonal antibody (clone 
JLA20 from Calbiochem) at a 1:5000 dilution was used to control loading. 
 
 
 
Mitochondrial damage 
 
 
Purified recombinant Bcl-2 family protein Bid  
A number of different proapoptotic signals trigger mitochondrial membrane permeability (MMP). One 
such stimulus is provided by GzmB which can cleave the Bcl-2 family protein Bid to a truncated pro-
apoptotic form, namely t-Bid. The truncated from then translocates from the cytosol to the 
mitochondrial outer membrane resulting in the formation of pores. MMP culminates in the complete 
loss of the barrier function of the outer mitochondrial membrane and the subsequent release of pro-
apoptotic proteins such as cytochrome c.  
 
As reported for the analysis of recombinant procaspases, purified recombinant human Bid (5 µM, a 
kind gift from Shirely Gil-Parrado) was incubated with nM concentrations of either recombinant 
GzmH or GzmB for 1 h at 37 °C in activity buffer (50 mM Tris HCl pH 8, 150 mM NaCl, and 0.01% 
triton) in a final volume of 10 µl. Refer to figure legend for final GzmB and GzmH concentrations. 
Samples were boiled in reducing Laemmli buffer, loaded and separated on an 18% polyacrylamide 
gel. Electrophoretically separated bands were visualized by silver staining. 
 
 
Mitochondrial trans-membrane potential loss  
The loss of mitochondrial membrane potential (ΔΨ) is a hallmark in apoptosis. It is an early event that 
precedes phosphatidylserine (PS) externalization and that is thought to coincide with caspase 
activation, although this is not always thought to be the case (Balasubramanian et al., 2001; Savill et 
al., 2002). JC-1 is a cationic dye that measures the mitochondrial membrane potential in cells. Indeed, 
in non-apoptotic cells JC-1 (5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolyl-carbocyanine 
iodide) exists as a monomer in the cytosol (green) and accumulates as aggregates in the mitochondria 
which stain red. Here, the negative charge established by the intact mitochondrial membrane potential 
allows the lipophilic dye, bearing a delocalized positive charge, to enter the mitochondrial matrix 
where it accumulates. Finally, when the critical concentration is exceeded, J-aggregates form which 
become fluorescent red. In apoptotic and necrotic cells however, the mitochondrial membrane 
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collapses subsequently leading to the release of the dye into the cytosol where is assumes its 
monomeric form and becomes green. The aggregate red form has an absorption/emission maxima of 
585/590 nm whereas the green form has an absorption/emission of 510/527 nm. For the measurement 
of mitochondrial depolarization our target cells were prepared for staining as explained in the AV/PI 
method. The cells were then stained with JC-1 (Merck Biosciences) at a final concentration of 10 
µg/ml in PBS for 15 min and directly analyzed by FACS.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III.4 - Mitochondrial depolarization. NIH 3T3 fibroblasts stained with JC-1 following exposure to 
hydrogen peroxide. JC-1 is a cationic dye that produces two emissions depending on the mitochondrial 
membrane potential. Red indicates polarized mitochondria (the dye is aggregated) and green depolarized 
mitochondria (the dye is found as a monomer). Taken from the Perugia University Medical School library.  
 
 
ROS production 
Mitochondria play a central role in the regulation of apoptosis and in ROS generation. It remains 
unclear, however, how mitochondrial ROS production is regulated during apoptosis and if ROS 
generation is at all necessary for the completion of cell death.  
 
In this work intracellular ROS production was monitored by adding 2 µM DHE (Molecular Probes, 
Eurgene, OR) just before FACS analysis to cells treated at 37°C with GzmH (20 µg/ml), the inactive 
variant (20 µg/ml) or GzmB (10 µg/ml) every 5 minutes up to 90 minutes. For ROS measuring 
experiments, SLOC530A, a SLO variant mutated at the activating residue Cys530 was used to 
circumvent the need for prior activation under reducing conditions. In these cases mercaptoethanol 
(ME) was omitted from RPMI GlutaMax medium containing 0.5% BSA as well as 100 U/ml penicillin 
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and streptomycin. As a positive control, cells were exposed to 1 to 3% H202  (hydrogen peroxide, 
Merck, Darmstadt, Germany).  
 
 
Cytochrome c release from mitochondria 
Digitonin is a weak nonionic detergent that, at low concentrations, selectively renders the plasma 
membrane permeable, releasing cytosolic components from cells but leaving other organelles intact 
(Heibein et al., 1999). This is an ideal compound with which to study the release of mitochondrial 
inter membrane space proteins (MIMPs) such as cytochrome c, the smallest members of the 
proapoptotic MIMPs.   
 
Following treatment with GzmH (20 µg/ml) or GzmB (10 µg/ml) after 1, 2 and 6 hours, K562 cells (1 
x 105 / 50µl) were washed twice with 1x PBS and resuspended in 200 µl digitonin lysis buffer (75 mM 
NaCl, 1 mM NaH2PO4, 8 mM Na2HPO4, 250 mM sucrose, 190 µg/ml digitonin, pH 7.4). After 5 min 
on ice, cells were spun for 5 min at 14,000 rpm at 4 °C. Supernatants were transferred to fresh tubes, 
and the pellets resuspended in Triton lysis buffer (25 mM Tris HCl, pH 8.0 , 0.1% Triton X-100). 
Aliquots of both pellet and supernatant for each sample were added SDS-loading buffer and boiled for 
5 min. Boiled samples were then loaded onto 15% polyacrylamide gels followed by electrophoresis 
and transfer to nitrocellulose membranes, membranes were blocked overnight at 4°C in PBS-T, 5% 
milk. Blocked membranes were incubated with a monoclonal anti-human cytochrome c antibody 
(Clone JLA20, Merck Biosciences, 1:2000 dilution) in PBS-T containing 5% milk for 1 h at room 
temperature. Membranes were washed three times (5 min each) with PBS-T. The anti-actin mouse 
monoclonal antibody (clone JLA20 from Calbiochem) at a 1:5000 dilution was used to control 
loading. Specific mouse and rabbit antibodies were detected with goat anti-mouse (1:2000, Perbio 
Science, Bonn, Germany) or goat anti-rabbit antibodies (1: 5000, Jackson Immunoresearch, Hamburg, 
Germany) conjugated to horseradish peroxidase (HRP) respectively. Bound HRP antibody conjugates 
were visualized with the SuperSignal West Pico substrate (Perbio Science) (Heibein et al., 1999).
 
 
 
Characterization of monoclonal GzmH antibodies 
 
 
ELISA (Enzyme-Linked Immunosorbent Assay) can be performed in a number of ways. One of the 
most useful methods is the two antibody “sandwich” ELISA which requires two antibodies that bind 
to epitopes which do not overlap on the antigen of interest. In our method however recombinant 
GzmH was directly coated to special immuno absorbent plates. Unbound products are removed with a 
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washing step and then labeled with the specific antibody or “detection” antibody.” Thereafter, the 
primary antibody specificity is measured through the use of a colorimetric substrate. 
 
Indeed, to evaluate the specificity of monoclonal antibodies, purified recombinant GzmB and GzmH 
at a final concentration of 2.5 µg/ml were coated in a buffer containing 0.01 M Na2CO3, 0.04 M 
NaHCO3, 0.02% NaN3, pH 9.6 over night (100 µl / well). After washing and blocking with 0.05% 
Tween 20 and 2% caseine in PBS, the primary antibody against human GzmH (MAB1377, R&D 
Systems) or a mouse isotype control antibody (BD #553447) was added at a final concentration of 1 
µg/ml. The solid phase ELISA was developed with peroxidase-conjugated goat anti-mouse antibodies 
and 3.3’,5.5’-tetramethylbenzidine (TMB) as a chromogenic substrate (GE Healthcare Europe, 
Munich, Germany). Optical density of the reaction product was measured at 405 nm using the 
Dynatech MR4000 plate reader. 
 
 
 
Isolation of peripheral blood leukocyte subsets and NK cells 
 
 
Peripheral blood leukocyte subsets  
Monocytes were obtained from the remaining CD56-negative cell population by depletion of the 
nonmonocytic cells using a cocktail of biotin-conjugated antibodies (Miltenyi Biotec, Bergisch-
Gladbach, Germany, catalog no. 130-091-153). CTLs were purified from PBMCs by positive selection 
with anti-CD8 dynabeads, and activated and expanded using anti-CD3/anti-CD28 dynabeads, 
overnight without the addition of IL-2. (refer to CD3/CD28 T-cell expander kit PDF from Invitrogen). 
For Western blot analyses, cells were lysed (50 µl / 3 x 106 cells) in a buffer containing 150 mM NaCl, 
20 mM Tris HCl pH 7.2, 1% Triton X-100 (“lysis buffer”). A volume of 10 µl of lysis supernatant was 
loaded per lane. 
 
 
NK cell isolation 
CD56 positive cells were purified from human PBMC by positive selection with the CD56 MultiSort 
Kit (Miltenyi Biotec, Bergish-Gladbach, Germany, catalog no. 130-055-401) and thereafter used for 
GzmH and GzmB detection by western blot analysis. NK cells for killing assays were purified from 
fresh PBMCs using the Dynal® NK cell negative isolation kit (Invitrogen, Karlsruhe, Germany). 
Negatively isolated NK cell purity was assessed by FACS analysis with the PE-labelled CD16 and 
CD56 antibodies but also with the FITC labeled CD3 antibody (Immunotools, Friesoythe, Germany). 
Following FACS analysis, NK cell purity was found to be greater than 90% (see Figure III.5).  
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Figure III.5 - Purity of negatively isolated Natural Killer cells. Naive NK cells were isolated using the Dynal 
Negative selection kit to avoid any kind of activation and hence up-regulation of granzymes. PBMCs and NK 
cells were stained for NK cell markers CD16 (FL2) and CD56 (FL2) and the T-cell lineage marker CD3 (FL1) 
after which they were analysed by FACS.   
 
 
 
NK cell cytotoxicity and granzyme release 
 
 
NK cell killing of target cells 
Killing assays were performed for 4 hours in RPMI 1640 supplemented solely with 100 U/mL 
penicillin/streptomycin and 2 mM L-glutamine and IL-2 100 U/ml (Roche) in small cell culture flasks 
in a volume of 8 ml containing 8 x 106 NK cells and 4 x 106 K562 cells. Killing efficiency of target 
cells was determined by FACS after AV/PI staining using specific forward/sideward scatter 
characteristics which permitted us to discriminate between NK and K562 cells. Refer to Figure IV.31. 
 
 
GzmH release from NK cells 
Following killing verification, the culture supernatants were collected by sequential centrifugation 
(500 g for 10 min following by 20000 g for 15 min at 4 °C) and concentrated 40-fold (5 KNMWL 
ultrafree, Millipore, Schwalbach, Germany). FBS was not used during NK killing as we had 
encountered problems during the gel run, the FBS being too concentrated and thus blocking normal 
protein migration. Twenty microlitres of the concentrated supernatant was loaded and immunoblotted 
against GzmH (monoclonal antibody MB1377, R&D systems) or GzmB (monoclonal antibody GB11, 
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Hiss Diagnostics GmbH). Mouse isotypes controls were also used, namely #553447 and #557351 (BD 
biosciences) for the granzymes respectively. In some cases concentrated supernatants were pretreated 
with hyaluronidase (Sigma-Aldrich) at 80 µg/ml for 30 min at RT. Hyaluronidase was added to 
supernatants in an attempt to release GzmH from proteoglycans.  
 
 
 
Cellular morphology and nuclear fragmentation 
 
 
Apoptotic nuclei 
To distinguish living cells from those with apoptotic nuclei, bright field pictures were taken with an 
inverted microscope (Zeiss, Axiovert 200M, 40x objective, numerical aperture 0.6) connected to a 
Coolsnap-HQ camera (Photometrics, Roper Scientific, Ottobrunn, Germany). Additionally, staining of 
GzmH and GzmB treated cells for apoptotic nuclei was done in solution in annexin V binding buffer 
with annexin V-FITC (30 nM) and the Hoechst dye 33342 (Merck Biosciences) at 4 µg/ml for 10 min 
at RT. Cells were washed, bound on poly-L-lysine (Sigma Aldrich) coated coverslips, fixed with 2% 
formaldehyde, washed and mounted with Moviol (Sigma Aldrich). Fluorescent pictures were taken 
with an inverted microscope (Zeiss, Axiovert 200M) using a 40x objective or a 63 x oil objective 
(Zeiss) and processed using MetaMorph software (Visitron Systems, Puchheim, Germany). For 
quantification one half of a visual field showing about 50 to 200 cells was evaluated.  
 
 
Nuclear fragmentation 
The DNA content of K562 target cells and the rate of apoptotic cells that appear in the sub-G1 peak of 
DNA histograms were analyzed by FACS after staining with PI (Sigma-Aldrich). After DNA 
fragmentation, the sub-G1 method relies on a series of simple steps. Cells are first fixed in EtOH 
before being rehydrated. Membrane poration for PI entry is then performed using a detergent, a 
process in which cleaved apoptotic DNA is lost. RNA is also removed as it is also stained by PI. 
FACS analysis then reveals that in cells undergoing cell death, which have lost DNA, less PI is taken 
up and thus appear on the left of the G1 peak.  
 
Treated cells (1 x 105 cells / well) were first spun down (3000 rpm, Eppendorf) and resuspended in 
PBS (300 µl) before 100% ice cold ethanol (900 µl, from -20 °C) was added drop wise using a vortex. 
Samples were then kept at -20°C for 15 minutes (for up to several weeks) before being centrifuged 
(6000 rpm) and the pellet resuspended in 0.5 ml PBS, 0.1% NP-40 and left on ice for 10 minutes. 
After another spin down, the pellet was resuspended in PBS (279 µl) to which 6 µl RNase A (10 
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mg/ml) was added. The samples were then left at RT for 15 minutes before PI was added to a final 
concentration of 50 µg/ml and left in the dark for up to an hour. FACS analysis followed.  
 
 
3H-Thymidine release assay 
The 3H-Thymidine assay allows the determination of the amount of DNA that is degraded upon 
treatment of cells with cell death causing agents such as our granzymes.  The principle of this assay is 
to radioactively label the target cell DNA by growing the cells in presence of 3H-Thymidine. The 
radioactive 3H-Thymidine is then incorporated into the host DNA. After exposure of cells to GzmB 
and GzmH, the target cells are harvested and the release of radioactively labeled DNA measured. To 
calculate the percentage of DNA fragmentation the counted radioactivity (counts per minute = cpm) of 
cells that were not treated is compared with the cpm in cells that were treated.  
 
Target cells were labeled by adding 5 µCi/ml [methyl-3H] thymidine (Amersham Biosciences, 
Freiburg, Germany) for 20 h to cell cultures in the logarithmic growth phase. The cells (1 x 105 / 50 µl) 
were then washed three times with RPMI GlutaMax medium (0.5% BSA and 100 U 
penicillin/streptomycin) and prepared for exposure to GzmB and GzmH in a final volume of 50 µl of 
medium. After the indicated times of incubation at 37°C the cells were lysed with an equal volume (50 
µl) of 1% Triton X-100 in 100 mM Tris, 50 mM EDTA, transferred to 1.5 ml Eppendorf tubes, 
vortexed, and centrifuged for 10 min at 4 °C at 15,000 x g to pellet intact nuclei. For analysis of total 
DNA labeling, the respective samples were lysed with an equal volume of 2% SDS in 0.1 M NaOH 
and vigorously vortexed. Thereafter, 25 µl of supernatant was removed to scintillation plates, mixed 
with 100 µl of scintillation mixture (PerkinElmer Life Sciences), and counted on a Wallac MicroBeta 
Trilux counter. The specific 3H release was calculated as: [(sample cpm – spontaneous cpm)/(total cpm 
– spontaneous cpm)] × 100. 
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IV - Results 
 
 
To assist in our functional studies on recombinant GzmH and its role, among other granzymes such as 
GzmB, in immune surveillance, we took to the parallel production of both active and inactive variant 
of the protease. Inactive GzmH resulted from a modification made in the enzyme’s catalytic triad, the 
main player in the catalytic mechanism, where the serine (Ser) residue, at position 195, was replaced 
which an alanine (Ala).  
 
 
 
IV.1 - Construction of the GzmH plasmid and Variants 
 
 
The expression cassettes of GzmH and the point-mutated inactive GzmHS195A were all cloned into the 
pET24c(+) plasmid (Invitrogen) (refer to the appendix), sequenced and subsequently transformed in to 
an appropriate expression host.   
 
pET24c(+)MKH6GzmH 
GzmH cDNA was amplified from the homo sapiens cDNA clone IMAGE: 15434 (vector pT7T3D) 
using the sense-strand primer DJ 2715 (5´-GAG GAT ATC ATC GGT GGC CAT GA-3´) and the 
antisense-strand primer DJ2716 (5´-GCC TAA CGT TAG AGG CGT TTC ATG GTA CGT TTG 
ATC C-3´). The resulting PCR product was digested with Eco RV and Hind III and subsequently 
cloned into the Pml I and Hind III (173) cut pET24c(+) E. coli expression vector. The pET24c(+) 
plasmid vector was previously modified by introducing the codon sequence MKH6 into the vector’s 
multiple cloning site cleaved at restriction sites Nde I and Bam HI. The MKH6 tag was constructed as a 
duplex with primers DJ2333 (5’-TAT GAA ACA TCA CCA TCA TCA CCA C/GT G-3’ introducing 
codons Met and Lys and the mentioned Pml I site) and DJ2334 (5’-GAT CCA CGT GGT GAT GAT 
GGT GAT GTT TCA-3’). The cloning of modified GzmH cDNA directly upstream from the MKH6 
tag produced a sequence coding for a mature-like GzmH starting with codons Ile-Ile-Gly-Gly. Refer to 
the GzmH amino acid sequence in the appendix page 146. 
 
pET24c(+)MKH6GzmHS195A
The catalytically inactive GzmHS195A construct was obtained using pET24c(+)GzmH as a template for 
the amplification of sense primer DJ 2871 (5’-ACA CA/C CGG TTT CAA AGG TGA CGC CGG-3’) 
introducing a 5’ Age I restriction site, and antisense primer T7-ter from. Sense primer DJ 2871 
contains a point mutation which replaces the reactive Ser195 with Ala and rendering the protease 
unable to act proteolytically. The resulting PCR product was digested with Age I and Hind III and sub-
 - 58 -
 Results 
____________________________________________________________________________
  
 
cloned into the identically cut pET24c(+)MKH6GzmH vector. The sequences of positive clones from 
both constructs were verified by sequencing analysis and transformed into the E. coli strain B834 
(mentioned later page 32) ready for expression (DE3) (Novagen). Refer to the GzmH amino acid 
sequence in the appendix page 146. Serine 195 in highlighted in bold. 
 
The pET24c(+) based constructs with the incorporated GzmH variants: MKH6GzmH and 
MKH6GzmHS195A were separately transformed into the E.coli stain DH5α, the plasmid DNA purified 
and their sequences sent for verification analysis. Correct sequence readings for the wild-type (WT) 
GzmH cDNA and both of the inactive and tagged counterparts allowed us to then to think towards 
protein production and the selection of an appropriate expression hosts.  
 
 
 
IV.2 – Production GzmH and Variants from inclusion body material 
 
 
GzmH expression yields high amounts of pure inclusion body material  
In the next paragraphs, and as an example of the procedure followed to produce the two GzmH 
variants, I report, in a step wise fashion, the production and purification of WT recombinant GzmH 
from inclusion body (IB) material. The data shown here is based upon an optimised protocol used for 
both constructs. The following results were obtained from a single procedure and are representative of 
the many individual batches, regardless of the variant in question, produced throughout the study.    
 
The expression of recombinant GzmH and the inactive variant GzmHS195A in E. coli was accomplished 
under the guidelines of the pET system from Novagen. This method uses the bacteriophage T7 
promoter to direct expression of target genes (see detailed explanation of the system in materials and 
methods, pages 32 & 33). It was therefore important to transform our established plasmids into an 
expression host bearing the T7 RNA polymerase gene (λDE3 lysogen). Knowing that the production 
of both GzmK (Wilharm et al., 1999), and later GzmB (Kurschus et al., 2004; Kurschus et al., 2005), 
had been successfully performed in our lab using the E. coli expression host B834 (DE3), this previous 
work provided us with enough reassurance for the use of B834 (DE3) in our initial attempts to express 
and purify GzmH IB material. Indeed Wilharm and colleagues clearly demonstrated that the B834 
(DE3) stain yielded larger amounts of IB protein over other stains, even the B834 derived host BL21, 
also a methionine auxotroph deficient in harmful proteases.   
  
GzmH expression in B834 (DE3) and purification of inclusion body material was successful; the IB 
yield resulting in quantities of almost 1 g/l culture medium as previously described (Wilharm et al., 
1999). Cultures (B834 in 10 L LB) of correct density (0.6 OD at 595 nm) and under the correct 
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selective pressure (kanamycin), were exposed to IPTG. Samples, taken before and after expression 
initiation, were then analysed by SDS-PAGE thus providing confirmation of protein expression 
(Figure IV.1). After extensive washing and centrifugation, the resulting aggregated IB protein was 
again denatured and analysed by SDS-PAGE. Figure IV.2 shows a silver stained SDS-PAGE analysis 
combining both the expression of the GzmH precursor and purification of the resulting inclusion body 
material for bacterial debris. On average, a 10 L culture yields roughly 6 g (wet weight) of GzmH IB 
material. 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure IV.1 - Silver stained SDS-PAGE analysis combining both the expression of the GzmH precursor 
and the purification of the resulting inclusion body material for bacterial debris.  Samples of 1ml (from the 
10 L culture) were taken before and after 6 hours of ITPG induction. Thereafter, the samples were spun down at 
6000 rpm, the supernatant discarded, and the pellet resuspended with PBS and Laemmli buffer (4x). Boiling at 
95°C for 5 minutes was then followed by loading 1 to 3 µl of sample on a 15% SDS polyacrylamide gel. 
Inclusion body visualisation was performed in a similar manner, 50 µl of IB material (in 75 ml Wash II buffer, 
see methods p 34) being resuspended in PBS, boiled in presence of Laemmli buffer and loaded. The thick IB 
bands reveal a pure IB preparation. 
 
 
Interchain disulphide bond rich GzmH inclusion bodies are efficiently solubilised    
Recombinant wild type (WT) GzmH contains 7 cysteine residues. Solubilisation (SB) of the 6 g of IB 
aggregates was carried out in SB buffer (60 ml) containing oxidised and reduced glutathione as a 
redox system (1 ml/ 100 mg IB). The addition of these thiol reagents in combination with the 
chaotroph guanidinium chloride (GdmCl) allowed the reduction of the protease’s interchain disulphide 
bonds by thiol-disulphide exchange. Homogenisation of the IB in solubilisation buffer, followed by 
over night stirring, resulted in the efficient solubilisation of GzmH IB material. The redox system was 
then removed by a series of dialysis steps against the GdmCl at pH 5.5, the low pH stabilising the 
deformed mixed disulphides. After 3 changes every 8 hours, the concentration of the solubilised 
protein was determined spectroscopically using ε280nm = 24,960 M -1 cm -1. Following homogenization 
and dialysis, 90 ml of the solubilisate contained a total of 1.15 g precursor GzmH (12.8 mg/ml). 
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Renaturation and dialysis of GzmH results in correctly folded soluble protein  
Renaturation was performed in 5 L of refolding buffer (RF buffer) in which GzmH solubilisate was 
added at the optimal final concentration of 100 µg/ml (Wilharm et al., 1999). In comparison to the RF 
buffers used for the production of our GzmB and GzmK, the composition of the GzmH RF buffer 
included the addition of 20 mM calcium chloride (CaCl2), reported to improve refolding by stabilizing 
the protein in question (Rudolph and Lilie, 1996). Other components known to aid refolding were also 
tested. Polyethylene glycol (PEG), thought to improve in vitro structure formation by preventing 
aggregation at stiochiometric amounts (1%), unfortunately showed no improvement while elevating 
sodium chloride (NaCl) concentrations from 0.15 to 0.5 M also revealed no amelioration in yield. 
Variations in temperature, pH and duration of renaturation were also tested without amelioration. 
Finding the optimal refolding conditions is crucial, if one is to obtain high yields of the desired protein 
but unfortunately, despite numerous trials with the above components, we could not reach the high 
yields obtained in the case of GzmB (Kurschus et al., 2004). Satisfactory yields of pure, active GzmH 
were nevertheless obtained using a RF buffer based on work of Wilharm and colleagues (Wilharm et 
al., 1999). The addition of 20 mM CaCl2, adjustment of the pH to 7.3 and reduction of the refolding 
period to over night incubation (begun at room temperature and cooled down to 4°C by incubation in a 
cold chamber) were the modifications made to the refolding procedure. Filtration of the RF buffer was 
thereafter performed to rid the protein solution of precipitates which, if left, are known to encourage 
further precipitation as well as clog up wide-surface filtering membranes used to concentrate the 5 L 
preparation (Rudolph and Lilie, 1996). 
 
Dialysis into an appropriate buffer is a crucial step if protein purification is to succeed, providing a 
stable environment for the desired protein. MES [2-(N-Morpholino)-ethanesulfonic acid] buffer at pH 
6, again complimented with 20 mM CaCl2 and 0.15 M NaCl, provided the most stable conditions for 
GzmH. Tris [Tris-(hydroxymethyl)-methane] and PBS (phosphate buffered saline) based buffers both 
caused much higher degrees of precipitation to occur after 5 rounds of dialysis. The five exchanges 
were necessary to efficiently remove the positively charged arginine which could later have an effect 
during ion exchange purification, possibly competing with the granzyme for binding in a column 
packed with cation exchange media. Sodium chloride was kept at physiological concentrations, 
throughout the procedure, an essential requirement for all future cell-based apoptosis assays.  
 
Figure IV.2 shows the loss of refolded protein, subject to precipitation, that occurs during renaturation 
and especially during dialysis, despite the optimized conditions mentioned above. Roughly 40 ml of 
solubilisate (12.8 mg/ml) was added to the RF buffer (5 L), thus diluting the protein to the optimal 
concentration of 100 µg/ml (Wilharm et al., 1999). After overnight renaturation and subsequent 
filtration, protein concentration was measured spectroscopically at 280 nm against RF buffer alone. 
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From the 512 mg of protein added (40x 12.8 mg/ml), only 145 mg remained in solution. Protein 
concentration was again measured after the 5th round of dialysis. At this stage 30 mg of soluble 
granzyme remained, thus a loss of almost 95% of the total amount initially added to the RF buffer. 
Interestingly, when all of the above samples were analysed side by side by SDS-PAGE, the four 
precursor GzmH bands appeared in a step-like fashion, suggesting that the presence of 0.6 M arginine 
(Arg), which influences ionic charge, might cause the bands to run incorrectly. Once Arg was fully 
removed by dialysis, ho eight position of 26 kDa.  
 
 
wever, MKH6GzmH ran at the correct molecular w
igure IV.2 - Silver stained SDS-PAGE analysis showing WT GzmH and the loss of partially refolded 
rotein yield that occurs between renaturation and dialysis.  In all cases, 25 µl of proGzmH (in lanes 1 and 2 
roGzmH was taken from 5 L refolding (RF) buffer and lanes 3 and 4 from 1 L 25 mM MES buffer containing 
 
 
 
 
 
 
 
 
 
 
 
 
 
F
p
p
150 mM NaCl) was added to (4x) Laemmli, boiled and loaded onto 15% acrylamide SDS gels. Lane one 
represents proGzmH in refolding solution and lane two, proGzmH in filtrated RF solution. Lane 3 shows the 
concentrated, dialysed RF material whereas in lane 4 the latter has been filtered (0.22 µm). ProGzmH appears to 
run at different sizes on the gel due to the high concentration of arginine (0.6 M) in the RF buffer. 
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GzmH is efficiently purified via ion exchange FPLC  
GzmH was purified using a fast protein liquid chromatography (FPLC) system from Pharmacia 
equipped with an ion exchange column. Protein separation was based on the reversible interaction 
between the charged granzyme and an oppositely charged chromatographic medium “Source 15S”. 
Elution of both proform and active GzmH was performed by an increase in NaCl concentration in 
form of a continuous gradient, while protein elution was monitored by a UV detector. 
 
 
25 mM MES pH 6
150 mM NaCl 
25 mM MES pH 6 
150 mM NaCl 
25 mM MES pH 6
2 M NaCl 
25 mM MES pH 6
2 M NaCl 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV.3 - WT GzmH purification via ion exchange FPLC.  Precursor GzmH, dialysed into 25 mM MES 
buffer (pH 6) containing 150 mM NaCl and 20 mM CaCl2, was loaded onto a Source S15S based column and 
eluted by a salt gradient ranging in concentrations from 0.15 to 2 M NaCl. (A) At 700 mM, Fractions 6, 7 and 8, 
of correct size and purity, were pooled and further converted by cathepsin C (0.5 U/mg) overnight at 30°C. (B) 
Converted GzmH was then again purified over a second identical column where at 250 mM, fractions 2, 3 and 4 
containing the active enzyme where pooled and verified for their purity and activity. As expected, the remaining 
precursor GzmH eluted at NaCl concentrations just short of 1 M.    
 
 
Following dialysis and filtration, proGzmH, contained within approximately 1 L of buffer A (25 mM 
MES pH 6, 150 mM NaCl and 20 mM CaCl2), was successfully loaded onto the ion exchange 
SOURCE 15S packed column. After lengthy washing in buffer A, devoid of CaCl2, a 60 minute salt 
gradient (0 to 100% buffer B, 1 ml/min) was initiated feeding from both buffers A and B (25 mM 
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MES pH 6, 2 M NaCl). Absorbance at 280 nm reached its highest readings at approximately 700 mM 
NaCl, defining the peak of the elution curve (Figure IV.3A). Once collected, all fractions were 
analysed spectroscopically but also visually after SDS-PAGE and silver staining. As expected, gel 
analysis of fractions flanking the elution peak revealed pure bands running between the 25 and 30 kDa 
marker proteins at a molecular weight (MW) of 26,247 kDa (pI: 10.0), representative of 
unglycosylated recombinant precursor GzmH. Once pooled, the progranzyme fractions were 
concentrated to 0.5 mg/ml and appropriately converted to their active conformation by DTE-pre-
activated bovine cathepsin C before undergoing a second round of purification over a Source 15S ion 
exchange column. Following dilution in 25 mM MES buffer, necessary to lower salt concentrations to 
gain physiological conditions, converted GzmH was again loaded and eluted as described above. This 
second purification step efficiently separated the active GzmH from cathepsin C and other applied 
converting agents as well as remaining precursor enzyme (Figure IV.3B).  
 
Because cathepsin C action removes the adjoined eight amino acid residues MKH6-tag and because of 
the basic nature of the histidine (His) residue, the resultant active GzmH was on the whole less basic 
than its precursor counterpart (which at pH 6,0 carries 6 protons more then active GzmH) and hence 
less able to compete for binding to the column media in the presence of increasing salt concentrations. 
Elution of active GzmH therefore occurred at the considerably lower NaCl concentration of roughly 
250 mM, the remaining pro-form following suit at concentrations of NaCl just below 1 M (Figure 
IV.3B). 
 
Pure, converted active and inactive GzmH are stored in physiological buffering conditions    
To ensure that mature GzmH was stored in the correct buffering environment at physiological salt 
concentrations, converted GzmH fractions were first of all analysed by SDS-PAGE. Fraction samples 
revealing pure and efficiently converted GzmH were then pooled and dialysed into an appropriate 
stabilising buffer, here 25 mM MES pH 6 complimented with 150 mM NaCl, to ensure uniform 
physiological salt conditions. Thereafter, the recombinant protease was concentrated and measured 
spectroscopically at 280 nm until a final concentration of 500 µg/ml was obtained. The concentration 
of converted GzmH was measured using the following formula: c (mg/ml) = (A280 x MW) / (ε280 x b) 
where the molecular weight of converted GzmH is 25165.35 kDa and the extinction coefficient 25110 
(ExPASy ProtParam tool); b represents the path length, which for most spectrometers is 1 cm. 
Converted GzmH was subsequently aliquoted, in stable conditions, into one-time-use volumes of 20 µl 
and stored at –80°C. Figure IV.4 shows proform, active and inactive GzmH on a silver-stained SDS-
PAGE. Clean bands with the expected sizes of 26 and 25-kDa respectively demonstrate the 8 amino 
acid (1100.2 Daltons) shift from proform to mature GzmH. 
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Difference in yields between active and inactive GzmH  
On average, a total amount of 3 mg precursor GzmH was obtained from 500 mg solubilised GzmH 
(renaturation being performed with a protein concentration of 100 µg per ml RF buffer). After removal 
of the MKH6 tag by cathepsin C treatment and further purification over ion exchange columns, a total 
of 1.3 mg of converted GzmH remained. In comparison to the yields of active WT GzmH, yields of 
the converted inactive variant were noticeably higher. Indeed, after renaturation of GzmHS195A, a 
marked decrease in precipitation was observed throughout the dialysis procedure, probably due the 
lack of proteolytic activity acquired following cleavage of the MKH6 tag.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV.4 - Pure, recombinant unglycosylated GzmH variants. SDS-PAGE allowed the visualization of the 
two correctly folded and converted GzmH constructs along with the GzmH precursor.. The SDS gel was run at 
200 mV until the 17 kDa marker band reached the extremity of the 15% acrylamide matrix. Thereafter, silver 
staining revealed clean bands representing, in order from top to bottom, proGzmH in blue (precursor protein of 
26 kDa with the adjoined N-terminal MKH6 peptide), wild-type GzmH (Red, 25 kDa) and inactive GzmHS195A 
(Yellow, 25 kDa). Each protein band represents 50ng of loaded sample. All proteins were of expected size as 
indicated. 
 
 
 
IV.3 - GzmH Activity 
 
 
GzmH has chymotrypsin-like (chymase) activity  
Edwards and colleagues were the first to report the esterolytic but not amidolytic activity of 
glycosylated recombinant GzmH secreted from baculovirus-infected Sf21 insect cells (Edwards et al., 
1999). The authors nicely demonstrate that their recombinant GzmH processed chymotrypsin-like 
(chymase) activity by showing the efficient cleavage of the thiobenzyl ester Suc-Phe-Leu-Phe-SBzl. 
Furthermore, testing with numerous other thiobenzyl esters, such as Z-Lys-SBzl (tryptase), revealed 
that that GzmH has no tryptase or aspase activity. The group then measured GzmH activity against a 
more comprehensive panel of synthetic oligopeptide thiobenzyl esters and aminomethylcoumarin 
(AMC). Although none of the AMC substrates were hydrolyzed, the thiobenzyl ester substrate Boc-
Ala-Ala-Met-SBzl, was hydrolysed at the second best rate demonstrating that GzmH can also tolerate 
   GzmH S195A
Cathepsin C 
His6  
propeptide 
GzmH
GzmHMKHHHHHH 
30
24 25 25 26 28 
KDa
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aliphatic residues such as methionine (Met) at the P1 position. Here we confirm the above finding, 
with regard to the thiobenzyl ester Suc-Phe-Leu-Phe-SBzl as a good GzmH substrate, by 
demonstrating that enzymatic hydrolysis of the tripeptide thioester substrate (with GzmH at 20 nM) is 
indeed efficient. Suc-Phe-Leu-Phe-SBzl is reported to be an excellent substrate for Cathepsin G which 
was therefore used to control the procedure (Figure IV.5) (Edwards et al., 1999). In contrast to the WT 
GzmH, the Ser-to-Ala mutant showed no proteolytic activity towards the thiobenzyl ester substrate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV.5 - GzmH cleaves the thioester substrate Suc-Phe-Leu-Phe-SBzl. Enzymatic hydrolysis of the 
peptide thioester substrate Suc-Phe-Leu-Phe-SBzl (30 mM) by GzmH (20 nM) was measured at RT in activity 
buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 0.01% Triton X-100) containing 0.3 mM 5,5’-dithiobis-2-
nitrobenzoic acid (DTNB). Once the substrate added, its hydrolysis was monitored by measuring the absorbance 
at OD 405 using a Dynatech MR4000 microplate reader. Cathepsin G (20 nM) was used as positive control.  
  
 
GzmH cleaves AMC based substrates 
Two GzmH specific tetrapeptide sequences, based on a study by Mahrus et al. in which all human 
granzymes were compared at positions P1 to P4 by using combinatorial libraries of protease 
substrates, were kindly synthesized and adjoined to AMC groups by Novabiochem (Laufelfingen, 
Switzerland) (Mahrus and Craik, 2005) (refer to Figure IV.6). For the first time we were able to show 
that GzmH was able to cleave amide bonds by the hydrolysis of the above predicted peptide 
substrates, namely Pro-Thr-Ser-Tyr-AMC and Ala-Thr-Ser-Tyr-AMC. GzmH showed a marked 
preference for a proline at the P4 position over an alanine which occupies the same site in the 
alternative tetrapeptide (Figure IV.7). Yet again, cathepsin G was clearly the more efficient enzyme 
when exposed to Pro-Thr-Ser-Tyr-AMC or Ala-Thr-Ser-Tyr-AMC. Expectedly, like GzmH, cathepsin 
G also preferred proline at the P4 position. GzmB was also included as a control, showing that the two 
substrates were specific for chymotrypsin-like enzymes. It would of course be of interest to compare 
the above tetrapeptide sequences with the tripeptide sequence Phe-Leu-Phe also attached to an AMC 
group.  
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P T S Y 
 
Figure IV.6 - Figure showing the substrate specificity of human granzymes (Mahrus et al. 2005). 
Recombinant GzmA, GzmB, GzmH (outlined in red) and GzmM were profiled at positions P4-P2. The y axis 
represents relative activity, and the x axis represents the fixed P4, P3, P2 or P1 amino acids (with norleucine 
represented by n). Activities for each granzyme are relative to the highest activity at each of the four substrate 
positions. The library profiles indicate, contrary to previous work, that GzmH exhibits a strong preference for 
tyrosine over phenylalanine and tryptophane at the P1 position , the preferred P4 to P1 sequence being PTSY 
(see Figure IV.8 below). Taken from Mahrus et al. Chemistry and Biology, vol. 12, 567-577, 2005. 
PTSY
B 
AMC 
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ig hr-
er-Tyr-AMC (PTSY-AMC) and H-Ala-Thr-Ser-Tyr-AMC (ATSY-AMC) are a kind gift from Dr. Doerner 
erck Biosciences, Läufelfingen, Switzerland). They were dissolved in DMSO and applied at 250 µM in 
ctivity buffer. All proteases were added at end concentrations of 20 nM, Fluorescence intensities were recorded 
ith a Fluostar Optima (BMG Labtech, Offenburg, Germany) at RT and evaluated using the Fluostar Optima 
ftware. (B)  Fluorescent dye based peptide substrates are synthesized by coupling the carboxy group of the 
esired peptide of a specific sequence to the amine group of a dye, in this case AMC (7-amino-4-
ethylcoumarin). Before enzymatic hydrolysis, these substrates have no or very weak fluorescence. On 
nzymatic hydrolysis, the dye is released, greatly increasing the fluorescence. 
Δ
 
 
F ure IV.7 - GzmH cleaves amide bonds in synthetic peptides. (A) The new peptide substrates H-Pro-T
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IV.4 - GzmH inhibition 
e were interested in pursuing work on GzmH inhibition as it is in our plans to attempt the 
a finding that suggests a role for  proapoptotic function of GzmB 
edelies et al., 2004).  
ote subsite for very hydrophobic structures. Again, we were able to confirm 
at GzmH was completely inhibited by DCI at the even lower end concentration of 1 and even 0.1 
ibi  µM) with 0.5 µl 
n at room temperature (see materials and methods). The substrate, DTNB, and buffer 
ere added to assay the residual enzyme activity as described above. At a enzyme ratio of 1:100, DCI nearly 
mpletely inhibited GzmH. Complete inhibition was accomplished at the lower enzyme:inhibitor ratio of 1:10.  
 
 
W
crystallization of GzmH bound to a specific inhibitor, the inhibitor here rending the active enzyme 
more stable in general while teaching us more about the specificity of the enzyme. Furthermore, and in 
line with the main theme of this study, a specific, efficient, non toxic and cell permeable inhibitor 
(such as phosphonates) would allow us to learn about the potential contribution GzmH makes, among 
other released granzymes, towards the death of target cells. A study from Sedelies and colleagues in 
2004 already point towards GzmH being frequently more abundant than GzmB in natural killer (NK), 
 GzmH in complementing the
(S
 
GzmH is efficiently inhibited by the general protease inhibitor DCI 
Edwards and colleagues also attempted to inhibit GzmH with inhibitor compounds such as 
isocoumarins, peptide chloromethyl ketones, and peptide phosphonates. The most effective inhibitor 
reported was the general protease inhibitor 3,4-dichloroisocoumarin (DCI) with PMSF also providing 
some inhibition but at concentrations of 1 mM in comparison to 0.1 mM DCI. The peptide 
phosphonates with the Phe-Leu-Phe sequence also provided moderate inhibition at 0.1 mM 
concentration, the most effective being interestingly FTC-Aca-Phe-Leu-Phe(p)(OPh)2 indicating that 
GzmH may have a rem
th
µM of the general protease inhibitor (Figure IV.8).  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure IV.8 – GzmH inh
inhibitor (4 mM) for 20 mi
tion. Inhibition was measured by incubating 4.5 µl Gzm (4.44
w
co
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 IV.5 - GzmH and Apoptosis Induction 
 
IV.5.1 - GzmH is a cytotoxic protease able to induce cell death 
he cell death inducing potential of GzmH, in comparison to that of GzmB, was assessed in an 
fector cell-independent system. Recombinant granzymes were used in combination with purified 
erforin (PFN), the natural pore forming protein of CTL and NK cell secretory vesicles, and as an 
lternative the PFN substitute, streptolysin O (SLO), a bacterial cholesterol-binding exotoxin (Walev 
t al., 2001). Pooled, pure active GzmH was prepared for cell culture experiments by dialysis into 25 
M MES pH 5.5, 150 mM NaCl followed by high speed centrifugation (14000 rpm) and filtration 
 
Sublytic concentrations of PFN and SLO are essential for Gzm specific killing  
In an initial attempt to study the possibility of GzmH possessing cytotoxic potential, we first defined 
the sublytic window for the pore forming protein SLO in combination with GzmB, a known potent 
apoptosis inducer. Sublytic perforin concentrations, which were also tested similarly, followed at a 
later time point during this work. The sublytic window is defined as the concentration of pore forming 
protein required to produce maximum cell death, induced here by GzmB, while maintaining 
background levels of cell death (10-15% AV+/PI+ cells), in the presence of the translocator alone. Cell 
death was monitored using annexin V FITC (AV) and propidium iodide (PI), the percentage of 
cytotoxicity defined as the sum of both apoptotic and dead cells (AV+/PI- + AV+/PI+ cells).  
 
Sublytic SLO concentrations were determined with target cells K562, HL60 and U937 whereas the 
sublytic PFN window was only defined for both K562 and HL60 cells. PFN usage was limited to two 
cell lines due to the cost and availability of recombinant translocator. In the presence of GzmB, cell 
death levels (AV+/PI+ cells) of K562 cells were at their highest at PFN and SLO concentrations of 200 
and 150 ng/ml respectively (refer to Figure IV.9A and C respectively). Importantly, background death 
levels, for both translocators, were optimal (under 10-15% AV+/PI- + AV+/PI+ cells). As for HL60 
cells, concentrations of 75 and 100 ng/ml of PFN and SLO respectively provided the optimal window 
for specific GzmB killing (refer to Figure IV.9B and D respectively). Cell death studies with U937 cells 
were only performed in combination with SLO where the most efficient “translocator background” 
versus “cell death” ratio was achieved using SLO concentrations in the range of 150 ng/ml.  
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(0.22 µm). Enzyme concentration was measured spectroscopically at 280 nm and the active protease 
was stored at -80°C at a stock concentration of 500 µg/ml. 
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i
 within one 
 incubated 
r 2 hours and then analysed by FACS after Annexin V-FITC and propidium iodide staining. Apoptotic cells 
herefore, 
zmH dilutions, reaching final concentrations of between 1-20 µg/ml, were applied to K562 and 
L60 cells before sublytic concentrations of SLO were respectively applied (Figure IV.10). Analysis 
after 24 hours of incubation revealed that GzmH had reached maximal killing efficiency killing 70 to 
80% of K562 or HL60 cells. Killing was achieved with final GzmH concentrations of 15-20 µg/ml 
Figure IV.9 - Sublytic concentrations of PFN and SLO are essential for Gzm specific killing.  (A and C) 
K562 cells (1 x 105 / 50 µl) were exposed to vary ng concentrations of SLO (A) and PFN (C). (B and D) HL60 
cells were also exposed to different concentrating of SLO (B) and PFN (D). In all cases, GzmB was previously 
added to the cells at a final concentration of 10 µg/ml. GzmB is known to efficiently induce apoptosis
hour of exposure at sublytic concentrations of pore forming proteins such as SLO and PFN. Cells were
fo
are here defined as AV+/PI- + AV+/PI+ cells. The red line present in each graph represents the sublytic 
concentration of pore-forming protein chosen for our apoptosis assays. 
  
 
SLO delivered GzmH is able to induce cell death  
With the sublytic window set for each cell line with regards to PFN and SLO, the next step was to 
address the question of whether GzmH is indeed able to induce cell death. To address this question, 
we used GzmB to control our experiments. Work from our lab by Kurschus and colleagues, has indeed 
shown that unglycosylated recombinant GzmB is potently apoptogenic, killing various target cell lines 
within an hour (Kurschus et al., 2004; Kurschus et al., 2005). We also set out to determine the range of 
extracellular concentrations necessary if GzmH were indeed to efficiently trigger cell death. T
G
H
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with K562 cells and slightly lower concentrations of 10-15 µg/ml with HL60 cells. GzmB however, 
achieved comparable levels with both cell lines already at a concentration of 10 µg/ml. Importantly, 
inactive GzmH, in combination with sublytic SLO, revealed similar levels of cell death obtained with 
SLO alone. U937 cells were also efficiently killed by GzmH. Figure IV.10B shows the percentage of 
dead cells after 12 hours of exposure to GzmH and GzmB in the presence of sublytic SLO. Cell death 
was here separately monitored by PI and trypan blue staining.  
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Figure IV.10 - Cell death induced by recombinant GzmH. (A) Effective ranges of GzmH concentrations that 
induced cell death in K562 or HL60 cells. The cells (1 x 105 / 50 µl) were analysed after 24 hours having been 
treated with sublytic SLO (125 ng/ml and 75 ng/ml respectively) and GzmH (20 µg/ml), GzmHS195A (20 µg/ml) 
or GzmB (10 µg/ml). GzmB was used at 10 µg/ml, a concentration at which the protease efficiently induced cell 
death. Importantly, inactive GzmH (20 µg/ml) was applied at the highest concentration of Gzm used, only 
caused background levels of cell death. Cells were analysed after Annexin V-FITC/Propidium iodide staining by 
FACS, the graphs showing the sum of dead and apoptotic cells (AV+/PI- + AV+/PI+ cells). The experiment shows 
the mean of triplicates, ± standard deviations (SD) and is representative of two independent experiments. (B) 
GzmH triggered cell death of U937 cells (1 x 105 / 50µl). U937 cells were exposed to GzmH (25 µg/ml) and 
GzmB (10 µg/ml) in the presence of sublytic SLO concentrations for 12 hours. In this combined graphic both 
propidium iodide and trypan bleu stainings were performed. PI staining was performed and analysed by FACS. 
Trypan blue staining was analysed under the microscope. The experiment represents single measurements. N.t: 
non-treated. 
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e percentage of apoptotic and necrotic 
lls re  
ontaneous cell death is also shown to indicate the minimal contribution of sublytic SLO (see red 
row in Figure IV.11) to the total background values. After several repetitions we were reassured that 
zmH, at least delivered with sublytic SLO, could efficiently kill K562 cells within 10 to 12 hours 
ter delivery.  
igure IV.11 - GzmH killing in K562 cells (shown 
 the mean of triplicates, representative of two independent experiments). GzmH (20 µg/ml), induced cell death 
SLO delivered GzmH requires 10 to 12 hours to efficiently kill target cells 
To better define the time required for optimal GzmH triggered killing, we performed a time course 
killing assay in which treated K562 cells were analysed every two hours after the addition of sublytic 
concentrations of SLO. The experiment was performed with SLO and not PFN due to limited PFN 
availability, the experiment still giving us an impression of the time required for GzmH to reach 
optimal killing efficiency. Ten hours after GzmH delivery, th
ce ached a plateau, an effect GzmB achieved within only two hours. The percentage of
sp
ar
G
af
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
F Cell death induced by recombinant GzmH. Time course of 
is
within 10 hours. GzmB (10 µg/ml) was used to control the efficiency of SLO delivery. Sublytic SLO at 125 
ng/ml induced an additional 10% cell death on top of the natural background values obtained for untreated cells 
(red double headed arrow). Cells were analysed after Annexin V-FITC/Propidium iodide staining by FACS, the 
graphs showing the sum of dead and apoptotic cells (AV+/PI- + AV+/PI+ cells). 
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Figure IV.12 - Raw FACS data demonstrating the capacity of GzmH to trigger cell death. Representative 
FACS data for K562 cells (1 x105 / 50µl), twelve hours after treatment in medium alone, in medium containing 
sublytic SLO and finally medium containing SLO plus the following proteases: GzmHS195A (15 µg/ml), GzmH 
(15 µg/ml) and GzmB (7.5 µg/ml). Apoptotic and dead cells were identified by annexin V and PI staining. Dead 
cells are characterized by low FSC and high SSC signals. (A) Plots showing forward scatter (FCS) versus side 
scatter (SSC) signals. (B) Dot plots showing how GzmB and GzmH induced killing as deduced by the presence 
of high percentages of apoptotic (AV+/PI-) and necotic (AV+/PI+) cells. 
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igure IV.12 shows representative FACS data of AV/PI stained K562 cells 12 hours after treatment 
ith the indicated proteases. The right column shows how active GzmH and GzmB strongly induced 
 the presence of high percentages of apoptotic and necrotic cells. The left column 
f plots, forward scatter (FSC) versus side scatter (SSC) signals showed similar changes that occurred 
 both GzmH- and GzmB-treated cells. The dying apoptotic cells, here characterized by low FSC and 
igh SSC signals, are typical of apoptotic cells.  
ently kills K562 and HL60 cells 
formed a series of experiments analysing K562 and HL60 cells 10 to 12 hours after 
sublytic Streptolysin O (SLO) or Perforin (PFN). In accordance with the 24 
our killing assay results mentioned above, pooled data from three independent experiments revealed 
at GzmH can indeed efficiently kill both cell types after this reduced incubation period (Figure 
.13A). Importantly GzmH was also able to trigger cell death after the addition of PFN as the delivery 
gent with cell death levels reaching 70% (AV+/PI- + AV+/PI+ cells) after 24 hours (Figure IV.13B), 
zmHS195A clearly demonstrating the importance of protease’s proteolytic activity with regard to cell 
eath induction.  
 is important to note that the values representing PFN/SLO alone were only 5-10% higher than the 
atural cell death background observed in untreated cells. To ascertain the unique apoptosis-inducing 
pecificity of GzmH, K562 cells were additionally treated with mast cell chymase, a closely related 
hymotrypsin-like serine protease and a member of the GzmH-GzmB gene cluster on chromosome 
4q11.2. Although mast cell chymase efficiently cleaved our chymase substrates, the enzyme was not 
ble to induce SLO mediated target cell death. Indeed, the percentage of AV+/PI- + AV+/PI+ cells 
ached levels similar to those observed after being exposed to GzmHS195A (Figure IV.13A).  
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zmH triggered cell death is distinguishable from GzmB cell death  
o assess the morphological changes triggered by GzmH, we performed live cell imaging of GzmH 
d GzmB treated cells. GzmH, similar to GzmB, induced many of the typical morphologic changes 
at occurred during apoptotic cell death, such as high granularity, nuclear condensation, apoptotic 
ody formation and irregularities of the cell surface membrane. Importantly, inactive GzmHS195A 
gether with SLO did not elicit any of the above changes (Figure IV.14). Despite the lack of 
orphological differences spotted after exposure of target cells to GzmH or GzmB, GzmH treated 
lls, stained with trypan blue (a technique used to monitor cell membrane integrity and the emergence 
f cell necrosis), did reveal a marked difference in the percentage of positively stained cells. Samples 
ere assayed every two hours after GzmH or GzmB loading. Surprisingly, GzmH triggered the 
accumulation of trypan blue in target cells relatively quickly (45% of cells were positive after 4 hours), 
 
 
K562 + SLO 
Figure IV.13 - Cell death induced by recombinant GzmH. K562 or HL60 cells exposed to GzmH and sublytic 
concentrations of PFN or SLO resulted in near complete cell death. Viability of K562 and HL60 cells was 
examined by annexin V-FITC (AV) and propidium iodide (PI) staining 10-12 (SLO) and 24 (PFN) hours after 
the indicated treatments. Depending on the translocator of choice, graphic A showing SLO and graphic B 
showing PFN, GzmB or GzmH, were used at final concentrations of 5/10 µg/ml or 5/20 µg/ml respectively, the 
lower concentration used in combination with perforin. GzmHS195A and mast cell chymase were used at 25 
µg/ml. Presented, for both perforin and SLO mediated experiments, is the sum of apoptotic (AV+ and PI-) and 
necrotic (AV+ and PI+) cells from 3 pooled independent experiments (n=3, ± standard deviations (SD). Statistical 
significance is shown as * representing p<0.005 (significant) and * * p <0.001 (very significant).  In contrast to 
GzmH, mast cell chymase did not induce cell death.   
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whereas the percentage of secondary cell necrosis was only 30% at the 4 hour time point (Figure 
IV.15) in GzmB experiments. Membrane integrity was lost at a later time in response to GzmB, but 
GzmH required more time to induce noticeable cell death in the majority of target cells. On the basis 
of these initial findings, the cell death programs triggered by GzmH and GzmB appeared to be clearly 
distinguishable. 
 
 
 
 
Figure IV.14 - GzmH treated K562 cells displayed many of the typical apoptotic morphological changes. 
To distinguish living cells from those with apoptotic nuclei, bright field pictures were taken with an inverted 
microscope (40x magnification). Ten hours after GzmH (20 µg/ml) treatment, K562 cells displayed a 
characteristic morphology with increased granularity, condensation of nuclei and membrane irregularities. GzmB 
was used at a final concentration of 10 µg/ml. Importantly, inactive GzmHS195A (25 µg/ml) together with sublytic 
SLO did not trigger similar changes. Scale bar equals 20 µm.   
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Figure IV.15 - GzmH induced cell death leads to the quick loss of membrane integrity. GzmH/SLO treated 
K562 cells were stained with trypan blue at various time points (n=3, ± SD). In contrast to GzmB, GzmH 
induced a much more pronounced trypan staining, with nearly 50% of cells positive after 4 hours. At this time 
point GzmB treated cells, in late phase apoptosis, accounted for only 30%. 
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GzmH induces nuclear fragmentation & chromosomal condensation 
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IV.5.2 - 
ells treated with GzmH display strongly fragmented nuclei with condensed chromatin 
o further investigate GzmH induced cellular changes, 10 to 12 hours after treatment with the protease 
d sublytic SLO, K562 cells were stained with the Hoechst dye 33342 and annexin V-FITC and then 
ubsequently analysed by immunofluorescence microscopy after fixation (see materials and methods).  
 
 
Figure 1V.16 - Nuclear fragmentation of K562 cells treated with GzmH or GzmB and sublytic SLO for 12 
hours. (A) Cells were stained either with the Hoechst dye 33342 alone (40x magnification) or (B) in 
combination with annexin V-FITC (63x magnification). After fixation fluorescent signals were analysed by 
microscopy. In contrast to treatment with GzmB (7.5 µg/ml) and GzmH (15 µg/ml), cells treated with SLO alone 
or in conjunction with GzmHS195A (15 µg/ml), (A-B, left) did not show fragmented nuclei with condensed 
chromatin or phosphatidylserine externalization. Hoechst stainings are representative of 5 independent 
experiments. Scale bar indicates 20 µm. 
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In  
optotic cells or AV+/PI- and AV+/PI+ populations) and displayed strong fragmented nuclei with 
cells 
cleavage has not been investigated so far, the presence of much smaller fragmented nuclei, compared 
 activation. The columns represent the mean with its standard deviation 
 contrast to cells treated with GzmHS195A, most cells stained positive for annexin V (dead and
ap
condensed chromatin (Figure IV.16). Interestingly, in comparison to GzmB, GzmH treated 
showed nuclei with a higher degree of fragmentation. The GzmB pathway is known to lead to the 
activation caspase activated DNase (CAD) which results in the cleavage of host DNA into segments of 
approximately 180-200 bps in length. The mechanism by which GzmH triggers eventual DNA 
to that induced by GzmB, pointing towards the possibility that GzmH mediated cell death results in 
the activation of endonucleases which cleave DNA into much shorter double-stranded pieces.  
 
In a separate experiment the nuclei of K562 cells treated with GzmH or GzmB in the presence or 
absence of the general caspase inhibitor zVAD-FMK, were analysed 4 and 12 hours after Hoechst 
33342 staining with the aim to acquire a better understanding of the speed with which GzmH harms 
the host cell’s nuclei. After 4 hours of exposure to GzmH, the nuclei of K562 cells still appeared 
normal under the microscope. Cells exposed to GzmB however already revealed maximum apoptotic 
nuclei (Figure IV.17). After 12 hours though a different story emerged, with most GzmH treated cells 
displaying apoptotic nuclei thus fitting well to the delayed killing capacity of GzmH (refer to Figure 
IV.13). GzmB-induced nuclear fragmentation, on the other hand, was strongly inhibited by zVAD-
FMK after 4 (94% inhibition) and 12 hours (70% inhibition). The latter GzmB induced phenomenon 
was thus caspase dependent. In contrast, in the presence of zVAD-FMK the effects of GzmH, after 12 
hours, were only moderately inhibited by about 30% indicating a caspase independent pathway for the 
protease. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV.17 - Apoptotic nuclei induction by GzmH. Quantification of apoptotic nuclei, following Hoechst 
33342 staining, 4 and 12 hours after treatment with GzmB or GzmH and sublytic SLO. GzmH was used at a 
final concentration of 20 µg/ml and GzmB at 10 µg/ml. Additionally, the general caspase inhibitor zVAD-FMK 
(100 µM) was used as a probe for caspase
om triplicate measurements. 
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 - 79 -
 Results 
____________________________________________________________________________
  
 
 - 80 -
GzmH mediated cell death causes a loss of typical cell cycle peaks 
To explore GzmH induced damage of cellular nuclei more explicitly, DNA analysis of the cell cycle 
was performed. As expected, K562 cells, treated with sublytic amounts of SLO and GzmHS195A, 
revealed the characteristic peaks of proliferating cells in the G1, S and G2 phases with no sub-G1 
peaks visible indicating the absence of double-stranded fragmented apoptotic DNA. On the other 
hand, cells treated with either active GzmB, or GzmH, eventually lost the characteristic cycle peaks of 
living cells while the number of cells located in the sub-G1 area (M1) increased (Figure IV.18A).  
 
 
Figure IV.18A - DNA content analysis of differentially treated K562 cells after 5, 12 and 24 hours. 
Following the exposure of K562 cells ( 1 x 105 / 50  µl) to GzmB (10 µg/ml) or GzmH (20 µg/ml), the two 
characteristic peaks (G1 and G2M, left and right peaks, respectively) of dividing cells were gradually lost (see 
time points), while cells with lower DNA content values in the so-called sub-G1 area appeared (indicated by 
M1). Importantly, inactive GzmH (20 µg/ml) did not cause a loss of the normal cell cycle peaks, G1 and G2M. 
The pan-caspase inhibitor zVAD-FMK was used at 100 µM.  
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ns. 
igure IV 18B - DNA co after 5, 12 and 24 hours. 
uantitative representation (n=3, +/- SD) of experiment A. Following the same trends as seen in the FACS data, 
zmB treated cells show early DNA degradation while GzmH works a slow, but progressive diminution of 
e percentage of Sub-G1 cells matching that induced by GzmB at the 24 h time point. 
zmH does not induce DNA laddering or ICAD cleavage 
uclear disintegration was analysed by agarose gel electrophoresis (Figure IV.19A). After 4 hours no 
ddering was detected in postnuclear lysates of GzmH treated cells although a slight background 
mear did become apparent at the 12 hours time-point. This background could be due to unspecific 
zmH events which occur before the 12 hour, a time point when 70-80% of cells are already dead. On 
e other hand GzmB, which efficiently activates procaspase 3 and in turn the caspase activated DNase 
AD, revealed a clear-cut laddering pattern after the 4 hours time point. To back up these 
Although both enzymes did lead to an increase in the percentage of cells containing a reduced DNA 
content, the GzmH mediated cell population in the sub-G1 area was only evident after 12 hours. In the 
case of GzmB, similar values of approximately 35% where already present at the 5 hour time point. 
After 24 hours however, the percentage of DNA contained within the sub-G1 area was the same. 
Consistent with the differential effects of zVAD-FMK on the nuclear morphology of GzmB- and 
GzmH-treated cells, the pan-caspase inhibitor also moderately prevented GzmH triggered DNA 
degradation, whereas inhibition by zVAD-FMK was highly efficient in protecting GzmB-treated target 
cells. Figure IV.18B is a quantitative presentation of our FACS observations in Figure IV.18A, 
specifying the percentage of sub-G1 cells (marker M1) after treatment under the above conditio
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observations, we decided to analyse levels of ICAD, the inhibiter of caspase activated DNase (CAD). 
As implied above, this DNase is thought to be largely responsible for the caspase induced laddering 
effect seen in many apoptotic pathways. In the case of GzmH induced cell death however, ICAD 
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e only detectable at the 12 
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3
ackground levels. Again treatment with zVAD-FMK totally abolished the initial effects of GzmB 
fter 4 hours again emphasizing the essential role caspases play in the GzmB death pathway. After 12 
remained untouched during time course experiments with minimal declin
hour time point (Figure IV.19B). Our observations strongly indicate that CAD activation does not take 
place during GzmH induced cell death and suggest the late decline in ICAD is the result of secondary, 
indirect events. The absence of CAD activation during GzmH mediated cell death provides yet more 
evidence, along with the ineffectiveness of the general caspase inhibitor, zVAD-FMK, that the 
pathway triggered by this protease is indeed caspase independent.   
A B
    
Figure IV.19 - GzmH treatment does not cause apoptotic DNA laddering or activate caspase activated 
DNase (CAD) via ICAD cleavage. (A) K562 cells (1 x 105 / 50 µl) were treated for 4 and 12 hours as indicated 
with GzmH (20 µg/ml) or GzmB (10 µg/ml) in the presence of sublytic concentrations of SLO. Cellular DNA 
was analysed on a 1% agarose gel and the experiment repeated three times. Lanes 2 and 3 (from left to right) 
show the intact cellular DNA from non treated K562 cells. Lanes 4 and 5 are representative of the GzmB effect 
on cellular DNA, showing DNA degradation and low molecular weight fragments differing by 200 bps in length. 
In lanes 6 and 7, GzmH treatment shows control-like results, with only a slight background after 12 hours. (B) 
562 cells (1 x 105 / 50 µl) were exposed to GzmB or GzmH. At the above defined time points, 100 µl of cells, 
x106 / 50 µl, were harvested and washed in PBS before being directly boiled in reducing Laemmli buffer and 
aded onto SDS gels. Following transfer, blots were then analysed for the presence of ICAD by immunoblotting 
(see materials and methods page 50 and 51). The blot was stripped and then analysed with an anti-actin antibody 
o control loading (see materials and methods page 50/51).  
GzmH induces the release of radioactively labeled nuclear DNA 
Degradation and release of radioactively labeled nuclear DNA into the cytosol was monitored by the 
H-thymidine release assay (refer to Figure IV.20). In line with the above experiments, GzmH induced 
slower 3H-thymidine release than GzmB, reaching maximum levels 24 hours after cell death induction. 
By contrast the catalytically inactive GzmHS195A mutant did not induce any significant effects above 
b
a
and 24 hours, however, cells treated with zVAD-FMK and either GzmB or GzmH displayed consistent 
3H-thymidine release at similar levels. Contrary to previous experiments demonstrating the absence of 
caspase involvement in GzmH triggered cell death, here the general caspase inhibitor diminished 3H-
12 h   12h    6 h    9 h   12 h   6 h    9 h   12 h  12 h  
GzmB 10 µg/ml kDa GzmH 20 µg/ml 
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ay.  After 4, 
2 and 24 hours, K562 d been treated with SLO 
cat
s executioner molecules 
thymidine release by approximately 40% at the 12 hour time point. This observation lead us to 
consider the possibility that zVAD-FMK might indeed be inhibiting other intracellular proteases such 
as the lysosomal cathepsin family. Indeed, members of this cysteine protease family have not only 
been reported to be irreversibly inhibited by most caspase inhibitors, especially zDEVD-CMK/FMK, 
acYVAD-CMK/FMK and zVAD-FMK (Rozman-Pungercar et al., 2003), but also to be involved in 
triggering various apoptosis pathways (Guicciardi et al., 2004). It was therefore conceivable that 
GzmH might be involved in unleashing these lysosomal proteases (Figure IV.26). In summary, GzmH 
induced a slow form of DNA-degradation, distinct from that of GzmB, which was only partially 
inhibited by zVAD-FMK.  
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 Figure IV.
1
20 - GzmH induces DNA fragmentation monitored by the 3H-thymidine release ass
 cells (1 x 105 / 50 µl), which had incorporated 3H-thymidine an
and the indi ed proteases (GzmH at 20 µg/ml and GzmB at 10 µg/ml) were monitored for fragmented DNA 
release into the supernatant. The caspase inhibitor zVAD-FMK (50 µM) only partially inhibited both proteases 
after 12 and 24 hours. The data points represent the average of triplicate measurements ± SD. 
 
 
 
IV.5.3 - GzmH does not activate main apoptosi
 
 
GzmH does not directly cleave recombinant effector caspases or recombinant Bid 
Executioner caspases are potent coordinators of apoptosis. Catalytically inactive variants of main 
executioner caspases 3 and 7 (C285A mutants), kindly provided by G. Salvesen and S. Riedl, allowed 
us to verify if GzmH could directly cleave these essential coordinators of apoptosis. Recombinant 
GzmB was used as a positive control, the aspase widely reported to directly target executioner 
caspases 3 and 7 and the Bcl-2 family member Bid after entry into the cytosol (Barry et al., 2000; 
Metkar et al., 2003).  
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pase 3 and 7 even after 5 minutes 
incubation at 37°C, incubation with GzmH for 1 hour resulted in no cleavage whatsoever, both 
procaspase bands identical to the controls in lanes 1 and 2 (Figure IV.21B). Likewise, recombinant Bid 
was also not cleaved after exposure to GzmH (Figure IV.21C). Indeed, truncated Bid (t-Bid) is another 
potent coordi
mo
 
 
 
 
 
Electrophoretically separated bands were visualized by silver staining.  
GzmB modifies procaspases by cleaving after aspartic acid residues. This then results in the liberation 
of the prodomain and the generation of a small and a large fragment. The smaller fragment, namely 
p10 or p11, p10 referring to the molecular weight of the caspase 3 fragment and p11 to that of caspase 
7. The remaining p22/24 fragment, or large fragment, goes on to form a heterodimer with fragment 
p10/11 which in combination with a second heterodimer produces an active tetramer (refer to Figure 
IV.21A). In contrast to GzmB, which efficiently cleaves both procas
nator of apoptosis which damages the mitochondrial outer membrane and which, 
reover, is another direct substrate of GzmB.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV.21 - GzmH does not cleave recombinant procaspases 3 and 7 or recombinant Bid. (A) Scheme 
representing procaspase cleavage and activation. (B) The catalytically inactive human procaspases 3 and 7 (5 
µM), with the active site Cys285 replaced by an Ala residue to avoid autoactivation, and (C) recombinant Bid (5 
µM), were incubated with either recombinant GzmH (50 nM) or GzmB (50 nM) for 1 h at 37°C in activity 
buffer. Samples were boiled in reducing Laemmli buffer, loaded and separated on a 18% polyacrylamide gel. 
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baseline readings. To rule out any late surge in caspase activity, prolonged 
easurements, of up to 15 hours, were performed but no increase was observed. As expected, the 
dition of the general caspase inhibitor zVAD-FMK completely inhibited GzmB induced executioner 
spase activity. 
he effect of GzmH was weaker, but clearly above the background levels caused by 
t determined. 
GzmH induced cell death does not activate initiator or effector caspases  
To investigate GzmH-related caspase involvement more thoroughly, we continuously monitored the 
activity of caspases 3, 6, 7, 8 and 10 in living cells for up to 10 hours using the cell penetrating 
fluorogenic substrate acDEVD-AMC (see handbook on caspase inhibitors and substrates from 
Calbiochem).  
 
Figures IV.22A and B show the efficient cleavage of acDEVD-AMC in response to GzmB, after K562 
cells were exposed to both sublytic concentrations of SLO or PFN respectively. Conversely, GzmH or 
GzmHS195A resulted only in 
m
ad
ca
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Figure IV.22 - GzmH does not activate effector caspases in living cells. Using cell penetrating caspase 
substrates we analysed caspase activities in living cells (1 x 105 / 50 µl) 10 hours after granzyme treatment. Data 
was normalized to GzmB and pooled from 3 (A) and 2 (B) independent experiments, ± SD. In contrast to cell 
death mediated by sublytic concentrations of perforin (B) or SLO (A), GzmH (20 µg/ml) did not induce cleavage 
of acDEVD-AMC which monitors the activities of caspases 3, 6, 7, 8 and 10. Addition of zVAD-FMK (50 µM) 
completely blocked the activation of caspases by GzmB (10 µg/ml). The same observations were seen with the 
caspase 9 substrate, acLEHD-AMC, here only monitored using SLO as a translocator. Cleavage of the caspase 2 
substrate, acVDVAD-AFC, was observed in both GzmB and GzmH-SLO treated K562 cells, where in 
comparison to GzmB, t
sublytic SLO alone. N.d.: no
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ytosolic fractions of GzmH treated K562 cells were 
repared and analysed at different time points following cell death induction. Digitonin, a weak 
o nic detergent that selectively renders the plasma membrane permeable, releasing cytosolic 
rom cells but leaving other organelles intact (Heibein et al., 1999), was used at low 
oncentrations (see materials and methods) to monitor the release of cytochrome c. Digitonin is an 
eal compound with which to study the release of mitochondrial inter membrane space proteins 
IMPs) such as cytochrome c, the smallest members of the proapoptotic MIMPs. Following 
eatment with zmH or GzmB after 1, 2 and 6 hours, K562 cells were washed and resuspended in 
igitonin lysis buffer. Supernatants and pellets loaded onto polyacrylamide gels followed by 
lectrophoresis and transfer to nitrocellulose membranes for Western blot analysis. GzmH treated 
rget cells did not show any detectable cytochrome c loss from the inner membrane space of 
itochondria (Figure IV.23). As expected, cytosolic levels of cytochrome c did increased over time in 
562 cells that had been treated with GzmB, while levels of the cytochrome declined in the respective 
embrane fractions.  
 
 
  
 
 
igure IV.23 - GzmH mediated cell death does not result in the release of cytochrome c. Western blot 
nalysis (representative of 2 independent experiments) reveals that cytochrome c release is not a hallmark of 
GzmH mediated cell death does not lead to apoptosome formation and cytochrome c release 
We also measured caspase 9 activity using the fluorogenic substrate acLEHD-AMC (Figure IV.22A). 
Whereas caspase 9 activity was easily detected in GzmB-treated K562 cells over time, no activity 
towards ac-LEHD-AMC was found after SLO mediated delivery of GzmH or GzmHS195A. Despite the 
lack of caspase 9 activity after GzmH treatment, we nevertheless chose to verify cytochrome c release, 
the smallest of the proapoptotic mitochondrial intermembrane space proteins. If the outer 
mitochondrial membrane were damaged by GzmH, cytochrome c would be expected to be released 
into the cytosol thereby triggering the formation of the apoptosome complex and procaspase 9 
activation (Zou et al., 1999).  
 
To ascertain the lack of cytochrome c release, c
p
n nio
c mponents fo
c
id
(M
tr  G
d
e
ta
m
K
m
 
kDa 
 
 c 
c 
6 h      6       2 h    1 h    1 h      2 h     6 h  h      6 h
 
F
a
GzmH induced cell death. K562 cells (1 x 105 / 50 µl) were exposed to GzmH (20 µg/ml) or GzmB (10 µg/ml) 
and sublytic SLO for the indicated times. After cytosolic and membrane supernatant preparation, cytochrome c, 
in the case of GzmH treatment, could only be detected in the membrane fraction. The membrane fractions 
prepared, 1, 2 and 6 h after exposure to GzmB show a gradual decline of cytochrome c, and gradually reappear 
in the cytosolic fractions.   
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ed independent of caspase activation. Recently, interest has been mounting regarding 
e role of caspase 2 in cell death with various studies by Sten Orrenius and colleagues suggesting that 
aspase 3 has been shown to cleave the caspase 2 specific sequence, VDVAD (refer to Figure IV.24C 
and D). Since we demonstrated the lack of caspase 3 activity in response to GzmH induced cell death 
(refer to Figure IV.24Ai), cleavage of the fluorogenic acVDVAD-AFC substrate should uniquely 
monitor caspase 2 activity in GzmH treated cells. Interestingly, GzmH, delivered to K562 cells with 
sublytic SLO concentrations, generated some acVDVAD-AFC cleaving activity, whereas GzmB again 
showed a much greater effect at every recorded time-point (Figure IV.24Aiii). In experiments 
repeatedly performed with GzmHS195A, only background signals were recorded, whereas the caspase 2 
inhibitor zVDVAD-FMK, as well as zVAD-FMK, completely prevented GzmH dependent caspase 2 
like activity. GzmH apparently does not activate caspase 2 directly, or in a protease mediated manner, 
since, in contrast to GzmB, activity against acVDVAD-AFC was not induced in a cytosolic (S100) 
K562 lysate after GzmH addition (Figure IV.24B). 
 
 
 
 
GzmH induced cell death leads to weak caspase 2 activation 
As previously demonstrated the use of the zVAD-FMK during GzmH triggered cell death resulted in a 
slight decrease of the protease’s cytotoxic ability. Using recombinant effector caspases as well as cell 
penetrable, caspase specific peptides, we showed that the mechanisms underlying GzmH induced cell 
death were inde
th
caspase 2 is activated in response to DNA damage and genotoxic stress. Thereafter an alternative cell 
death pathway is induced based on damage to the mitochondria (Robertson et al., 2004; Zhivotovsky 
and Orrenius, 2005) although the exact mechanism by which the cysteine protease executes cell death 
still remains obscure. Therefore, we investigated whether caspase 2 activity might contribute towards 
GzmH mediated cell death.  
 
C
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igure IV.24A - Cytotoxic activity of GzmH does not depend on caspases. Full time-lapse 
munofluorescence analysis of the 10 hour time point experiments summarized in Figure IV.22A (Refer to 
igure IV.22A experimental detailis). The curves represent the average fluorescence signals of individual, 
iplicate measurements taken at 5-min intervals (1 h intervals presented). Each graph is representative of three 
pendent experiments.  
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igure IV.24B, C and D - Cytotoxic activity of GzmH does not depend on caspases. Cytosolic fractions from 
562 cells (1.5 µg/µl, 20 µg total in 100 µl) were exposed to GzmB (10 µg/ml) or GzmH (25 µg/ml). Caspase 2 
ivity was measured by the hydrolysis of the fluorogenic caspase 2 substrate acVDVAD-AFC (final 
oncentration 200 µM). (B) Unlike, GzmB, GzmH does not lead to caspase 2 substrate cleavage in a direct or 
rotease mediated fashion. (C and D) To ensure that acVDVAD-AFC was truly monitoring caspase 2, and no 
ther caspase activity, the immunoprecipitation (IP) of caspase 2 (C), and both caspases 2 and 3 (D) from 
ytosolic fractions of untreated K562 cells was tested using specific caspase 2 and caspase 3 monoclonal 
ibodies from Alexa. Key: lysate, cytosolic fraction; IP, immunoprecipitation; C2 and C3, caspases 2 and 3; 
.t., not treated. 
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s independent of caspases in K562 and HL60 cells. Shown is the percentage of 
rviving cells (Annexin V-FTIC-/propidium iodide-) which had been treated with sublytic SLO and GzmB (10 
l) (refer to graphs i and iii) or GzmH (20 µg/ml) (refer to graphs ii and iv) for 12 hours. Prior to granzyme 
nd SLO treatment, K562 cells (1 x 105 / 50 µl) had been separately exposed to the caspase inhibitors zVAD-
MK (Caspases 1, 3, 7), zDEVD-FMK (Caspase 3) and zVDVAD-FMK (Caspase 2) for 30 minutes. Values 
present the average of three independent experiments ±SD. The caspase inhibitors zVAD-FMK and zDEVD-
MK rescued cells from GzmB induced apoptosis in a dose dependent fashion, whereas killing by GzmH was 
inimally affected. Notably, the caspase 2 inhibitor, zVDVAD-FMK did not protect the cells against the actions 
f GzmH. 
 GzmB treated cells, zVAD-FMK and zDEVD-FMK restored the percentage of surviving cells to 
e level of untreated cells (Figure 25i and iii), while none of these inhibitors, even at the highest 
oncentration of 50 µM were able to offer protection against GzmH after 10-12 hours. By contrast, 
Caspase 2 activity, along with all apoptotic caspases, is not required for GzmH cell death 
Finally, to investigate whether or not the observed caspase 2 activation was essential for GzmH 
induced cell death, we pretreated K562 or HL60 cells with various concentrations (5, 25, 50 µM) of 
zVDVAD-FMK, a specific caspase 2 inhibitor. Additionally, we also treated cells with other caspase 
inhibitors, namely zVAD-FMK (a pan-caspase inhibitor) and zDEVD-FMK (inhibiting the initiator 
caspase 8 and 10 and the executioner caspases 3, 6 and 7) and monitored cell survival by AV/PI 
staining after 10 hours of incubation (Figure IV.25).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV.25 – GzmH kill
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progression of GzmH induced cell death, as monitored by the reduction of surviving cells after 10-12 
hours, was poorly affected by all three inhibitors implying that caspase activation, and especially 
caspase 2 activity, was not crucial for GzmH mediated cell death (Figure IV.25 ii and iv). 
 
Cysteine proteases, the cathepsins, are not mediators of GzmH killing 
Our observation that the general caspase inhibitor zVAD-FMK offered slight degrees of protection 
against various GzmH mediated effects (Figures IV.17, 18 and 20) lead us to investigate the possible 
impact of lysosomal cysteine proteases (cathepsins) in this death cascade.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
athepsins are inhibited by a number of irreversible caspase inhibitors including zVAD-FMK 
ozman-Pungercar et al., 2003). We therefore compared the death inhibiting effects of the cell 
ermeable general cysteine protease inhibitor E64d with that of zVAD-FMK in GzmH and GzmB 
eated target cells (Figure IV.26). E64d did not result in any reduction of cell death that occurred 
ithin 12 hours after exposure of GzmB or GzmH to K562 cells. We, therefore, conclude that the 
zmH triggered cell death is not mediated by lysosomal breakdown and concomitant release of 
sosomal proteases into the cytosol.  
FMK 
 
 
 
Figure IV.26 - Lysosomal cathepsins are not mediators of GzmH killing. Treatment of K562 cells (1 x 105 / 
50 µl) with the cell permeable general cathepsin inhibitor E64d (20 µM) provides no protection against sublytic 
SLO and GzmH (20 µg/ml) or GzmB (10µg/ml) induced cell death after 12 h. Additionally, the general caspase 
inhibitor zVAD-FMK was used at a final concentration of 50 µM. Cells were analysed by FACS after annexin V 
FITC (AV) and propidium iodide (PI) staining. The red arrow indicates the effect of zVAD-FMK on sublytic 
SLO concentrations, the pan caspase inhibitor most likely mitigating the unspecific sublytic effects of SLO. 
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wever, if observed, could occur if damage to the 
ner membrane of the mitochondria is sustained.   
zmH trigge
sing the green fluorescent probe JC-1, which accumulates and aggregates in the inner membrane 
pace and appears red in intact mitochondria, we monitored the depolarization and potential loss 
m) of inner mitochondrial membranes in K562 cells. As expected, GzmB exerted its strong 
epolarizing effect on mitochondria already after 4 hours with a near complete loss of red fluorescence 
isible by FACS analyses after 24 hours (Figure IV.27 A and B). GzmH treated cells displayed a similar 
ss of the membrane potential within 24 hours, but this effect occurred with some delay (Figure 
.27A and B). Treatment of K562 cells with GzmHS195A clearly confirmed that the decline was due to 
e proteolytic activity of GzmH.  
egarding GzmB mediated cell death, it is well documented that the aspase is able to induce caspase 
dependent mitochondrial damage by two distinct pathways. One, requires the cleavage and 
ctivation of Bid, at a site distinct from that of caspase 8, leading to the release of MIMPS, the release 
f ROS and the loss of ΔΨm (Alimonti et al., 2001; Barry et al., 2000; Heibein et al., 1999; Sutton et 
l., 2000). The other, whose molecular basis is unknown, involves direct action on mitochondria to 
duce increased ROS and loss of ΔΨm but not release of cytochrome c and other MIMPs (Heibein et 
l., 1999; MacDonald et al., 1999; Sutton et al., 2000; Thomas et al., 2000). Indeed, treatment of K562 
y though, this was not found to be the case for following GzmH addition to K562 cells. At 
e 4 hour time point, and in the presence zVAD-FMK, no difference was seen in mitochondrial 
IV.5.4 - GzmH induces mitochondrial damage and ROS production 
 
 
With the indication that cytochrome c (15 kDa), the smallest of the pro-apoptotic mitochondrial 
intermembrane space proteins (MIMPs), was not released during GzmH mediated cell death (see 
Figure IV.23), the likelihood that others MIMPS, such as the apoptosis inducing factor (AIF) at 57 kDa 
and endonuclease G (endo G, 30 kDa), should exit into the cytoplasm is very slim (Barry et al., 2000; 
Heibein et al., 1999). Mitochondrial depolarization ho
in
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cells with the general caspase inhibitor zVAD-FMK prior to the addition of GzmB and sublytic SLO 
concentrations, confirmed that, after 24 hours, mitochondrial depolarization by GzmB can occur 
independently of caspase activation. Unlike the values observed at the 24 hour time point, at the 4 
hours, a 20% reduction in depolarization was measured in the presence of zVAD-FMK demonstrating 
that at early time points caspases do play a role in GzmB triggered mitochondrial depolarization. 
Importantl
th
depolarization values. At 24 hours, however, and under the same conditions, a 15% decrease was 
measured although at this late time point it is possible that unspecific caspase activation can occur. 
Additionally, we performed a time course experiment and analysed ΔΨm for up to 8 hours (Figure 
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MK  
bitor (50 µM) for 4 or 24 hours and analysed by flow cytometry after JC-1 staining. The loss of ΔΨm is 
etected by a decrease of red fluorescence (FL2), and has been quantified by the percentage of cells appearing in 
e), which is oxidized by ROS, particularly superoxide (O2-) to 
IV.27B). Compared to GzmB, mitochondrial depolarization induced by GzmH is less efficient but 
nevertheless is closely correlated, time-wise, with the extent of cell death (also see Figure IV.13). 
 
Figure IV.27 - GzmH induces a loss of the mitochondrial membrane potential ΔΨm. (A) K562 cells (1 x 105 / 
50 µl) were treated with GzmH (20 µg/ml) or GzmB (10 µg/ml) in the presence or absence of the zVAD-F
A 
B
FMK 
FMK 
inhi
d
the R2 region. (B) Accumulation of cells with loss of ΔΨm over time. The experiment shows the mean of 
triplicates (± SD) and is representative of two experiments. Depolarization in most cells was already observed at 
the 4 hour time point after GzmB treatment; comparable effects were visible after 8 hours in GzmH-treated cells. 
 
 
GzmH triggers the release of mitochondrial reactive oxygen species (ROS) 
To test whether mitochondrial dysfunction, as indicated by ΔΨm loss, was associated with increased 
ROS formation, we stained K562 cells with the oxidation sensitive fluorogenic probe 
dihydroethidinium (DHE, hydroethidin
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product 5). We 
und that GzmH, in the presence of the redox insensitive SLOC530A, induced an early, but partially 
s with strong red fluorescence, namely 2-hydroxyethidium or 2-OH-E+ (Zhao et al., 200
fo
A 
transient ROS increase (indicated by region R2 in Figure IV.28A) which peaks at 30 minutes after SLO 
addition (Figure IV.28B). Conversely, GzmHS195A triggered a much reduced transient ROS increase 
(Figure IV.28A). Thereafter, ROS declined to slightly elevated levels but gradually increased from 4 
hours onwards as cell death became more apparent.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure IV.28 - GzmH induces ROS formation in target cells. (A) ROS levels measured by DHE staining in 
GzmH (20 µg/ml) and GzmB (10 µg/ml) treated K562 cells after 30 min and over the first 90 min. As in the 
previously described cell death assays, K562 cells (1 x 105 / 50µl) were treated with the indicated granzymes 
and sublytic SLOC530A (redox insensitive SLO) and then analysed by FACS. The dye is oxidized by ROS to the 
strongly red fluorescent ethidium (R2 in the dot-blots). H2O2 (1%) was used as positive control. The green 
rectangle is explained on p 95. (B) GzmH induced a rapid, but transient ROS increase which peaked after 30 
minutes. The data represent the average percentage of cells in area R2 of the raw FACS data. Shown is the mean 
of triplicates ±SD of one experiment representative for two experiments.  
30 minutes
B 
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were 
displayed in a different fashion on the FACS dot-plot (Figure IV.28A). Indeed, GzmB treated cells 
present in R2 were reduced by more then half in comparison to those treated with GzmH. 
Interestingly, GzmB treatment additionally formed another distinct population of cells, this time the 
dye oxidizing two products with green fluorescence (see green region). Zhao and colleagues recently 
reported that DHE can be oxidized by oxidants other than O2-, such as cytochrome c which do not 
generate 2-OH-E+ as an end-product (Benov et al., 1998; Zhao et al., 2003a). We speculate that 
because GzmB mediates the rapid release of cytochrome c, a product from the mitochondrial 
respiratory chain, this new population of cells could indeed mark cytochrome c release, an event which 
is absent in GzmH triggered cell death. If this is indeed the case, the cytochrome c generated 
population (in green) would be another proof that GzmH does not lead to the release of the 15 kDa 
heme protein.  
 
 
 
IV.5.5 - GzmH expression in NK cells and release during cytotoxic attack 
 
 
Natural killer (NK) cells were shown to be the major source of GzmH in the lymphocyte population, 
where GzmB was interestingly found to be less abundant (Sedelies et al., 2004). Because it has been 
postulated that GzmH plays an important role in the innate immune response (Sedelies et al., 2004), 
the fact that we now show that Gz mpted us to 
complement our data whic lls during effector cell 
attack. This fact still remai
 
GzmH is expressed at h
he specificity of a new monoclonal antibody (R&D systems) against GzmH was first confirmed in 
e major GzmH expressing human lymphocyte population (Sedelies et al., 2004). Neither monocytes, 
l population, after 
Whereas GzmH mediated ROS production, as defined by cells present in the R2 region, was 
demonstrated by the reaction between DHE and O2- (producing 2-OH-E+), GzmB treated cells 
mH is a alternative cytotoxic effector protease, pro
h evidence, that GzmH is indeed released form NK ce
ns to be demonstrated in the field of granzyme biology.       
igh levels in CD3-, CD56+ NK cells  
T
Western blots and ELISA using all known human granzymes produced in our lab (Figure IV.29A and 
B). We next analysed the expression of GzmH in different human cell lines and purified cell 
populations. Unfortunately, only the YT cell line, which is reported to be a poor killer, was found to 
express relatively high levels of GzmH. Using two different isolation methods (positive selection by 
MACS beads or negative selection by Dynal beads) we confirmed the recent findings that NK cells are 
th
nor activated CD8-positive CTLs showed any GzmH expression. In the residual cel
depletion of monocytes and NK cells, a weak GzmH signal was observed (Figure IV.30) probably 
corresponding to the weak expression of GzmH in CD4+ T cells reported by Sedelies and colleagues. 
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29 - Specific detection of GzmH by immunoblotting and ELISA. (A) Purified human granzymes 
repared in our lab (lanes 2 to 6) along with a commercial preparation of recombinant proGzmH (lane 1) were 
parated by  analysed by SDS-
AGE. Silver staining revealed that all granzymes were indeed present in equal amounts. The mouse monoclonal 
ntibody MAB1377 specifically recognizes proGzmH and GzmH (A, lanes 1 and 2). The N-terminally tagged 
GzmH generated in NS0 cells is glycosylated and migrates as several bands with apparent molecular masses 
etween 38 and 42 kDa. The secreted GzmH proform, moreover, carries 20 artificial glutamate residues at the N-
rminus and is, therefore, larger than the bacterially expressed recombinant granzymes. (B) The specificity of 
e anti-GzmH antibody was also tested against all human granzymes in a solid phase ELISA. Granzymes were 
oated on microtiter plates and incubated with either MAB1377 or an isotype control antibody. The means 
own were calculated from duplicate measurements.  
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Figure IV.30 - Specific detection of GzmH in leukocyte subsets. Expression of GzmB and GzmH in leukocyte 
subsets of human peripheral blood and tumor cell lines (for the preparation of all leukocyte subsets see materials 
and methods) was assessed by immunoblotting after SDS-PAGE. Loading of cellular lysates was controlled by 
immunostaining of actin after antibody stripping (C upper panel). Purified recombinant granzymes (50 ng left 
panels; 20 ng right panels) and lysates of different human leukocyte populations or cell lines (10 µg) were 
probed against GzmB (using monoclonal antibody 2C5) or GzmH (MAB1377). GzmB blots also showed some 
high molecular mass bands between 60 and 70 kDa (red arrow). These bands are suggested to represent 
covalently linked GzmB complexes that are artificially formed between the GzmB and its serpin inhibitor, PI-9, 
in the lysates. 
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GzmH is released from NK during killer cell attack 
At an effector to target ratio of 2:1, NK cells freshly isolated by negative selection were capable of 
killing K562 cells in IL-2 containing medium free of FCS and BSA. In comparison to the necessary 
controls, Figure IV.31A shows how NK cells efficiently kill K562 after 4 hours of coincubation. The 
raw FACS data in Figure IV.31B depicts in more detail how the populations of NK and K562 cells 
were counted. Additionally, the dot plots show that after 4 hours incubation without FCS or BSA, both 
unchallenged cell populations remain healthy (AV-, PI-).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
otted after SDS-
 
9, see red arrows).  
 
 
 
 
 
Figure IV.31 - NK cells efficiently kill K562 cells in the absence of FCS or BSA. (A) Freshly isolated and 
purified human naïve NK cells were incubated with K562 cells at a ratio of 2:1 in protein free IL-2 (100 U/ml) 
containing medium for 4 hours. (B) Killing of K562 cells was evaluated by flow cytometry and was found to 
exceed 60% in all experiments. Importantly NK cells did not die in response to activation by IL-2 and K562 
cells. 
 
The culture supernatant of effector and target cells were concentrated and immunobl
PAGE (Figure IV.32). Specific GzmH signals were only found in co-incubations of NK and K562 cells 
(Figure IV.32, lanes 5, 7 and 9). Recombinant GzmH (Figure IV.32, lane 9) was added to the 
concentrated culture supernatant to ensure that the native GzmH was running at the correct position as 
expected (Figure IV.32, lanes 2 and 3). Treatment with hyaluronidase which removes 
glycosaminoglycans from potential SDS stable complexes (Metkar et al., 2002; Raja et al., 2002), did 
not increase the recovery of soluble, extracellular GzmH (refer to lanes 3, 4 and 7, Figure IV.32). In 
addition to the band of native glycosylated GzmH running as high as GzmH in the NK cell lysates, 
other higher molecular weight bands were observed. Since NK and K562 lysates alone did not yield 
such signals on the blots, covalently linked and partially degraded complexes between a cytosolic 
serpin and GzmH may have formed in K562 cells during killer cell attack (Figure IV.32, lane 5, 7 and
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AGE and immunoblotting using a monoclonal antibody against GzmH and compared to those from NK cell 
K56  lysates (5 µg total protein). To confirm the migration behavior of GzmH, recombinant GzmH 
(rGzmH g) was added to the concentrated supernatant. Recombinant GzmH ran at the expected position 
ight lane). GzmH immunoreactivity was only found in supernatants of NK cells mixed with K562 cells, but not 
 supernatants of NK or K562 cells alone. Staining of high molecular weight bands may represent covalently 
nked complexes between GzmH and as yet undefined serpins which appeared to be partially degraded (red 
rows). Despite the lack of FCS or BSA used during NK cell attack of K562 cells, it is possible that during the 
urification of NK cells and the culturing of the K562 cell line, albumin (65 kDa) could have stuck to the surface 
f both cell types (refer to blue arrow). Alternatively, albumin could have been endocytosed by the cells. 
yaluronidase was added to supernatants in an attempt to release GzmH from proteoglycans. 
 
Figure IV.32 - Release of GzmH from NK cells during cytotoxic attack. Concentrated supernatants from NK 
 x 106
42 
77 77 
42 
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on 
another through their unique proteolytic 
pecificities. Although GzmA and GzmB have been reported to be potent inducers of cell-death (Barry 
nd Bleackley, 2002; Lieberman and Fan, 2003), whether this stands true for the so-called “orphan 
ranzymes” is still not known (Grossman et al., 2003). So too does the answer to the question of 
hether granzymes use additional mechanisms against pathogens that hijack the cellular apoptosis 
achinery, thus avoiding or resisting immune attack. In this work, we have shown that granzyme H 
zmH), known previously as an orphan granzyme, is a novel cytotoxic protease which induces an 
lternative, caspase independent cell death pathway. Dying cells showed typical hallmarks of 
eneration, DNA degradation, and chromatin condensation. Moreover, in collaboration with Felipe 
ndrade from the Department of Medicine, at the John Hopkins hospital in Baltimore, we 
emonstrated that GzmH is an antiviral protease which directly and efficiently cleaves vital viral 
roteins. The first biological substrates for the enzyme will, in this dicussion, be briefly addressed in 
V.1 - Recombinant granzyme production 
ia led to the first reports of the expression of recombinant, active GzmB in 
V - Discussi
 
 
Among the mechanisms used by cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells to 
destroy their targets, the granule exocytosis pathway is by far the most critical in the host’s defence 
against intracellular pathogens and transformed tumor cells. Once released, these granules eliminate 
rogue cells by unleashing their content which, through the aid of perforin (PFN), achieves entry into 
the target cell cytosol. Granzymes differ from one 
s
a
g
w
m
(G
a
programmed cell death such as mitochondrial depolarization, reactive oxygen species (ROS) 
g
A
d
p
more detail.    
 
 
 
 
 
Eukaryotic and prokaryotic host systems 
Granzyme isolation was first reported in the late eighties. At the time, granzymes were purified from 
cultures of cytotoxic lymphocytes in small quantities which hindered the comprehensive studies of 
their biological functions. Indeed, these preparations, although extremely pure, were burdened by 
contamination with enzymes with different specificities, namely the other members of the granzyme 
family (Smyth et al., 1993; Woodard et al., 1998). Additionally, the inability to assess the effects of 
site-specific mutations using this method prevented progression. Only in the last decade has it become 
possible to express and purify granzymes from recombinant sources. As a result, the study of 
granzyme function, both biochemical and biological, was greatly facilitated by the ability to work with 
uncontaminated preparations of both active and inactive granzymes. Indeed, independent studies by 
Smyth, Pham and X
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mammalian, yeast and baculovirus-infected insect cells, respectively (Pham et al., 1997; Smyth et al., 
1995; Xia et al., 1998). Around this time, proGzmA was being purified from the bacterial periplasmic 
space of Escherichia coli (E. coli) and, thereafter, activated with enterokinase in work by Lieberman 
and colleagues (Beresford et al., 1997). In 1999, work from our laboratory by Wilharm et al. showed 
the generation of catalytically active GzmK from E. coli inclusion bodies (IB) (Wilharm et al., 1999). 
IB preparations, which differ from the above preparations that produce active granzymes by secretion 
and transport of precursor forms carrying signal sequences, were here chosen as a starting material for 
in vitro folding. Refolded precursor molecules of IB material were then converted to their active form, 
following treatment by cathepsin C.  
 
In the late nineties, Trapani and colleagues first demonstrated the production of the active GzmH in 
the supernatant of baculovirus-infected Sf21 insect cells, but were unsuccessful in expressing soluble 
GzmH in yeast or bacterial expression systems (Edwards et al., 1999). Nevertheless, with this 
recombinant insect cell based method, Edwards et al. were able to report the esterolytic activity of 
glycosylated recombinant active GzmH by showing cleavage of the thiobenzyl ester Suc-Phe-Leu-
at GzmH had chymotrypsin-like (chymase) esterase 
mplexities encountered upon refolding of the desired protein outside the host, once the optimal 
conditions are found, the cytosolic formation of IB expression is largely beneficial. Indeed, the 
formation of IB is favourable for the host as they protect the bacteria from the harmful effects of 
biologically active recombinant proteases, while at the same time sheltering the protein of interest 
from degradation by cytosolic host proteases. These advantages, however, are not present during the 
periplasmic expression of recombinant proteases in E. coli. Here, not only may the active granzyme be 
destructive for the bacterial host but once in the periplasmic space the recombinant granzyme, itself, 
would be exposed to bacterial proteases and, thus, to a potentially harmful environment. In additional 
support of inclusion bodies as the method of choice, is the fact that high levels of pure, active, 
homogeneous recombinant proteins can be obtained and purified at concentrations well inside the 
milligram per millilitre range. Such quantities are sufficient to attempt formal structural analysis of 
granzymes by crystallography, although the sample must be extremely pure and void of aggregates.  
 
Phe-SBzl, thereby suggesting, for the first time, th
activity.  
 
What are the advantages of refolding from E.coli inclusion body material?  
Our laboratory focused on E. coli as an expression host for the expression and purification of human 
granzymes, three of which had already been produced and studied, namely GzmA, GzmB and GzmK 
(Hink-Schauer et al., 2003; Kurschus et al., 2004; Wilharm et al., 1999). E. coli is one of the most 
frequently used prokaryotic expression systems (Hannig and Makrides, 1998) and, despite the 
co
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Thus, to obtain milligram amounts of h zmH for functional tests and possible 
ystallization trials, we expressed the human GzmH with a cathepsin C cleavable pro-sequence in    
ported to act on the plasma membrane and is known to trigger a plasma membrane 
pair response which, as in the case of PFN, is characterized by the exocytosis and fusion of 
sosomes with the plasma membrane (Keefe et al., 2005; Rodriguez et al., 1997; Walev et al., 2001). 
The decision to use SLO of the protein’s stability 
 cell death assays but also because of its affordability and availability. Perforin, on the other hand, 
 NK cells, is expensive, while its purity and activity are 
ighly active and pure G
cr
E. coli and developed an optimized refolding and purification protocol by modifying previously 
established procedures for GzmA, GzmB and GzmK. Compared with preparations of GzmH produced 
by baculovirus-infected cells in Trapani’s lab, our bacterially expressed GzmH was not modified by 
heterologous and heterogeneous carbohydrates or a His-tag at the C-terminus which may alter the 
enzyme’s interactions with the target cell surface and, furthermore, its internalization.   
 
 
 
V.2 - Cytosolic delivery of granyzmes by pore-forming proteins 
 
 
Human perforin versus bacterial streptolysin O  
To avoid any interference by other granzymes, the cell death inducing properties of GzmH were 
demonstrated in an effector cell-independent system using purified human perforin (PFN), but 
principally bacterial streptolysin O (SLO), as a translocator, with recombinant GzmH and GzmB as 
the effector proteases. SLO and PFN monomers assemble on target-cell membranes into multimeric  
complexes and enable granzymes to cross the cellular membrane (Tschopp et al., 1986; Walev et al., 
2001). Whether PFN oligomerises on plasma membranes or on membranes of internalized endosomes 
of nucleated cells to allow granzyme entry is not yet clear (see introduction on perforin). SLO, 
however, is re
re
ly
 as the main translocator was taken not only because 
in
although the natural delivery agent of CTL and
uncertain.  
 
SLO is an appropriate substitute for perforin 
Our cellular model system allowed SLO delivered GzmB to induce apoptosis efficiently, in a highly 
reproducible manner identical to that observed in studies using purified human perforin (Fellows et al., 
2007; Martinvalet et al., 2005; Pinkoski et al., 1998). The delivered recombinant GzmB led to the 
observation of typical apoptotic hallmarks such as rapid fragmentation of target cell DNA, caspase 
activation and phosphatidyl serine externalization. Hence, our results obtained with SLO and both 
GzmB and GzmH can be regarded as a homologous experimental approach to deliver both proteases 
from the extracellular space into the cytosol.  
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In collaboration with Christopher Froehlich from the Evanston Northwestern Research Institute, we 
managed to obtain enough pure, highly active perforin to perform a crucial number of basic apoptosis 
assays. As expected, in the presence of sublytic concentrations of PFN, GzmH induced cell death in a 
comparable fashion to that analyzed in combination with SLO (refer to Figures IV.13). Indeed, after 10 
hours of exposure to GzmH concentrations of 25 µg/ml (about 1 nM) and sublytic SLO, target cells 
underwent biological and morphological changes indicative of nuclear damage and both plasma and 
mitochondrial membrane perturbation. Importantly, these effects were triggered neither by GzmHS195A 
nor the neighbouring chromosome 14 chymotrypsin-like proteases cathepsin G or chymase. No 
additional effect by GzmH was observed in the absence of translocators, implying that GzmH-induced 
ell death required the limited proteolysis of intracellular substrates that are accessible only after 
 on GzmH was continuously controlled with GzmB. GzmB has received unparalleled 
tention in the granzyme field due to its ability to trigger fast and efficient cell death. Indeed, the 
poptosis but also 
edium containing fetal calf serum (FCS), indicating that apoptotic events are indeed ATP 
c
membrane translocation (refer to Figure IV.13).  
 
 
 
V.3 – Cell death induction by GzmH 
  
 
Our work
at
aspase is particular in its ability to directly and indirectly activate caspase mediated a
death pathways independent of caspase activation (Barry et al., 2000; Barry and Bleackley, 2002; 
Heibein et al., 1999; Metkar et al., 2003; Sutton et al., 1997). In this work, GzmH was found to 
efficiently induce cell death of a range of target cells in a novel, caspase independent manner. Indeed, 
as opposed to GzmB, GzmH induced cell death did not require the cleavage of Bid, the release of 
cytochrome c or the degradation of ICAD, but depended on common events such as mitochondrial 
depolarization, ROS generation, chromatin condensation and DNA degradation.   
 
GzmH treated cells are morphologically different from those exposed to GzmB 
The first evidence that cells treated with GzmH were undergoing a different, caspase independent type 
of cell death came from microscopical observations. Indeed, GzmH induced cell death displayed 
unique morphological characteristics that were not previously observed in target cells treated with 
GzmB. GzmB cytotoxicity was characterized by cellular transparency, shrinkage, fragmentation and 
apoptotic body formation. Additionally, membrane irregularities were observed, along with nuclear 
fragmentation and condensed chromatin, all typical hallmarks of apoptosis and arguably caspase 
activation.  
 
Interestingly, apoptotic body formation was more visible in experiments in which cells had been 
exposed to m
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dependent. However, because FCS contains potent serine protease inhibitors, such as α1-antitrypsin 
and α1-antichymotrypsin, all of our assays were performed in FCS free RPMI medium supplemented 
with BSA. BSA was not found to interfere with the activity of our granzymes. Of additional interest is 
the finding that GzmB suffered minimal activity loss in the presence of serum levels of α1-antitrypsin, 
a requirement necessary for the success of GzmB based immunoconjugates (Kurschus et al., 2004).  
 
Conversely, target cells treated with GzmH displayed unique morphological features. After 1 hour of 
cubation, when maximum apoptotic nuclei were already visible for GzmB, cells exposed to GzmH 
still possessed normal nuclei only acquiring certain morphological similarities after approximately 4 
hours. These sim  
agmented ic nuclei, 
tting well to the delayed killing capacity of GzmH. Importantly, cellular swelling was a unique 
ast to GzmB treated cells, were not subject to 
strated that PS externalization can be regulated independently of caspases, and may in fact 
sult from oxidative stress, such as the formation of reactive oxygen species (ROS). Indeed, work by 
evention of PS oxidation by the use of antioxidants 
in
ilarities included cellular transparency, membrane irregularities and the apparition of
 nuclei with condensed chromatin. After 12 hours, most cells displayed apoptotfr
fi
characteristic of GzmH treated cells, which, in contr
shrinkage, fragmentation and apoptotic body formation.  
 
In this study, cellular changes were additionally analyzed by immunofluoresence. The Hoechst dye 
22242 and annexin V-FITC were used to visualize both nuclear fragmentation and phosphatidyl serine 
(PS) externalization, respectively. After 12 hours, both proteases caused considerable nuclear 
fragmentation in nearly all cells. GzmH treatment, however, lead to the formation of considerably 
smaller bodies, suggesting that the cell death pathway triggered by GzmH involves the direct or 
indirect cleavage of substrates distinct from those cleaved by GzmB (refer to Figure IV.16). PS 
externalization is a hallmark of apoptosis and is otherwise known as an “eat me” signal for 
macrophages, which possess specific receptors towards the phospholipid. PS externalization was much 
less obvious on the plasma membranes of cells exposed to GzmH after 10-12 hours, an event that has 
been repeatedly reported to be a consequence of executioner caspase activation such as caspase 3 
(Diaz et al., 1999; Martin et al., 1996; Naito et al., 1997). More recently, however, a number of studies 
have demon
re
Kagen and colleagues has demonstrated that the pr
inhibits PS externalization (Kagan et al., 2002; Tyurina et al., 2004). Interestingly, although GzmH did 
not activate executioner caspases, both GzmB and GzmH did lead to ROS generation, which could 
explain the difference in intensity in PS externalization observed after treatment with the two 
granzymes.  
 
 
 - 103 -
 Discussion 
____________________________________________________________________________ 
GzmH induces cell death independently of caspase activation 
This work defines GzmH as a caspase independent cell-death inducing protease. The occurrence of 
caspase activity was mainly controlled using the general caspase inhibitor zVAD-FMK which along 
with zDEVD-FMK (caspase 3 inhibitor) and zLEHD-FMK (caspase 9 inhibitor), efficiently blocked 
GzmB induced apoptosis. Although the major caspase inhibitors did not halt the progression of GzmH 
triggered cell death (refer to Figure IV.26), an approximate 10% reduction was often observed, 10 to 
12 hours after exposure to GzmH. Propidium iodide (PI) and annexin V-FITC (AV) staining was used 
to differentiate between apoptotic cells (PI-/AV+) and necrotic cells (PI+/AV+). In particular, annexin 
V-staining, without PI uptake, indicated strong PS externalization and caspase dependence (Diaz et al., 
1999; Martin et al., 1996; Naito et al., 1997). FACS analysis of both GzmH and GzmB treated cells 
revealed that cells exposed to GzmH were mainly PI+/AV- regardless of the length of exposure to the 
ranzyme. Cells exposed to GzmB, however, were first clustered in an exclusively annexin-positive-
nly population and shifted to a PI-positive-only cluster in the well-advanced stages of cell death. In 
the case of GzmH induced pulation after 10-12 hours 
uld well be explined by the observed damage to the inner mitochondrial membrane and the release 
th pathway in 
 level then that triggered by GzmB (refer to Figures IV.22 and 24iii).  
g
o
cell death, the appearance of a minor PI-/AV+ po
co
of reactive oxygen species (ROS), the latter which have been implicated in the translocation of  
phosphatidylserine (PS) (refer to Figure IV.12). However, in the presence of zVAD-FMK, an overall 
reduction of 10% in GzmH triggered cell death was observed, the reduction being primarily noticed in 
the PI-/AV+ cluster. A similar reduction was also found in cultured cells that were treated with SLO 
alone, zVAD-FMK most likely mitigating the unspecific sublytic effects of SLO rather than the 
genuine downstream effects of GzmH (refer to Figure IV.26 – red headed arrow). Nevertheless, to 
completely exclude the involvement of caspases, the activation of caspase 2 was investigated which 
has recently been reported to trigger cell death.     
 
Is caspase 2 activity a prerequisite for GzmH mediated cell death? 
The activation of caspase 2 has recently been shown to induce an alternative cell-dea
response to cytotoxic stress such as DNA damage. Additionally, caspase 2 is also thought to be 
implicated in mitochondrial permeabilization and possible ROS generation leading to the 
amplification of caspase activity (Lassus et al., 2002; Zhivotovsky and Orrenius, 2005). In these 
studies, caspase 2 activity was investigated using the fluorogenic, cell permeable caspase 2 specific 
substrate acVDVAD-AFC. Although, the major executioner and initiator caspases had previously been 
tested, caspase 2 activity was nevertheless observed following GzmH delivery, although at a much 
more reduced
 
The preparation of S100 (cytosolic) and nuclear fractions from untreated K562 cells allowed us to 
address whether caspase 2 was being directly cleaved by GzmH. Whereas the exposure of both 
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cytosolic and nuclear fractions to GzmB resulted in the cleavage of acVDVAD-AFC, GzmH exposure 
did not yield any activity indicating that GzmH can not cleave procaspase 2 directly or in a protease 
mediated indirect manner (Figure IV.24B). To ensure that the VDVAD sequence was truly monitoring 
the activity of caspase 2 and no other caspase, immunoprecipitation (IP) of caspase 2 (Figure IV.24C), 
and both caspases 2 and 3 (Figure IV.24D) from S100 fractions of untreated K562 cells was performed. 
he S100 lysate-containing acVDVAD-AFC was then exposed to GzmB which can directly activate 
ecessary for GzmH induced cell death, the 
spase 2 specific inhibitor zVDVAD-FMK was preincubated with cells prior to GzmH treatment. In 
arly consequence of oxidative stress. Whether ROS are the cause of lysosomal rupture or 
ise as a consequence of lysosomal breakage and act as an amplifying loop causing further lysosomal 
reach remains unknown (Brunk et al., 2001; Zhao et al., 2003b). This work widely uses the pan-
caspase inhibitor zVAD-FMK to control the involvement of caspase involvement. Interestingly, 
T
caspase-3. In cell lysates depleted of caspase 2, substrate cleavage was subsequently reduced by more 
than two thirds, whereas acVDVAD-AFC cleavage in lysates lacking both caspase 2 and 3 was 
completely abolished. These results suggested that caspase 3 is the only other protease with a strong 
preference for acVDVAD-AFC cleavage in K562 cells. Because caspase 3 is not activated in GzmH 
triggered cell death (refer to Figures IV.22 and 24), acVDVAD-AFC can, indeed, be efficiently used in 
our system to test caspase-2 activity.  
 
To investigate whether caspase 2 activity was at all n
ca
line with our overall findings, GzmH cell death was not suppressed by zVDVAD-FMK. ZVDVAD-
FMK, however, only weakly inhibited GzmB triggered apoptosis suggesting that the activity of 
caspase 2 is not essential for the progression of cell death (refer to Figure IV.25). As a final note, one 
could speculate that because caspase 2 activation is reported to lead to mitochondrial damage, and 
possibly the generation of ROS (Lassus et al., 2002), the indirect activation of caspase 2, observed in 
GzmH mediated cell death, may indeed also contribute towards the externalization of PS and hence 
the population of annexin V single positive cells noticeable from the FACS data (refer to Figure 
IV.12).   
   
Is lysosomal rupture and cathepsin release a hallmark of GzmH induced cell death? 
This work demonstrates that GzmH mediated cell death is mediated by several key events, namely, 
mitochondrial depolarization, ROS generation, chromatin condensation and DNA degradation. In 
particular, mitochondrial damage and the release of ROS have recently received much attention.  
Indeed, as it has just been discussed, it has been suggested that ROS play an essential role in 
lymphocyte cytotoxicity (Martinvalet et al., 2005; Zhao et al., 2007a). Additionally, it has recently 
been suggested that the release of ROS contributes towards the oxidation of PS and its externalization 
(Kagan et al., 2002; Tyurina et al., 2004). Lysosomal destabilization and disruption is thought to be 
yet another e
ar
b
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various caspase specific inhibitors, such as zVAD-FMK and zDEVD-FMK, have been reported to 
ce, the direct addition of GzmH, or our control 
rnazyme, GzmB, to the mitochondira did not induce any potential loss at all (data to be reported 
ch as components of the 
zmH induced ROS 
rmation, the general caspase inhibitor zVAD-FMK was used. As expected, no effect on ROS 
potently inhibit cathepins (Rozman-Pungercar et al., 2003), namely lysosomal cysteine proteases that 
have been implicated in the activation of apoptosis (Stoka et al., 2001; Turk et al., 2000). Various 
cathepsin family members have been reported to be involved in both caspase dependent and 
independent cell death (Michallet et al., 2003; Stoka et al., 2001). The slight inhibition (approximately 
10%) conferred upon GzmH mediated cell death by zVAD-FMK prompted us to investigate the 
possibility that cathepsin activity might account for this discrepancy and might also, in fact, play a role 
in GzmH induced cell death. The general cathepsin inhibitor E64d, however, did not provide any 
protection to cells exposed to GzmH or GzmB. GzmH mediated cell death, thus, seems to be mediated 
independently of lysosomal rupture and cathepsin activity (refer to Figure IV.26), although it must be 
stated that we did not test the effect of E64d on recombinant cathepsins as a positive control.  
 
Is ROS release essential or an epiphenomenon for GzmH induced cell death? 
As observed in GzmB cytotoxicity, GzmH triggered cell death was marked by a prompt increase of 
intracellular ROS levels and gradual mitochondrial depolarization. Contrary to GzmB, GzmH did not 
cleave Bid, both in vitro (human recombinant Bid) and in vivo (western blot analysis), nor did the 
granzyme lead to the release of cytochrome c, the smallest of the mitochondrial intermembrane space 
proteins (MIMPs). Recent work by Martinvalet and colleagues highlighted the importance of ROS by 
demonstrating that both GzmB and GzmA can directly trigger the release of ROS and the loss of ΔΨm 
when exposed to isolated mitochondria. We therefore set out to investigate whether the direct addition 
of GzmH or GzmB to freshly isolated and energized mitochondria from mouse liver would induce 
potential loss (ΔΨm). Although the toxin valinomycin/oligomycin easily induced ΔΨm loss, as seen by 
the instant decrease of rhodamin 123 fluoresen
g
elsewhere). Mitochondrial membrane specific substrates for GzmH, su
permeability transition pore that, once cleaved, may lead to ROS generation and ΔΨm loss, have 
therefore not been identified in these experiments.  
 
GzmH triggered ROS release initially surged within 30 min of exposure to the protease, an 
accumulation more intense then that seen in cells exposed to GzmB (refer to Figure IV.28). However, 
at later time points, GzmH mediated a surge in ROS accumulation that was slower than in GzmB-
treated cells but occurred with kinetics similar to the mitochondrial membrane depolarization observed 
in target cells. In order to completely exclude caspase involvement during G
fo
induction was observed.  
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To further evaluate the causative role of ROS in cell-death induction, we preincubated several 
antioxidants, including Tiron, D1417 and MnTBAP [Mn(III)tetrakis(4-benzoic acid) porphyrin 
chloride], a cell-permeable superoxide dismutase (SOD) mimetic, with target cells, before exposing 
them to recombinant GzmH and GzmB. In the presence of antioxidants, the target cells survived the 
usual menace presented by both granzymes. It is, however, possible that the above antioxidants may, 
in fact, be interfering with the delivery of GzmH and GzmB, the survival of the target cells therefore 
not being due to the antioxidative effect of the applied compounds (data to be reported elsewhere).  
 
At first glance, our observations are in line with studies by the groups of Lieberman and Fan. Recent 
work by Martinvalet et al. allegedly demonstrated that GzmA induced cell-death requires the 
generation of ROS to eradicate diseased cells, although GzmA has previously been shown to directly 
cleave a number of proapoptotic substrates. Even though the authors suggest that ROS production is 
quired for nuclear localization of the SET complex, which harbours components that mediate GzmA 
 SLO oligomerisation and, hence, reduce the entry of granzymes into the target cell cytosol.  
re
induced DNA degradation, the suggestion that ROS inhibition by antioxidants should then alleviate 
the effects of GzmA treatment should be treated with utmost caution. Recently, Zhao et al. again 
confirmed the critical role attributed to ROS in caspase independent cell-death. Indeed, the group 
showed that GzmK is also able to provoke rapid ROS generation and that the blockade of ROS, by 
preincubating target cells with N-acetyl cysteine (NAC) or Tiron, abolishes GzmK induced cell death 
(Zhao et al., 2007a). Mark Williams and Pierre Henkart discussed the necessity of ROS generation in 
lymphocyte cytotoxicity in a comment to ‘Immunity’ entitled “Do cytotoxic lymphocytes kill via 
ROS” (Williams and Henkart, 2005). In line with our ongoing experiments, we suspect that these 
antioxidants, some of which were applied at concentrations as high as 40 mM, might actually perturb 
PFN and
 
Does GzmH trigger a different kind of DNA degradation?  
DNA damage is a key feature of programmed cell-death. GzmA and GzmK, along with murine GzmC, 
have been reported to cause DNA nicks (Johnson et al., 2003; Shi et al., 1992), whereas GzmB and 
GzmM appear to inflict double stranded DNA fragmentation upon target cells (Lu et al., 2006; Trapani 
and Sutton, 2003). GzmH-mediated DNA degradation is at present relatively undefined, but occurs 
independently of caspase activation. Indeed, executioner caspase activity was not found in vitro or in 
target cells treated with GzmH. In this work, DNA fragmentation was investigated using GzmB as a 
control. GzmH did not, however, cleave ICAD in target cells, which unleashes the caspase activated 
DNase CAD, nor did the granzyme trigger DNA laddering at various time-points leading up to 12 
hours (refer to Figure IV.20). This outcome is reminiscent of GzmA and GzmK cytotoxicity, both 
proteases solely causing single-stranded DNA nicks.  
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GzmH DNA damage was analyzed by monitoring the DNA content of cells as they progress through 
the G1, S, and G2 phases of the cell cycle. In this method, cells undergoing cell-death lose a large 
portion of their DNA and, when analyzed by FACS, are clearly distinguishable as a separate 
population, termed sub-G1. The method uses PI for nuclear staining. Interestingly, after 12 hours of 
incubation, target cells treated with either GzmH or GzmB displayed sub-G1 populations that differed 
in appearance. Cells that had been exposed to GzmH retained noticeably less DNA than those that had 
been treated with GzmB, displaying a weaker hypodiploid (sub-G1) peak in height, but still easily 
discriminative from the narrow peaks of cells with normal (diploid) DNA content. Nevertheless, both 
GzmH and GzmB populations accounted for roughly 35% of the total cell population analyzed at 12 
hours (refer to Figure IV.18A). GzmH-mediated cell death is suggestive of a different DNA degrading 
mechanism to that triggered by GzmB and, hence, the targeting of different DNA-degrading 
bstrates. One could interpret these results by suggesting that the oligonucleosomal double-stranded 
dily exit target 
f
through endocytosis. GzmA cleaves IGAAD 
(SET) which then no longer binds and inhibits 
GAAD (NM23-H1). It is not known whether 
su
DNA fragments, mediated by GzmB and produced for example by CAD, do not as rea
cells following treatment in PBS buffer containing low detergent concentrations. GzmH does not lead 
to GzmB-like DNA double-stranded fragmentation, the sub-G1 data hinting possibly towards nuclear 
disintegration and DNA loss due to loss of membrane integrity (refer to GzmH triggered cell death 
analyzed by trypan blue staining, Figure IV.15).  
 
 
 
 
 
 
Figure V.1 – Model for DNA damage during 
CTL-Mediated cell-death. Model for DNA 
Damage during CTL-mediated apoptosis, CTL 
granules containing perforin and granzymes 
are released into the synapse formed with the 
target cell. Gzms enter the target cell 
cytoplasm either via per orin-induced 
perturbation of the plasma membrane or 
Gzms 
Perforin 
Procaspase 3 
Caspase 3 
Cytoplasm 
Perforin 
Gzms 
SET is cleaved in the cytoplasm or nucleus or 
both. Uninhibited GAAD in the nucleus makes 
single-stranded DNA nicks. GzmB, directly or 
indirectly via caspases destroys the CAD 
(caspase activated DNase) inhibitor ICAD. 
Cleaved ICAD no longer binds CAD, which 
then moves to the nucleus to cause double-
stranded breaks. Figure taken from Fan et al. 
‘Cell’ 2003 (Fan et al., 2003). 
DNA Nicks 
DNA  Fragmentation 
Nucleus 
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Following granzyme treatment, DNA degradation was also addressed by estimating the release of 
DNA fragments labelled with 3H-thymidine (refer to Figure IV.20). This technique, along with the 
method above, uses mild detergent concentrations to liberate 3H-thymidine-labelled DNA fragments 
from target cells. As expected, GzmB-induced fragmentation was observed at near maximum levels 
following analysis at the first time point of 4 hours. GzmH treated cells, however, triggered a much 
reduced 3H-thymidine release, reaching significant levels only after 12 hours, a time point, however, 
which runs in line with maximum cell-death achieved by the protease (refer to Figure IV.11). In the 
revious paragraph, it was suggested that GzmH triggered nuclear disintegration and that DNA loss 
 
itro as a result of cells not being cleared by macrophages. Secondary necrosis is defined by presence 
 the loss of membrane integrity and, 
ical example being the actions of GzmB, cells 
rst shrink and their nuclei condense. Target cells then further disintegrate into well-enclosed smaller 
p
might account for the reduced DNA content of the GzmH sub-G1 population. The Sub-G1 data 
collected at both 12 and 24 hours show that both GzmH and GzmB have near identical percentages of 
cells in the Sub-G1 population. However, GzmH-mediated 3H-thymidine release at the 12-hour time 
point was considerably lower than that induced by GzmB. Because cells treated with GzmH reached 
the maximum percentage of cell-death at the 10-12 hours mark, if GzmH-mediated cell death does 
lead to nuclear disintegration and DNA loss, one would expect the percentage of 3H-thymidine release 
to be more prominent (refer to Figure IV.20).  
  
DNA degradation is a well known hallmark of programmed cell death (PCD) and the underlying 
mechanisms that govern the GzmH-triggered cell death pathway need to be studied in greater detail. 
Indeed, whether GzmH treatment mediates single-stranded DNA nicking similar to that caused by 
GzmA (Beresford et al., 1999; Fan et al., 2003) remains to be studied. However, one cannot exclude 
the possibility that GzmH cytotoxicity may, in fact, not lead to DNA damage by the direct or indirect 
activation of DNA degradation enzymes. Indeed, at the 10-12 hour mark, the observed damage 
inflicted upon the DNA of GzmH-treated cells might be the result of secondary necrosis that occurs in
v
of nuclear condensation and/or fragmentation along with
consequently, PI uptake (Kelly et al., 2003). It is interesting to note that, although GzmH triggered cell 
death lacks typical apoptotic hallmarks such as caspase activation, GzmH cytotoxicity does lead to 
caspase independent PS externalization. Whether or not GzmH-induced cell death should be defined 
as “apoptotic-like” in the absence of caspases, or rather “necrotic-like” because of its morphological 
features will be discussed in the following chapter.  
 
GzmH cytotoxicity: an apoptotic or necrotic-like from of cell death? 
Morphologically, necrosis is distinctly different from apoptosis. For a long time, necrosis was 
considered as an alternative to PCD. Cells rapidly swell followed by plasma membrane collapse and 
cell lysis. During apoptosis or PCD, however, a class
fi
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apoptotic bodies. The biochemical hallmarks of apoptosis such as activation of pro-caspases and 
oligonucleosomal DNA fragmentation are usually absent in necrosis. However, recent improvements 
in the techniques used to distinguish between these two forms of cell-death have revealed that some 
biochemical and morphological characteristics of both modes can be detected in the same cell. This 
indicates that there may be a spectrum of suicidal programs in cells, and that “classical” necrosis, 
defined by the rapid efflux of cell constituents, and apoptosis, defined by the rapid, ATP-dependent 
elimination of target cells without disruption of the plasma membrane, are the extremes of this 
spectrum. Necrosis, then, may not simply be the result of extreme conditions but, in context, may be a 
normal, physiological and regulated (programmed) event. Indeed, various stimuli (e.g. cytokines, heat, 
irradiation and pathogens) can cause both apoptosis and necrosis-like symptoms in the same cell 
population. Furthermore, signalling pathways such as death receptors, kinase cascades and 
mitochondria have been found to participate in both processes, and by modulating these pathways, it is 
possible to switch between apoptosis and necrosis (Proskuryakov et al., 2005). The consequences of 
“classical” necrotic and apoptotic cell-death are well distinct from one another, necrosis provoking an 
inflammatory response because of spillage of cellular constituents, while apoptosis attracts the 
attention of macrophages which safely engulf the cellular content concealed within apoptotic bodies. 
The inflammatory response caused by necrosis may, however, have obvious adaptive significance 
under some pathological conditions such as cancer and infection. On the other hand, disturbance of the 
 be a key element in the development of some 
consequently, does not display the typical apoptotic morpho
cytotoxicity, GzmH-triggered cell-death leads to PS exter
“eat-me” signals, deemed important for the removal of intac
al., 2003; Lauber et al., 2004). Annexin V- FITC labels PS
PS externalization is thought to be mainly the result of 
showed that, despite the lack of caspase activation, GzmH does trigger PS externalization, 
mitochondrial dysfunction and the release of ROS being the
et al., 2004). Indeed, ROS generation peaked after 30 min
could trigger the externalization of various essential phosp
clearance (Lauber et al., 2003). However, despite 15-20% o
FITC positive at the 4 hours time point, in an independen
30% of cells were also positive for trypan blue, indicating a loss of membrane integrity (refer to 
Figure IV.15). Morphologically, the plasma membranes of target cells at this stage appeared normal 
but the cells had become transparent, their nuclei clearly visible. GzmB-treated cells required only 1-2 
fine balance between the two types of cell-death may
diseases.  
 
In contrast to GzmB cytotoxicity, GzmH does not induce typical apoptotic hallmarks and, 
logy mentioned above. Similarly to GzmB 
nalization and probably other lipid-based 
t diseased cells by macrophages (Lauber et 
 sites on target-cell membranes. Although 
executioner caspase activation, our study 
 likely stimuli (Kagan et al., 2002; Tyurina 
utes of GzmH treatment, an event which 
holipids involved in macrophage-mediated 
f GzmH treated cells appearing annexin V-
t experiment, and at the same time point, 
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hours to achieve maximum death and so the trypan blue and PI staining at 4 hours (45-50% and 60-
80% respectively) is already indicative of secondary necrosis.  
 
In cells exposed to GzmH prior to the 4 hour mark, mitochondria, monitored by JC-1 staining, 
appeared mostly intact. Thereafter, depolarization became apparent and continued to increase, 
reaching maximal levels, already obtained by GzmB at the 4-hour time point. Although an initial ROS 
surge was observed, levels quickly declined, only to increase again from the 4 hours time point when 
cell death became more apparent. This suggests that prior to the 4 hour mark putative ATP-dependent 
processes of GzmH cytotoxicity would most likely not be impaired. Morphologically, GzmH induced 
cell death became increasingly apparent from 4 hours onwards and, at 10-12 hours, cells appeared 
rather swollen with membrane irregularities, again indicative of necrosis. However, cells still 
displayed PS on their plasma membranes. Furthermore, target cell nuclei were noticeably condensed 
and fragmented and in a manner quite different from that observed post GzmB treatment (refer to 
Figure IV.16).   
 
Taken together, GzmH-induced cell death is not reminiscent of typical necrosis or of classical 
ily member, as a 
apoptosis. Instead, GzmH triggers a lengthy form of programmed cell death, cells reaching maximum 
cell death after 10-12 hours, which displays both apoptotic and necrotic features. Furthermore, the 
high expression levels of GzmH in naive NK cells strongly support the role of the granzyme in 
triggering an alternative cell death pathway in innate immunity. GzmH is most likely contained within 
granules rich in other NK cell associated granzymes, such as GzmA and GzmM. Contrary to our 
observations in vitro, our NK killing experiments showed that 70-80% of target cells die within 4 
hours of exposure to freshly isolated and primed NK cells (refer to Figure IV.31A). It is highly unlikely 
that NK cell cytotoxic granules contain only one type of granzyme and, hence, it is the combined work 
of the family rather than the exploits of one particular member which accounts for the efficient 
eradication and clearance of diseased cells in a non-inflammatory fashion.  
 
 
 
V.4 – GzmH and its siblings 
 
 
Is GzmH cell death reminiscent of GzmA cytotoxicity?  
Work by the Lieberman group has characterized GzmA, the second most studied fam
caspase-independent cell-death inducing protease (Beresford et al., 1999; Lieberman and Fan, 2003; 
Martinvalet et al., 2005). Like GzmA, GzmH-triggered cell death does not require caspase activation 
but leads to mitochondrial damage and DNA degradation, with affected cells showing apoptotic 
morphology such as PS externalization. Furthermore, both granzymes lead to ROS generation and loss 
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of mitochondrial membrane potential. Like GzmB, GzmA destroys the nuclear envelope by targeting 
lamins, and opens up DNA for degradation by targeting histones, but, conversely, GzmA, like GzmH, 
does not cleave initiator or executioner pro-caspases, Bid or ICAD, and does not lead to the release of 
proapoptotic intermembrane space proteins such as cytochrome c. 
 
GzmA is reported to target and cleave three substrates which form the SET complex, a complex 
associated with the endoplasmic reticulum. These substrates are the nucleosome assembly protein 
SET, the DNA binding protein HMG-2 and the base excision repair enzyme Ape-1 (Lieberman and 
Fan, 2003). The SET complex also contains the tumor suppressor protein pp32 and the GzmA-
activated DNase NM23-H1, which is inhibited by SET. In a manner reminiscent of the activation of 
CAD by cleavage of its inhibitor ICAD, GzmA cleavage of SET unleashes NM23-H1 which goes on 
to nick single-stranded chromosomal DNA (Fan et al., 2003). Whether or not GzmH mediated cell 
death also leads to single-stranded DNA nicks by targetting SET, or whether GzmH might cleave 
other members of the SET complex, remains to be tested.   
 
GzmH and the orphan granzymes  
Along with GzmK and GzmM, GzmH was previously referred to as an orphan granyzme (Grossman et 
al., 2003). However, these three granzymes have recently received much attention, and with our latest 
contribution to the field, it is now quite clear that all five human granzymes are truly a family of 
cytotoxic proteases. It is fascinating to note that each granzyme possesses unique proteolytic 
y that probably accounts for their individual cell death pathways. Indeed, GzmA, specificities, a propert
a tryptase which cleaves after basic residues and GzmB, an aspase, preferring acidic residues, have 
evolved distinct cell death programs. Compared to GzmA and GzmB, the most widely studied 
granzymes of the family, the ex-orphan human granzymes still require significant attention. Indeed, as 
we shall see, studies on GzmM come into conflict with one another, introducing doubt into the 
mechanisms proposed by these authors (Kelly et al., 2004; Lu et al., 2006). Regarding the third 
orphan, GzmH, this work represents the first functional study on the protease’s involvement in target 
cell death.  
 
Granzyme K (GzmK) 
GzmK appears to kill in a manner very similar to GzmA. The two tryptases both induce cell death 
marked by single stranded DNA nicks, mitochondrial depolarization, ROS generation and PS 
externalization, in a pathway independent of caspases activation. Initially, like GzmA, GzmK was also 
shown to target the nucleosome assembly protein SET resulting in the release of DNase NM23HI and 
single-stranded nicking (Zhao et al., 2007b). More recently, the same group showed that GzmK can 
directly cleave Bid in a cell death pathway characterized by the disruption of the outer mitochondrial 
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membrane and the release of cytochrome c and endonuclease G, the only similarities with GzmA and 
GzmH being ROS generation, collapse of ΔΨm and the absence of caspase activity (Zhao et al., 
007a). The authors report that both GzmK and GzmB process Bid in a similar manner and that the 14 
GzmM) 
ow GzmM mediates cytotoxicity remains unclear. One study claimed that the metase, like GzmA, 
to the true identity of GzmM’s cytotoxic abilities. 
In summary, unlike GzmB and the group of granzymes which 
flict death upon diseased cells independently of caspase activation by targeting and damaging 
d, most likely, GzmK, GzmH cell death 
2
kDa truncated Bid (tBid) is able to recruit Bax to the mitochondrial membrane through a caspase 
independent mechanism (Heibein et al., 1999; Heibein et al., 2000). Cytochrome c release however is 
a crucial event in the activation of downstream caspases (Yang et al., 1997); the heme protein acts as a 
cofactor in conjunction with Apaf-1, procaspase-9 and ATP to form the apoptosome. The lack of 
caspase activation reported by the authors is probably a result of potent mitochondrial damage and 
lack of ATP without which the apoptosome cannot form. Collectively, these studies suggest that 
although GzmA and K prefer to cleave after the basic residues Arg or Lys, their distinct specificities at 
positions P2 and P4 (Mahrus and Craik, 2005) contribute to the cleavage of different substrates and, 
hence, to the induction of distinct cell death pathways.  
 
Granzyme M (
H
GzmK and GzmH, was also able to induce cell death in a caspase independent manner but, unlike the 
above granzymes, did so with no damage inflicted upon mitochondria. Like GzmH, GzmM did not 
trigger chromosomal DNA fragmentation (Kelly et al., 2004). A more recent work, however, 
demonstrated just the opposite, showing that GzmM initiates caspase-dependent cell death with typical 
apoptotic nuclear morphology. Moreover, this study showed that GzmM can directly cleave both 
ICAD and the DNA repair sensor PARP, leading to DNA fragmentation without DNA nicking (Lu et 
al., 2006). The authors show that the pan-caspase inhibitor (zVAD-FMK) completely blocked cell 
death marked by DNA fragmentation and procaspase 3 processing, indicating that, although the 
enzyme can directly cleave both ICAD and PARP in vitro, caspase activation is likely to be required 
for such events to occur within target cells. Taken together, these two studies are in serious 
disagreement with each other, a situation which highlights the urgent need for further investigation 
in
 
possibly GzmM, GzmH belongs to 
in
mitochondria and DNA. Indeed, as is the case with GzmA an
was defined by PS externalization, interruption of the inner mitochondrial  respiratory chain resulting 
in ROS formation and depolarization and DNA degradation that did not involve the formation of 
oligonucleosomal double-stranded breaks. GzmH cytotoxicity, like that of GzmA, did not, however, 
lead to the cleavage of Bid and ICAD as has been reported for GzmB, GzmK and GzmM. GzmH-
mediated cell death, like GzmA-mediated cell-death, occurred without the release of MIMPs, although 
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GzmA was reported to directly damage isolated mitochondria, a feat that still needs to be thoroughly 
addressed for GzmH. GzmH triggered DNA degradation also requires more detailed studies if the 
underlying processes are to be clearly undertood. Although much more work is needed to understand 
the pathways that govern GzmH-induced cell death, it is now becoming clearer from work by Mahrus 
d Craik, who have recently confirmed the P4 to P1 substrate specificities of the five granzymes, that 
and M in unstimulated lymphocytes 
 contrast to GzmA and GzmB, the study of orphan granzyme expression in human lymphocytes has 
propriate antibodies. Recently, specific monoclonal antibodies 
 another study by the same group, GzmA, GzmK, and, this time, GzmB expression was also 
 human resting peripheral blood lymphocytes (Bratke et al., 2005). In 
an
each granzyme most likely targets a differential set of substrates. Indeed, as more functional data are 
gathered on the orphan granzymes, and their substrates, we will soon also be able to distinguish more 
clearly the unique traits which characterise each of their respective cell death pathways.  
 
 
 
V.5 – GzmH expression is restricted to NK cells 
 
 
Differential expression of human granzymes A, B, K 
In
been restricted because of the lack of ap
(mAbs) have been generated against human GzmK, GzmM and GzmH (Bade et al., 2005; Sedelies et 
al., 2004). In one study, the cytometric analysis of unstimulated human peripheral blood lymphocytes 
revealed that GzmA, GzmM and PFN showed a similar distribution, being expressed in CD3-
CD16+CD56+ NK cells, CD3+CD56+ NKT cells and various T cell sub-populations (refer to Table 
V.1). GzmK, on the other hand, was markedly absent in the highly toxic CD3-CD16+CD56+ NK cells 
and was preferentially expressed in the T cell lineage (refer to Table V.1). Interestingly, though, GzmK 
was found to be expressed in CD3-CD56bright+ cells, a small subset of NK cells which express very 
little CD16 and has been shown to be poorly cytotoxic. The majority of human peripheral NK cells 
display a CD3-CD16+CD56+ phenotype. However, according to the expression density of CD56, NK 
cells can be divided into CD56dim and CD56bright subsets, the CD56dim cytotoxic population 
representing the vast majority (90%) of human NK cells (Jacobs et al., 2001).  
 
In
analyzed by cytometry in
agreement with Bade et al. and Grossman et al., GzmA, GzmB and GzmK expression was mainly 
detected in T cells subsets, namely CD8+, CD56+ and TCRγδ+ T cells and, to a lesser extent, in CD4+ T 
cells (Bade et al., 2005; Grossman et al., 2004). With regard to NK cell expression, the authors found 
that GzmA and GzmB were detectable at high concentrations in cytotoxic CD3-CD16+ and CD3-
CD56dim NK cells. Additionally, and again in agreement with Bade et al., GzmK was again found to be 
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highly expressed in CD3-CD56bright cells. This was not the case for GzmB which was found at low 
levels (refer to Table V.1).  
 
 
 
 
 
 
 
 
 
 
Lymphocyte subset GzmA GzmB  GzmK GzmM 
B cells (CD19+CD3-) n.d. n.d. n.d. n.d. 
       
CD8 T cells (CD8+CD3+) Med Low Low Med 
TCRγδ cells (TCRγδ+CD3+) High Med Med High 
T helper cells (CD4+CD3+) Very Low Very Low Very Low Very Low 
       
NKT cells (CD3+CD56+) High Var Var High 
       
NK cells (CD3-CD16+ CD56+) High High Low High 
NK cells (CD3-CD56dim) High High Low n.d. 
 NK cells (CD3-CD56bright) Med./high Low Med./High Med./High
 
Table V.1 – Granzyme expression in unstimulated human lymphocytes.  N.d., not detected; very 
low, <10%; low, 10-50%; med (medium), 50-70%; high, >75% and var (variable), 0-100%. The 
symbols given represent percentages found in the respective cell populations of most donors. The table 
is fused from two independent studies from the same group. The authors agree on the expression 
patterns for both GzmA and GzmK in the above subpopulations (Bade et al., 2005; Bratke et al., 
2005).   
 
 
GzmH is predominantly expressed by NK cells and is stored in secretory granules  
GzmH protein expression in blood leukocytes was first studied by Sedelies et al. (Sedelies et al., 
2004). Here, GzmH was reported to be considerably more abundant than GzmB in naïve CD3-CD56+ 
NK cells (purified from PBMCs) despite there being a good correlation between GzmB and GzmH 
mRNA expression. Since the majority of human peripheral NK cells are of the highly cytotoxic 
phenotype (CD3-CD56dim), this study is in sharp contrast with the recent work from Bratke and 
Grossman who report that the GzmB protein is highly expressed in unstimulated human CD3-CD56dim 
NK cells (Bratke et al., 2005; Grossman et al., 2004). Upon stimulation of NK cells, however, Sedelies 
 al. show that GzmB protein expression was strongly upregulated although the same stimuli had no et
effect on GzmH protein levels. In the same study, GzmH expression was also distinct from that of 
GzmB in peripheral blood T lymphocytes. Various stimuli led to a marked induction of the GzmB 
protein, both in CD4+ and CD8+ PBMCs. However, the GzmH protein was expressed at low levels in 
CD4+ T cells but was not detected in CD8+ T cells, and was not induced upon T cell activation. 
Additionally, GzmH protein expression was completely absent in NKT cells and monocytes (Sedelies 
et al., 2004). Taken together, Sedelies et al. report that although both GzmB and GzmH are the 
products of tightly linked genes, they are regulated in distinct ways.   
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Because we have recently demonstrated that purified GzmH can induce cell death in an alternative, 
caspase-independent pathway, we sought, in comparison with GzmB, to strengthen our in vitro 
observations by supporting the results shown by Sedelies et al. Our results confirm that naïve NK 
(CD3-, CD56+) cells are the major GzmH-expressing lymphocyte population of the peripheral blood 
(refer to Figure IV.30). Additionally, we also confirm that neither monocytes nor activated CD8+ CTLs 
show any presence of GzmH. Neutrophils were also found to lack GzmH expression. We did however 
find some GzmH protein expression in CD3+ T-cells, the CD4+ population most likely to account for 
this expression as previously shown by Sedelies et al. The fact that the GzmH protein is constitutively 
pressed at high levels in resting NK cells strongly suggests a central role for the protease in innate 
munity.  
terestingly, the Le sion in murine NK 
lls. They showed that, although unstimulated NK cells came pre-loaded with the GzmA protein, 
e 
 
oes granzyme H play a vital role in innate immunity? 
 
specific sites following LAK cell attack. LAK cells (lymphokine activated killers) are lymphokine (IL-
ex
im
 
In y group has recently addressed granzyme and perforin expres
ce
very little GzmB or perforin protein was present despite the cells expressing abundant mRNAs of th
three genes (Fehniger et al., 2007). Once stimulated with cytokines, the minimally cytotoxic NK cells 
became potent killers with increased perforin and GzmB protein. Messenger RNA levels, however, 
remained unchanged. The study suggests that resting murine NK cells are minimally cytotoxic because 
of a block in gene translation that is released following activation, and that NK-receptor ligation 
probably represents the trigger required to direct granule release at the immunological synapse. The
abundant levels of GzmA protein in resting NK murine cells is reminiscent of the high levels of GzmH 
found in unstimulated human NK cells which also contain very little GzmB protein (Sedelies et al., 
2004). Despite the presence of the preloaded GzmA protein, murine NK cells deficient in GzmA, 
target and kill tumors equally as well as their wild-type counterparts (Ebnet et al., 1995). However, 
NK cells from GzmA and GzmB double deficient mice kill less efficiently than NK cells deficient in 
GzmA alone, suggesting that GzmA is a “fail-safe” granzyme, a role that GzmH might also fulfill in 
human NK cells.  
 
D
Our study shows that freshly purified CD3-CD16+CD56+ NK cells also contained low amounts of 
GzmB protein and that, upon stimulation with IL-2, the cells were able to kill K562 cells efficiently at 
a 2:1 effector target ratio (refer to Figure IV.31). As a result, both soluble GzmH and GzmB (data not 
shown) was detectable in the culture supernatant (refer to Figure IV.32). This observation strongly 
suggested the involvement of GzmH during the innate response. Evidence for the delivery of GzmH 
into the cytosol of target cells is, moreover, provided in a collaborative study (Andrade et al. 2007),
showing that an adenovirally transduced protein in the cytosol of K562 cells is cleaved at GzmH 
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2) activated adherent NK and T cells which have enhanced cytolytic activity, and which contain all 
granzyme activities at different ratios (Ortaldo et al., 1986; Phillips and Lanier, 1986). Andrade et al. 
onfirmed the presence of GzmH using the recently described GzmH specific monoclonal antibody  
G5) (Se
he obser tion that resting  hig ly cytotoxic NK cells, which constitute the first line of defence in 
nate imm  and GzmM, and suggests the view that the ex-
rphan hu role te es eo
ve human granzymes each process distinct substrate specificities shown to 
duce ce  caspas penden nners, sheds light on the combinatorial 
echanism tosis pathway to circumvent evasion strategies developed by 
iruses an itially res to one particular granzym ur next task 
es, then, ding the exact extent to whic s are expressed in the 
ifferent subsets of cytotoxic lymphocytes, but also in understanding the individual substrates 
V.6 - GzmH is an antiviral protease 
 work in 
g the double substitution was 
ereafter attempted to directly address the functional consequences of DBP cleavage by GzmH during 
c
(4 delies et al., 2004). 
 
T va , h
in unity, come preloaded with GzmA, GzmH
o man granzymes play critical s in the inna  immune r ponse. Mor ver, the fact that the 
fi  and now have all been 
in ll death in alternative, mostly e-inde t ma
m s used by the granule exocy
v d tumor cells which are in istant or more es. O
li  not only in fully understan h granzyme
d
granzymes have evolved to target.  
 
 
 
 
 
A recent collaborative work with Felipe Andrade demonstrated that granzymes do indeed
synergy to outsmart adenoviral defence strategies. In this work, we discovered the first two biological 
substrates for GzmH, namely the adenoviral DNA binding protein (DBP), and the L4-100K assembly 
protein (100K) which potently inhibits GzmB (Andrade et al., 2001; Andrade et al., 2007). We 
demonstrated that, in target cells infected with adenovirus, in which GzmB and downstream caspases 
are inhibited, GzmH directly cleaves the adenoviral DBP protein. The generation of a mutant 
adenovirus virus that encodes a GzmH resistant DBP protein allowed us to address the functional 
consequences of DBP cleavage by GzmH, an event which is responsible for the decay in viral DNA 
load after effector cell attack.  
 
Site-directed mutagenesis was used to determine the site where GzmH cleaved the IVTT (in vitro 
coupled transcription/translation) generated DBP protein. Initially, Phe 121 was changed to Gly but 
this substitution did not result in DBP cleavage by recombinant GzmH. However, when Met 118 was 
replaced by Val, the generation of the 47 kDa cleaved product (see Figure V.3) was greatly reduced. 
Moreover, when a double mutant containing both substitutions was exposed to GzmH, cleavage was 
completely abolished. The generation of a mutant virus containin
th
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target cell attack. By assaying the quantity of viral DNA load in infected cells at 12 hours, we were 
able to show that, in comparison to cells infected with the wild type adenovirus, the DNA load of the 
mutant virus was minimally affected (refer to Figure V.2) (Andrade et al., 2007). 
 
In experiments using the mutant virus, we found that, after 12 hours, viral DNA replication swiftly 
declined, suggesting that another antiviral force was at work. Because GzmH and GzmB both cleave 
the DBP protein, we wondered whether GzmH might be involved in the inactivation of another 
protein, namely the 100K assembly protein, a recently described GzmB substrate that potently inhibits 
GzmB mediated cell death (Andrade et al., 2001). Interestingly, when 100K, generated by IVTT, was 
preincubated with GzmH, the inhibitor blocked GzmB activity at early time points. At later time 
oints, however, inhibition of GzmB by 100K was lost, allowing the recovery of caspase 3 activation. 
2007). 
p
In conclusion, this work convincingly shows that in the case of GzmB inhibition, GzmH can equally 
contribute to DBP cleavage while also being able to relieve GzmB from inhibition by 100K protein. It 
remains to be seen, however, if granyzmes other then GzmH aid in the cleavage of the 100K protein 
and recovery of GzmB activity. It is necessary to point out though that our study did not include the 
generation of an adenovirus encoding both DBP and 100K GzmH resistant proteins. Nevertheless, this 
study identifies the first evidence that granzymes do indeed work in synergy to overcome viral 
defences involved in blocking granzyme function. Furthermore, the study also sheds light not only on 
the amino acids after which GzmH prefers to cleave in vivo, here Met118, but also opens our eyes to 
putative P4 to P4’ sequences preferred by GzmH.   
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
Figure V.2 - Adenovirus DNA replication and cleavage of DBP during LAK-mediated cell death. Wild-type 
(AD5wt) and mutant (Ad5DBP) adenoviruses were co-incubated in the absence (control) or presence of LAK   
cells at a effector:target ratio of 8:1. After 12 and 24 hours, genomic DNA was purified and the DNA viral load 
quantified by real-time PCR as described (see paper). Values are shown as percentages in which 100% 
represents the total viral DNA load in control, non treated cells at 12 or 24 h. The error bars represent the 
standard deviation. Taken from a study by Andrade et al. entitled “GzmH destroys the function of critical 
adenoviral proteins required for viral DNA replication and granzyme B inhibition”, EMBO J. (Andrade et al., 
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Figure V.3 - DBP is cleaved by GzmH in vitro. (A) GzmH cleavage sites in DBP were defined by mutating P1 
residues Phe 121 to Gly, Met 118 to Val and in a double mutation, Phe 121 to Gly and Met 118 to Val. Wild-
type and the mutated [35S] methionine
37°C. The 47 kDa bands are the produ
-labelled products were incubated with or without GzmH for 60 min at 
ct of GzmH action upon the DBP protein. The minor bands that appear 
elow the 47 kDa cleavage product are minor DBP fragments. (B) Schematic representation of the functional 
omains and the GzmB and H cleavage sites in DBP. DBP consists of a N-terminal domain (NH2) containing 
sidues 1-173 and a C-terminal domain (COOH) from residues 174 to 529. The N-terminal domain contains 2 
uclear localization signals (N) and a host range (hr) region. The anti-DBP monoclonal antibody recognizes 
residues 131-174 (Cleghon et a elipe Andrade and colleagues 
ntitled “GzmH destroys the r viral DNA replication and 
zmB inhibition”. EMBO Journal 2007 (Andrade et al., 2007).  
y variable 
umber of paralogous genes were identified in the region bordered by cathepsin G and GzmB. No 
be the result of a recen
b
d
re
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l., 1993). Taken from a work in collaboration with F
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V.7 - Human and mice granzymes 
 
 
The five human granzyme genes (GZMA, GZMB, GZMH, GZMK and GZMM) are clustered on three 
different chromosomes (Trapani and Smyth, 2002). GzmB and GzmH share high structural homology 
(71% amino acid identity) and belong to a tightly linked gene cluster (GzmB cluster) on chromosome 
14, which also harbors cathepsin G and mast cell chymase. Despite their high sequence homology 
both enzymes bear very distinct enzymatic activities. In the rodent GzmB cluster, a highl
n
structure activity relationships have so far been determined experimentally. Molecular modelling has 
predicted that the orphan murine granzymes D, E, F and G, but not GzmC which lies directly upstream 
and adjacent to murine GzmB on its 5’ side, will cleave after Phe similarly to GzmH in humans 
(Grossman et al., 2003; Kam et al., 2000). The GzmH gene has been shown to t 
intergenic recombination event between a chymase-like ancestor and GzmB (Haddad et al., 1991). 
Since this gene conversion occurred in the primate lineage after mammalian radiation, a genuine 
ortholog with conserved substrate specificity is unlikely to exist in rats and mice. 
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Leukocyte subset  GzmC GzmD  GzmE GzmF GzmG 
Resting CD4+ Tcells  - - - - - 
Activated CD4  Tcells + + + + + +
 
Table V.2 – Relative levels of murine orphan granzyme gene expression. +/++/+++, relative RNA expression; 
-, none detected; blank, not determined; LAK, lyphokine activated killer; GMG, granulated metrial gland. Table 
adapted from the following works: (Grossman et al., 2003; Jenne et al., 1988b; Jenne et al., 1988a; Jenne et al., 
1989; Jenne et al., 1991; Mullbacher et al., 1999; Pham et al., 1996) 
 
 
Human and murine granzyme expression in cytotoxic lymphocytes 
Our study on GzmH cytotoxicity shows that naïve NK (CD3-, CD56+) cells are the major GzmH 
expressing lymphocyte population, confirming recent findings by Sedelies and colleagues. Whether 
granzymes D, E, F or G, the potential candidates fo
Resting CD8+ Tcells  - - - - - 
Activated CD8+ Tcells + + + + + +  + + 
CTL cell line + + + + + + + + +  + + + 
NK cell lines + + + + + + 
GMG cells  + + + + 
LAK cells  + + + + + + + + + 
Thymocytes - cultured + + + + + + + + +  +  
Thymocytes - cell line +     
Activated B cells + - - - - 
Activated macrophages  - - - - - 
r a genuine GzmH homolog in mice, are also 
 expressed at the protein level in unstimulated NK cells remains to be clarified. However, 
everal studies have examined the mRNA expression pattern of murine orphan granzymes in a variety 
f different cell types, relying on northern blots, RNA protection assays, and/or RT-PCR analysis, to 
efine the cellular expression patterns. The results of these studies are summarized in Table V.2 
arcia-Sanz et al., 1990; Jenne et al., 1988b; Jenne et al., 1988a; Jenne et al., 1989; Jenne et al., 1991; 
acIvor et al., 1999; Pham et al., 1996). The majority of studies suggest that high-level expression of 
urine orphan granzymes is restricted to unstimulated LAK cells, NK cell lines, a subset of NK cells 
nown as granulated metrial gland (GMG) cells, and thymocytes. In T cells (both CD4+ and CD8+), 
 expression of most orphan granzymes is activation-dependent and is much lower than that of 
zmA or GzmB (refer to Table V.2).  
mainly
s
o
d
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M
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The systematic knockout of individual granzymes genes, including the remaining murine orphan 
group (granzymes D, E, F, G, K and M), should allow the thorough analysis of their individual 
functional importance. Because mice do not have a single GzmH ortholog, the identification of the 
closest functional GzmH equivalent among the various paralogs is essential for the design of 
appropriate knockout studies.  
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GzmA-/GzmB- deficient mice  
 vitro cytotoxicity assays, using immune effector cells from GzmA- or GzmB-deficient mice, have 
dicated that GzmB, but not GzmA, is required for the fast and efficient induction of target-cell 
optosis (Ebnet et al., 1995; Heusel et al., 1994; Shresta et al., 1995), although GzmA can 
mpensate for GzmB deficiency with delayed kinetics (Shresta et al., 1999). Moreover, effector cells 
eficient in both GzmA and GzmB have been reported to be as defective as perforin null cells in 
totoxicity (Mullbacher et al., 1999; Shresta et al., 1999; Simon et al., 1997). 
and colleagues report that their GzmA-/GzmB- mice were as incapable as 
erforin null mice of controlling primary infections by the natural mouse pathogen ectromelia, a 
oxivirus.  
terestingly, the original GzmB-deficient mice (which were a mixed B6/129 background) were later 
TLs from GzmB-cluster and GzmB-null mice show that GzmB-cluster deficient mice have a more 
vere defect in the cytotoxicity of their effector cells compared to those derived from GzmB null 
mice (Davis et al., 2001; Re house et al., 2006). Indeed, 
aterhouse and colleagues demonstrated that murine GzmA-/GzmB- deficient CTLs induced cell 
In
in
ap
co
d
mediating target-cell cy
For instance, Mullbacher 
p
p
 
In
found also to have downregulated expression of the downstream orphan granzymes, C, D, E, F and G 
owing to a neighborhood effect caused by retention of a PGK-Neo cassette in the GzmB gene (Pham 
et al., 1996). These mice are, therefore, more accurately described as GzmB-cluster-deficient mice 
which had previously been crossed with GzmA-null mice to produce GzmA and GzmB double 
knockouts. Subsequent generation of the same mutation on a pure 129/SvJ background revealed 
restriction of the neighbourhood effect to granzymes C and F. Furthermore, removal of the PGK-Neo 
cassette eliminated this effect, resulting in mice deficient only in GzmB. Recent studies comparing 
C
se
vell et al., 2005; Smyth et al., 2003; Water
W
death in a different manner to their wild-type counterparts or target cell death by perforin mediated 
lysis. Indeed, CTLs from GzmA-/GzmB- mice induced a novel form of programmed cell death (PCD) 
which shared similar features with, but was distinct from, apoptosis. Although, overall, the 
morphology of cell death in response to GzmA and GzmB null CTLs was similar to classic apoptosis, 
the simultaneous staining of Annexin V, and PI was reminiscent of perforin lysis. Additionally, PS 
externalization occurred, in parallel to the loss of membrane integrity, suggesting that these cells 
would not be efficiently engulfed by macrophages and, thus, may be perceived by the immune system 
as having undergone necrosis. Also, no DNA fragmentation was observed, which is typical of the 
actions of GzmB (Waterhouse et al., 2006). Taken together, these studies suggest that the murine 
orphan granzymes encoded in the GzmB-cluster might well play an essential role in effector-cell 
cytotoxicity.     
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Recently, GzmC, GzmK, GzmH and GzmM have been shown to be proapoptotic when delivered into 
targe ean sloc llow  2007 n e 3; Lu 
et al 7b; Zhao et al., 2007a). erefore, c  death ind ed by CTL
cells mA and G mB may not only be caused by perforin-mediated delivery 
of th granzymes any of , are pr cted to e after 
phen lso by granzymes K M.  
  
As p ntioned, in a collaborative work with Felipe Andrade, we rec ly demon  
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ritical in the control of the  o rp  (
2
important for regulating the early form (16 days post infection, dpi) of γHV68 latency. Additionally, 
GzmA-/GzmB- mice (which are not affected by the downregulation of downstream granzymes C, D, E, 
F
suggesting that at this stage only orphan granzymes are required. Perforin-
viral latent infection at both early and late time points. Importantly, GzmB-cluster knockout mice were 
used to demonstrate the role the murine orphan granzymes, but not granzymes K and M, had on 
regulating γHV68 latent infection. The authors were unable to determine which specific granzymes 
were responsible since mice deficient for individual orphan granzymes were not available, but were 
able to rule out caspase 3 activation. The study suggests that the requirement for specific granzymes 
differs for early versus late forms of latent infection, and that different granzymes play distinct roles in 
regulating γHV68 infection.   
 
Understanding the exact mechanisms by which GzmA-/GzmB- CTLs kill their targets will be 
important in furthering our knowledge of how effector cell-induced target cell killing helps prevent 
infection. Also, such studies will help unmask the key granzymes, other than GzmA and GzmB, in 
maintaining the relatively healthy immune status of GzmA-/GzmB- mice compared with perforin-
deficient mice. 
 
I
GzmH-induced cell death displayed several features which are reminiscent of murine GzmC 
cytotoxicity, although, on a molar basis, the kinetics of cell death of the murine protease showed 
greater similarity to those observed for GzmB (Johnson et al., 2003). Indeed, after 12 hours of GzmH 
exposure (1 µM), but not before 4 hours, K562 cell nuclei appeared condensed and fragmented, a feat 
achieved by GzmC after only 1
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of phosphatidyl serine (PS) and lack of initiator and effector caspase activation. Furthermore, the 
human GzmB (see Figure IV.23). Interestingly, a feature that was not observed in the case 
f GzmH was the direct swelling and membrane depolarization seen in isolated mitochondria exposed 
nce transfer from the adjacent GzmB locus to the ancestral GzmH locus 
o 142, similarity between human GzmH and human GzmB is very high. 
morphological changes of cellular nuclei were paralleled by the loss of mitochondrial membrane 
potential. As expected, zVAD-FMK did not prevent the loss of membrane potential following 
exposure to both GzmC and GzmH, with only a moderate protecting effect observed during the later 
stages in the case of GzmH mediated cell death (Fellows et al., 2007).  
 
Additionally, both proteases are similar in that, during their respective cell death pathways, neither of 
the enzymes caused the release of the smallest of the mitochondrial inter-membrane space proteins 
(MIMPs), namely cytochrome c. Cytochrome c release is an event which marks the actions of both 
murine and 
o
to recombinant GzmC. Although we set out to investigate whether the direct addition of GzmH or 
GzmB to freshly isolated and energized mitochondria from mouse liver would induce potential loss, 
no effect was seen as monitored by decrease in rhodamin 123 fluorescence. The addition of the toxin 
valinomycin/oligomycin did, however, easily induce ΔΨm loss. In conclusion, although murine GzmC 
and GzmH share many of the same cell death hallmarks, substrates involved in their respective 
cytotoxic pathways have yet to be uncovered. Despite the above similarities, comparing the nature of 
the function relationship between these proteases in a convincing manner is a difficult issue, as activity 
for GzmC has not been found. It is interesting to note, however, that GzmH shares more key amino 
acids, predicted to influence cleavage specificity, with murine granzymes D and E (see Figure V.4).   
 
GzmH homologs from different placental mammals 
The biological importance of the human GzmH gene is underscored by the fact that structural 
equivalents exist in all placental mammals. Primates like chimps and macaques, but also dogs and 
rabbits possess a single copy GzmH gene on the 5’ side of the GzmB gene. The structural hallmarks of 
all GzmH homologs are Thr (Ser, Ala)189, Lys (Arg)192 and Gly226 which determine the S1 subsite 
and Phe99 affecting S2 (see Figure V.5). GzmB homologs of all these species differ from GzmH by 
Arg226, but otherwise are identical with GzmH at positions 192 and 99 (see Figure V.4). Indeed, 
replacement of Arg226 by Gly226 converted human GzmB into a GzmH-like variant which cleaved 
Suc-Ala-Ala-Pro-Phe-SBzl and Boc-Ala-Ala-Phe-SBzl like the wild type GzmH (Caputo et al., 1994).  
 
GzmH-like equivalents have not yet been identified unambiguously in the genomes of rodents (rats, 
mice) and artiodactyls (cattle). Local gene duplications and conversions generated a highly diverse and 
much greater repertoire of paralogous genes in these species (Gallwitz et al., 2006; Haddad et al., 
1991). Owing to a seque
affecting residues 63 t
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Likewise, the mouse GzmC ancestor, which had already branched off from the GzmD-G precursor, 
was converted by adjacent GzmB sequences, but differently and independently in the rodent lineage 
(Haddad et al., 1991). The relatively high similarity between murine GzmC and GzmH (61% amino 
acid identity) and their immediate vicinity to the GzmB gene in the human and murine genome 
strongly suggests that GzmH is the human counterpart of murine GzmC.  
 
 
Figure V.4 - GzmH homologs from different placental mammals. Alignment of known and predicted amino 
acid sequences for GzmH homologs; hs, homo sapiens; pt, pan troglodytes, mul, macaca mulatta, oc, oryctolagus 
cuniculus, cf, canis familiaris, bt, bos taurus, rn, rattus norvegicus, mm, mus musculus. The numbering is 
according to bovine chymotrypsinogen A (btCtra) shown at the bottom. Conserved critical residues that 
determine the substrate specificity of GzmH at the first (P1) and second position (P2) N-terminal to the cleaved 
peptide bond are boxed. 
 
 
Predictive structure-function comparisons, however, indicate that the murine GzmD, GzmE and the rat 
functional homologs of human granzyme RNKP-7, in addition to GzmC, should be considered as 
GzmH. In GzmD and GzmE, the key residues at positions 99 (His in RNKP-7), Lys-192 and Gly-226 
are conserved, but not in mouse and rat GzmC. Suc-Phe-Leu-Phe-SBzl specific activity has indeed 
been reported to be involved in rat natural killer cell mediated killing (Woodard et al., 1994), but this 
peptidolytic activity has not been experimentally linked to the activity of purified rat GzmC which is 
 - 124 -
 Discussion 
____________________________________________________________________________ 
predicted to cleave after asparagine or serine at the P1 position (Barry and Bleackley, 2002; Trapani, 
2001). Interestingly, like GzmH, recombinant GzmD (R&D systems) is predicted, along with murine 
granzymes E and G, to cleave after bulky, aromatic amino acids such as phenylalanine at the P1 site 
and is, indeed, active against Suc-Phe-Leu-Phe-SBzl. To see if this recombinant murine GzmD could 
induce apoptosis in a similar fashion to GzmH, we analyzed GzmD-exposed K562 cells after 12 and 
f 
roteolytic events in the cytosol of target cells is most likely to be distinct for each granzyme, and may 
24 hours by FACS after annexin V FITC and PI staining. Unfortunately, nothing came of these 
experiments. A personal communication from R&D systems informed us that two thirds of the 
purified GzmD possessed N-terminal sequences starting with HVVKPHS instead of the correct 
sequence IIGGHVVKPHS. Consequently, only a third of the proteases in the preparation would be 
active, Ile16 having correctly formed a salt bridge with the carboxylate side chain of Asp194, so 
initiating the formation of the mature, active protease through conformational change. As substrate 
specificities and cleavage activities of purified GzmC and Gzms D to G have not yet been strictly 
determined, it remains to be proven whether any of the rodent granzymes fulfil the same molecular 
functions as human GzmH.  
 
Interestingly, although the chain of cause and effect has not yet been reconstructed for any of the 
known granzymes, cytotoxic activities of GzmA, GzmB, GzmH, GzmK and murine GzmC appear to 
converge and culminate in irreversible mitochondrial damage. Mitochondrial damage was observed 
with all of these granzymes in the absence of caspase activation, despite the broad diversity in 
cleavage specificities with chymase-, tryptase- and caspase-like activities. Thus, the initial chain o
p
hit on different cell death pathways.  
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VI - Conclusions and Outlook 
 
 
Because activated CD3-CD16+CD56+ NK cells express the strongly proapoptotic GzmA and GzmB 
along with perforin (Bade et al., 2005; Bratke et al., 2005; Grossman et al., 2004), the other granzymes 
of NK cells, namely GzmH, GzmK and GzmM, have until recently received little attention as genuine 
cell death inducing effector proteases. Several studies, however, conclude that granzymes may 
possibly be involved in a number of extra-cellular activities. Indeed, GzmA (Kramer and Simon, 
1987) and GzmB (Buzza et al., 2005) have been suggested to play a role in matrix remodeling and 
killer cell migration at the site of target cell attack. Similar extracellular functions may easily be 
envisaged for the cathepsin G-related GzmH. Hence, it was also important to explore the death-
inducing potential of the last true orphan of the granzyme family by means of a well-controllable 
delivery system. Our findings clearly indicate the importance of GzmH as a novel, alternative 
cytotoxic effector protease. Although we were unable to find a cell-death related substrate for GzmH, 
our study is strongly suggestive of target cell death defined by not only caspase independent apoptotic-
like morphology, but also caspase independent damage inflicted upon DNA and mitochondria. This 
initial study on the cell-death inducing properties of GzmH is most reminiscent of human GzmA, but 
also murine GzmC triggered cytotoxicity.  
 
The biological value and niche of GzmH, which was added to the arsenal of natural killer cells late 
during mammalian evolution, have just begun to be deciphered. Once clarified, however, they will 
contribute to a broader understanding of NK cell function, not only in tumour elimination and viral 
clearance, but also as a regulator of inflammation and tissue repair (Zong and Thompson, 2006). 
Indeed, together with Andrade and colleagues, we recently demonstrated the anti-adenoviral activity 
f both GzmB and GzmH (Andrade et al., 2007) thereby providing the first evidence that granzymes 
 peptide technologies, who offer a protease substrate set consisting of a 
lection of 360 peptides, we will attempt to better decipher the protease’s cleaving specificity, and 
o
can act in synergy to outflank viral defenses.  
 
These initial studies set the scene for GzmH as an important protease in innate immunity, while also 
setting the foundations for exciting further work on this chymotrypsin-like protease. Indeed, in 
ollaboration with JPTc
se
also cytotoxicity, by searching for GzmH specific substrates. These peptide derivatives contain the 
cleavage site sequences from P4 to P4’ and are flanked by DABCYL and Glu(EDANS)-amide 
moieties at the N and C-termini respectively. Therefore, upon incubation with GzmH, cleavage of any 
of the given sequences between the fluorophore and the quencher moiety will be detected using a 
microtiter fluorescence reader.  
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The search for cell-death related GzmH substrates has prompted us to attempt the structural analysis of 
the chymotrypsin-like enzyme in collaboration with Wolfram Bode from the MPI of Biochemistry, 
Martinsried. Our recombinant, non-glycosylated GzmH appears to be a perfect candidate for 
crystallization, not only because we are able to produce high quantities of inclusion body based 
protease, but also because pure recombinant GzmH lacks N-linked carbohydrates which facilitates 
crystallization. N-linked glycosylation can hinder crystallization because of its bulkiness, flexibility 
and heterogeneity. The three-dimensional crystal structure of active GzmH would be an extremely 
helpful tool in our efforts to understand better the protease’s overall structure, its substrate specificity 
(and therefore aid in the search for GzmH specific substrates) and to develop highly specific 
inhibitors. 
 
As a last remark, since the animal models of choice, namely the mouse or rat, do not possess a 
function equivalent to the human GzmH gene, functional studies on GzmH by knock-out methodology 
are not possible. As we learn more about the specificity of GzmH, either through the manipulation of 
nthetic peptides, the use of peptide substrate libraries,s or the discovery of novel protein substrates sy
such as DBP and 100K, the design of tailored GzmH inhibitors will dramatically improve our 
understanding of GzmH function. Indeed, specific inhibitors against the enzyme will allow us to study 
its biological importance in cell death induction and in the mechanisms of granzyme-pathogen 
interaction.
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VIII - Abbreviations and Initialisms 
 
 
A 
A 
a.a 
A.A   Acrylamide 
AFC 
AMC 
ATP 
AV  
Bid ain death agonist 
bp 
C 
CG 
CD 
CTH 
CTL 
Cyt.c   Cytochrome c 
DBP 
DCI 
DHE  
DTE 
DTT 
DMSO 
EDTA 
FACS 
FBS 
FCS   Fetal Calf Serum 
FMK 
FPLC    Fast Protein Liquide Chromatography 
ΔΨ   Membrane potential  
ε                                      Absorption coefficient   
  Absorbance 
  Amino acid 
Ab   Antibody 
  7-Amino-3-trifluoromethylcoumarine 
  7-Amino-4-Methylcoumarin  
  Adeninetriphosphate 
 Annexin V 
B 
b   path length  
  BH3 interacting dom
t-Bid   Truncated Bid 
BSA   Bovine Albumin  
  Base pair 
c   concnetration 
CAD / ICAD  Caspase activated DNase / Inhibitor of CAD 
  Cathepsin G  
  Cluster of Differenciation 
cDNA   Complementary DNA  
CML   Chronic Myelogenous Leukemia 
  Chymotrypsin 
  Cytotoxic Lymphocyte 
D 
  DNA Binding Protein  
  3,4-Dichloroisocoumarin 
 Dihydroethidium, hydroethidine 
DNA   Desoxyribonucleic acid  
DPPI   Dipeptidyl-peptidase I 
  Dithioerytritol    
  Dithiothretiol 
DTNB   5,5’-Dithio-bis(2-Nitrobenzoeacid  
dNTP   Deoxynucleotide triphosphates  
  Dimethyl sulfoxide 
E 
E   Enzyme  
  Ethylenediamine tetraacetic acid 
ELISA   Enzyme-linked immunosorbant assay 
F 
  Fluorescence-Activated Cell Sorter 
  Fetal Bovine Serum 
FITC   Fluorescein (reactive isothiocyanate form)    
  Fluoromethyl ketone 
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G 
GdmCl  
GSH   Glutathione (reduced) 
H202 
HL60 
HPLC 
I 
IB y 
J 
JC-1 -1,1′,3,3′-tetraethylbenzimidazolyl-carbocyanine iodide 
K 
kDa 
L 
LB   Luria-Bertani (medium) 
ME 
MES 
K 
P-40   Nonidet P-40 
 
D   Optical Density 
OMe   Esterified 
P 
p   Fragment 
PAGE   Polyacrylamide Gel Electrophoresis  
PBMC   Peripheral blood mononuclear cells 
PBS   Phosphate Buffered Saline  
PBS-T   Phosphate Buffered Saline - Tween 
PCD   Programmed Cell Death  
PCR   Polymer Chain Reaction  
PEG   Polyethylenglycol  
PFN   Perforin  
PI   Isoelectric Point / Propidium Iodide 
PMSF   phenylmethanesulphonylfluoride 
pNA   Paranitroanilid  
PS   Phosphytidyl serine 
PS-SCL  Postion  scanning synthetic combinatorial libraries 
PVDF   Immunobilon-PSQ 
RF   Refolding  
ROS   Reactive oxygen species 
RNA   Ribonucleic acid  
RNase   Ribonuclease  
  Guanidinium chloride 
GSSH   Glutathione (oxydised) 
H 
  Hydrogen peroxcide  
  Human caucasian promyelocytic leukaemia cell line 
  High Pressure Liquide Chromatography  
HRP   Horseradish Peroxydase  
I 
  Inhibitor 
  Inclusion Bod
IL-2   Interleukin-2 
IPTG   Isopropyl-ß-D-thiogalaktosid 
  5,5′,6,6′-tetrachloro
K562   Erythroleukemia cell line 
  Kilodaltan 
M 
  β-Mercaptoethanol 
  2-Morpholinorthansulphonic acid  
MIMP   Mitochondiral Inter-Membrane-space Protein 
MMP   Mitochondrial Membrane Permeability 
N 
NFPM   Non Fat Powered Milk 
  Natural Killer (cell) N
N
O
O
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rpm   
PMI   
T   Room Temperature 
cyl Sulphate  
f variegation, enhancer of zeste and Trithorax 
 
ethylendiamin  
amethylbenzidine 
)aminomethan 
te lymphoma cell line 
     
Revolutions per minute 
Roswell Park Memorial Institute R
R
S 
SB   Solubilisation  
SD   Standard Deviation 
SDS   Sodium Dode
SBzl   Thioester 
SET   ppr ssor oSu e
SLO   Streptolysin O
Suc   Succinyl  
T 
T Annealing temperature m   
TEMED  N,N,N’,N-Tetraethylm
TM
Tri
B   3,3’,5.5’-tetr
s   Tris(hydroxymethly
U 
U   nit U
U937   Human leukemic monocy
V 
V 
W 
   Volt  
WT   Wild type    
Z 
Z   Benzyloxycarbonyl
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IX - Appendix 
 - r T24c(+) vector contains kanamycin resistance. Unique 
onvention, so that the T7 
of the coding strand 
r to the Novagen pET-24a-d(+) vectors for full 
E +) constructed by cloning the MKH6 codon sequence  
he l I s cleaved at restriction sites Nde I and 
zmH NA w ectly upstream from the MKH6 tag, into the Pml I and Hind 
pET24c(+)MKH6  ection).   
 
 
Figure VIII.1  Vecto  pET-24c(+). The pE
sites are shown on the map. The sequence is numbered by the pBR322 c
cloning/expression region expression region is reversed on the map. The 
 T A  is shown. Refetranscribed by 7 RN  polymerase
 p (details. The T24c MKH6GzmH vector was 
 multiple cloning site, (introducing t Pm ite) into the vector’s
 dirBam HI. G cD as then cloned,
III (173) cut vector (see results s
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Figure VIII.2 - Human granzyme H (GzmH) nucleic- and amino-acid sequences in pET24c(+). 
The amino acid sequence is displayed in the single letter code, each representive letter positioned 
under the middle nucleic acid of each codon. The MKH6 tag is not included but would preceed the 
mature N-terminus sequence Ile-Ile-Gly-Gly. The amino acids in bold are conserved critical residues 
(bovine chymotrypsinogen A numbering) that determine the specificity of GzmH at the P1 (Thr189, 
Gly216 and Gly226) and P2 (Phe99) postitons. Also highlighted are the three residues that constitute 
the catalytic triad (His57, Asp102 and Ser195). Ile16 is marked in bold as once the MKH6 tag is 
removed, it proceeds to form a salt bridge with Asp194. The numbering above the cDNA sequence 
applies to the first nucleic acid of the codon. The red letters designate the nucleic acids after which 
restriction enzymes Eco RV (5’-End) and Hind III (3’-End) cut respecitively. The stop codon is 
marked by a dash ( - ).       
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